[
  {
    "id": "Medical-422500d5",
    "source": "Medical",
    "question": "Which anatomical locations are most commonly affected by basal cell carcinoma?",
    "answer": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas.",
      "Common sun-exposed areas for BCC include the face.",
      "Common sun-exposed areas for BCC include the head.",
      "Common sun-exposed areas for BCC include the neck."
    ],
    "evidence_relations": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck"
  },
  {
    "id": "Medical-5ad931db",
    "source": "Medical",
    "question": "How does fair skin affect the risk of developing BCC?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fair skin increases the risk of BCC."
    ],
    "evidence_relations": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-ec091b24",
    "source": "Medical",
    "question": "Is immune suppression a risk factor for BCC?",
    "answer": "Immune suppression is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immune suppression is a risk factor for BCC."
    ],
    "evidence_relations": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-88c0b2ba",
    "source": "Medical",
    "question": "Which diagnostic methods are used for BCC?",
    "answer": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of BCC involves medical history.",
      "Diagnosis of BCC involves family history.",
      "Diagnosis of BCC involves a physical exam.",
      "Diagnosis of BCC involves a skin exam.",
      "Diagnosis of BCC involves a biopsy.",
      "Diagnosis of BCC may involve imaging."
    ],
    "evidence_relations": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-ec7d8801",
    "source": "Medical",
    "question": "When might radiation therapy be used in BCC?",
    "answer": "Radiation therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy may be used in some cases of basal cell carcinoma."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-6884d3fa",
    "source": "Medical",
    "question": "What does follow-up for BCC typically include?",
    "answer": "Follow-up includes full skin exams with a doctor at least once a year.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for basal cell carcinoma includes full skin exams with a doctor.",
      "Follow-up for basal cell carcinoma occurs at least once a year."
    ],
    "evidence_relations": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-5f2cb8a5",
    "source": "Medical",
    "question": "Which systemic therapy may be considered for BCC?",
    "answer": "Systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Systemic therapy may be used in some cases of BCC."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-e3923e5f",
    "source": "Medical",
    "question": "Can BCC spread to lymph nodes?",
    "answer": "BCC recurrence can involve spread to lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCC recurrence can involve spread to lymph nodes."
    ],
    "evidence_relations": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-941c0004",
    "source": "Medical",
    "question": "Which anatomical locations are most commonly affected by BCC?",
    "answer": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas.",
      "Common anatomical locations affected by BCC include the face.",
      "Common anatomical locations affected by BCC include the head.",
      "Common anatomical locations affected by BCC include the neck."
    ],
    "evidence_relations": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck"
  },
  {
    "id": "Medical-acec9fa2",
    "source": "Medical",
    "question": "How does fair skin affect the risk of basal cell carcinoma?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fair skin increases the risk of BCC."
    ],
    "evidence_relations": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-624c452d",
    "source": "Medical",
    "question": "What diagnostic methods are used for BCC?",
    "answer": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of BCC involves medical history.",
      "Diagnosis of BCC involves family history.",
      "Diagnosis of BCC involves a physical exam.",
      "Diagnosis of BCC involves a skin exam.",
      "Diagnosis of BCC involves a biopsy.",
      "Diagnosis of BCC sometimes involves imaging."
    ],
    "evidence_relations": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-bc412bb6",
    "source": "Medical",
    "question": "When might radiation therapy or systemic therapy be used for BCC?",
    "answer": "Radiation therapy or systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy may be used in some cases of BCC.",
      "Systemic therapy may be used in some cases of BCC."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-cef34fff",
    "source": "Medical",
    "question": "Which exams are essential for diagnosing BCC?",
    "answer": "Physical exam and skin exam are essential for diagnosing BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Physical exam is essential for diagnosing BCC.",
      "Skin exam is essential for diagnosing BCC."
    ],
    "evidence_relations": "Physical exam, Skin exam"
  },
  {
    "id": "Medical-3e18a314",
    "source": "Medical",
    "question": "What treatments are available for BCC besides surgery?",
    "answer": "Radiation therapy and systemic therapy are treatments for BCC besides surgery.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy is a treatment for BCC besides surgery.",
      "Systemic therapy is a treatment for BCC besides surgery."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-74440a6a",
    "source": "Medical",
    "question": "What is included in annual follow-up for BCC patients?",
    "answer": "Annual follow-up includes a full skin exam.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Annual follow-up for BCC patients includes a full skin exam."
    ],
    "evidence_relations": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-a296a86b",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this context?",
    "answer": "Primary CNS lymphoma is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary CNS lymphoma is the primary cancer type."
    ],
    "evidence_relations": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system"
  },
  {
    "id": "Medical-b3c430ef",
    "source": "Medical",
    "question": "Name a cancer subtype of primary CNS lymphoma that affects the eyes.",
    "answer": "Vitreoretinal lymphoma is a subtype that affects the eyes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Vitreoretinal lymphoma is a subtype of primary CNS lymphoma.",
      "Vitreoretinal lymphoma affects the eyes."
    ],
    "evidence_relations": "Vitreoretinal lymphoma is a cancer subtype of primary CNS lymphoma that affects the eyes, retina, and vitreous"
  },
  {
    "id": "Medical-473eae59",
    "source": "Medical",
    "question": "Name two autoimmune conditions listed as risk factors for primary CNS lymphoma.",
    "answer": "Autoimmune disease and lupus are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Autoimmune disease is a risk factor for primary CNS lymphoma.",
      "Lupus is a risk factor for primary CNS lymphoma."
    ],
    "evidence_relations": "Risk Factor includes Autoimmune disease, Lupus"
  },
  {
    "id": "Medical-e306413c",
    "source": "Medical",
    "question": "Which laboratory test is commonly used during the diagnosis of primary CNS lymphoma?",
    "answer": "Complete blood count (CBC) is commonly used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complete blood count (CBC) is commonly used during the diagnosis of primary CNS lymphoma."
    ],
    "evidence_relations": "Laboratory Tests include Complete blood count (CBC)"
  },
  {
    "id": "Medical-64ef6350",
    "source": "Medical",
    "question": "What is a typical initial clinical assessment for suspected primary CNS lymphoma?",
    "answer": "A neurological exam is a typical initial clinical assessment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A neurological exam is a typical initial clinical assessment for suspected primary CNS lymphoma."
    ],
    "evidence_relations": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture"
  },
  {
    "id": "Medical-e05d0922",
    "source": "Medical",
    "question": "Which procedure is performed if cancer cells are found in the cerebrospinal fluid?",
    "answer": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid."
    ],
    "evidence_relations": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid"
  },
  {
    "id": "Medical-1c1492e7",
    "source": "Medical",
    "question": "What specialized treatment is given if the eyes are involved in primary CNS lymphoma?",
    "answer": "Intraocular chemotherapy or radiation may be used if the eyes are involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intraocular chemotherapy or radiation may be used if the eyes are involved in primary CNS lymphoma."
    ],
    "evidence_relations": "Intraocular chemotherapy or radiation may be used if the eyes are involved"
  },
  {
    "id": "Medical-3978515f",
    "source": "Medical",
    "question": "What are the two main treatment phases for primary CNS lymphoma?",
    "answer": "Treatment is typically given in phases: induction and consolidation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment for primary CNS lymphoma is typically given in phases.",
      "The two main treatment phases for primary CNS lymphoma are induction and consolidation."
    ],
    "evidence_relations": "Treatment is typically given in phases: induction and consolidation"
  },
  {
    "id": "Medical-a4081e18",
    "source": "Medical",
    "question": "Which performance measure is evaluated to guide treatment decisions in primary CNS lymphoma?",
    "answer": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is evaluated to guide treatment decisions.",
      "Performance status is evaluated to determine eligibility for clinical trials."
    ],
    "evidence_relations": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials"
  },
  {
    "id": "Medical-c99256ce",
    "source": "Medical",
    "question": "Name three neurological symptoms commonly caused by primary CNS lymphoma.",
    "answer": "Leg weakness, confusion, and seizures are common neurological symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Leg weakness is a common neurological symptom caused by primary CNS lymphoma.",
      "Confusion is a common neurological symptom caused by primary CNS lymphoma.",
      "Seizures are a common neurological symptom caused by primary CNS lymphoma."
    ],
    "evidence_relations": "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes"
  },
  {
    "id": "Medical-7b5a8ac6",
    "source": "Medical",
    "question": "Which diagnostic method is used to assess eye involvement in primary CNS lymphoma?",
    "answer": "Eye exam is used to assess eye involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Eye exam is used to assess eye involvement in primary CNS lymphoma."
    ],
    "evidence_relations": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture"
  },
  {
    "id": "Medical-f619b6ea",
    "source": "Medical",
    "question": "What is the role of corticosteroids in the treatment of primary CNS lymphoma?",
    "answer": "Corticosteroids are one of the treatment options for primary CNS lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Corticosteroids are one of the treatment options for primary CNS lymphoma."
    ],
    "evidence_relations": "Treatment options for primary CNS lymphoma include corticosteroids, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell rescue, and supportive care"
  },
  {
    "id": "Medical-9474c5bb",
    "source": "Medical",
    "question": "Which chemotherapy drugs, besides methotrexate, can be used in induction therapy for primary CNS lymphoma?",
    "answer": "Temozolomide, vincristine, procarbazine, cytarabine, pemetrexed, pomalidomide, lenalidomide, and ibrutinib can be used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Temozolomide can be used in induction therapy for primary CNS lymphoma.",
      "Vincristine can be used in induction therapy for primary CNS lymphoma.",
      "Procarbazine can be used in induction therapy for primary CNS lymphoma.",
      "Cytarabine can be used in induction therapy for primary CNS lymphoma.",
      "Pemetrexed can be used in induction therapy for primary CNS lymphoma.",
      "Pomalidomide can be used in induction therapy for primary CNS lymphoma.",
      "Lenalidomide can be used in induction therapy for primary CNS lymphoma.",
      "Ibrutinib can be used in induction therapy for primary CNS lymphoma."
    ],
    "evidence_relations": "Induction phase includes High-dose methotrexate, Rituximab, Temozolomide, Vincristine, Procarbazine, Cytarabine, Pemetrexed, Pomalidomide, Lenalidomide, Ibrutinib, Clinical trial"
  },
  {
    "id": "Medical-5825991f",
    "source": "Medical",
    "question": "Which procedure is included in laboratory tests for diagnosing primary CNS lymphoma?",
    "answer": "Lactate dehydrogenase (LDH) testing is included in laboratory tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lactate dehydrogenase (LDH) testing is included in laboratory tests for diagnosing primary CNS lymphoma."
    ],
    "evidence_relations": "Laboratory Tests include Lactate dehydrogenase (LDH)"
  },
  {
    "id": "Medical-a4dcffa3",
    "source": "Medical",
    "question": "What is a potential site of relapse for primary CNS lymphoma?",
    "answer": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary CNS lymphoma can relapse in the brain.",
      "Primary CNS lymphoma can relapse in the spinal cord.",
      "Primary CNS lymphoma can relapse in the eyes."
    ],
    "evidence_relations": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes"
  },
  {
    "id": "Medical-f05a2e9b",
    "source": "Medical",
    "question": "What supportive care interventions are recommended for patients with primary CNS lymphoma?",
    "answer": "Symptom management, palliative care, and quality of life interventions are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptom management is recommended for patients with primary CNS lymphoma.",
      "Palliative care is recommended for patients with primary CNS lymphoma.",
      "Quality of life interventions are recommended for patients with primary CNS lymphoma."
    ],
    "evidence_relations": "Supportive Care includes Symptom management, Palliative care, Quality of life interventions"
  },
  {
    "id": "Medical-5b1265c0",
    "source": "Medical",
    "question": "What is the second most common type of skin cancer?",
    "answer": "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer."
    ],
    "evidence_relations": "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer"
  },
  {
    "id": "Medical-d1e50927",
    "source": "Medical",
    "question": "Which cancer subtype is classified as a type of nonmelanoma skin cancer?",
    "answer": "CSCC is a type of nonmelanoma skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CSCC is a type of nonmelanoma skin cancer."
    ],
    "evidence_relations": "CSCC is a type of nonmelanoma skin cancer"
  },
  {
    "id": "Medical-9536f8e7",
    "source": "Medical",
    "question": "What are the main stages of cutaneous squamous cell carcinoma (CSCC)?",
    "answer": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CSCC is staged as local.",
      "CSCC is staged as regional.",
      "CSCC is staged as metastatic."
    ],
    "evidence_relations": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)"
  },
  {
    "id": "Medical-1f290988",
    "source": "Medical",
    "question": "What is a precancerous lesion that can progress to CSCC?",
    "answer": "Actinic keratosis is a precancerous lesion that can progress to CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC."
    ],
    "evidence_relations": "Actinic keratosis is a precancerous lesion that can progress to CSCC"
  },
  {
    "id": "Medical-a2555661",
    "source": "Medical",
    "question": "Which genetic syndromes increase the risk for CSCC?",
    "answer": "Xeroderma pigmentosum and RDEB increase risk for CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Xeroderma pigmentosum increases the risk for CSCC.",
      "RDEB increases the risk for CSCC."
    ],
    "evidence_relations": "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC"
  },
  {
    "id": "Medical-8866282b",
    "source": "Medical",
    "question": "What are common symptoms of CSCC?",
    "answer": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of CSCC include scaly patches.",
      "Common symptoms of CSCC include solid or misshapen skin lesions.",
      "Common symptoms of CSCC include lesions in areas of chronic damage."
    ],
    "evidence_relations": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage"
  },
  {
    "id": "Medical-d9522675",
    "source": "Medical",
    "question": "What biopsy types are used in the diagnosis of CSCC?",
    "answer": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biopsy types for diagnosis of CSCC include shave biopsy.",
      "Biopsy types for diagnosis of CSCC include punch biopsy.",
      "Biopsy types for diagnosis of CSCC include excision biopsy."
    ],
    "evidence_relations": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy"
  },
  {
    "id": "Medical-bfa9a27b",
    "source": "Medical",
    "question": "What therapies are used for actinic keratoses and superficial CSCC?",
    "answer": "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Photodynamic therapy is used for actinic keratoses and superficial CSCC.",
      "Cryotherapy is used for actinic keratoses and superficial CSCC.",
      "Topical therapies are used for actinic keratoses and superficial CSCC.",
      "5-fluorouracil is a topical therapy used for actinic keratoses and superficial CSCC.",
      "Imiquimod is a topical therapy used for actinic keratoses and superficial CSCC.",
      "Tirbanibulin is a topical therapy used for actinic keratoses and superficial CSCC."
    ],
    "evidence_relations": "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC"
  },
  {
    "id": "Medical-6a38af6d",
    "source": "Medical",
    "question": "What is a key biomarker used in risk assessment for CSCC?",
    "answer": "Perineural invasion is a key biomarker for CSCC risk assessment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perineural invasion is a key biomarker for CSCC risk assessment."
    ],
    "evidence_relations": "Perineural invasion is listed as a biomarker in the ontology for CSCC"
  },
  {
    "id": "Medical-8bf3a99b",
    "source": "Medical",
    "question": "How is risk assessment for CSCC performed?",
    "answer": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk assessment for CSCC is based on tumor location.",
      "Risk assessment for CSCC is based on tumor size.",
      "Risk assessment for CSCC is based on border definition.",
      "Risk assessment for CSCC is based on recurrence.",
      "Risk assessment for CSCC is based on depth.",
      "Risk assessment for CSCC is based on perineural invasion.",
      "Risk assessment for CSCC is based on lymphovascular invasion.",
      "Risk assessment for CSCC is based on tumor grade.",
      "Risk assessment for CSCC is based on patient immune status."
    ],
    "evidence_relations": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status"
  },
  {
    "id": "Medical-59292b3b",
    "source": "Medical",
    "question": "Which topical therapies are used for actinic keratosis?",
    "answer": "Topical therapies for actinic keratosis include 5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, and diclofenac.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "5-fluorouracil is a topical therapy for actinic keratosis.",
      "Imiquimod is a topical therapy for actinic keratosis.",
      "Calcipotriene is a topical therapy for actinic keratosis.",
      "Tirbanibulin is a topical therapy for actinic keratosis.",
      "Diclofenac is a topical therapy for actinic keratosis."
    ],
    "evidence_relations": "Topical therapy (5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, diclofenac) is listed for actinic keratosis"
  },
  {
    "id": "Medical-d8a3772b",
    "source": "Medical",
    "question": "Which immunotherapy agents are used for metastatic CSCC?",
    "answer": "PD-1 inhibitors such as cemiplimab and pembrolizumab are used for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-1 inhibitors are used for metastatic CSCC.",
      "Cemiplimab is a PD-1 inhibitor used for metastatic CSCC.",
      "Pembrolizumab is a PD-1 inhibitor used for metastatic CSCC."
    ],
    "evidence_relations": "PD-1 inhibitors (cemiplimab, pembrolizumab) are listed as systemic therapy options for metastatic CSCC"
  },
  {
    "id": "Medical-ff41533a",
    "source": "Medical",
    "question": "What is the preferred systemic therapy for metastatic CSCC?",
    "answer": "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC."
    ],
    "evidence_relations": "Systemic therapy (PD-1 inhibitor preferred) is listed for metastatic CSCC"
  },
  {
    "id": "Medical-c87c6baf",
    "source": "Medical",
    "question": "Which factors are included in clinical management risk assessment for CSCC?",
    "answer": "Risk assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, and immunosuppression.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk assessment for CSCC includes tumor location.",
      "Risk assessment for CSCC includes tumor size.",
      "Risk assessment for CSCC includes tumor border definition.",
      "Risk assessment for CSCC includes recurrence.",
      "Risk assessment for CSCC includes depth of invasion.",
      "Risk assessment for CSCC includes perineural invasion.",
      "Risk assessment for CSCC includes lymphovascular invasion.",
      "Risk assessment for CSCC includes tumor grade.",
      "Risk assessment for CSCC includes immunosuppression."
    ],
    "evidence_relations": "Risk Assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, immunosuppression"
  },
  {
    "id": "Medical-3e2b82f5",
    "source": "Medical",
    "question": "Which clinical management strategy is used for surveillance in high-risk or regional CSCC?",
    "answer": "Surveillance involves regular skin and lymph node exams and imaging for high-risk or regional disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance for high-risk or regional CSCC involves regular skin exams.",
      "Surveillance for high-risk or regional CSCC involves regular lymph node exams.",
      "Surveillance for high-risk or regional CSCC involves imaging."
    ],
    "evidence_relations": "Surveillance: Regular skin and lymph node exams, imaging for high-risk or regional disease"
  },
  {
    "id": "Medical-9b293f2c",
    "source": "Medical",
    "question": "What genetic alteration causes chronic myeloid leukemia?",
    "answer": "CML is caused by the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene."
    ],
    "evidence_relations": "CML is caused by the BCR::ABL1 fusion gene"
  },
  {
    "id": "Medical-e5676a79",
    "source": "Medical",
    "question": "What is required for a diagnosis of CML?",
    "answer": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Presence of the Ph chromosome is required for CML diagnosis.",
      "Presence of the BCR::ABL1 gene is required for CML diagnosis."
    ],
    "evidence_relations": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
  },
  {
    "id": "Medical-77457615",
    "source": "Medical",
    "question": "What are the two main diagnostic methods for CML?",
    "answer": "Blood tests and bone marrow tests are used to diagnose CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used to diagnose CML.",
      "Bone marrow tests are used to diagnose CML."
    ],
    "evidence_relations": "Blood tests and bone marrow tests are used to diagnose CML"
  },
  {
    "id": "Medical-72a77731",
    "source": "Medical",
    "question": "What is the primary treatment goal for CML?",
    "answer": "Treatment for CML aims to inhibit BCR::ABL1 protein activity.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary treatment goal for CML is to inhibit BCR::ABL1 protein activity."
    ],
    "evidence_relations": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-5fe38d4e",
    "source": "Medical",
    "question": "Which blood cell types are increased in CML?",
    "answer": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes).",
      "CML is characterized by abnormal platelet counts."
    ],
    "evidence_relations": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts"
  },
  {
    "id": "Medical-dc60c354",
    "source": "Medical",
    "question": "Which phase of CML is considered advanced?",
    "answer": "Blast phase CML (BP-CML) is considered advanced.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blast phase CML (BP-CML) is considered advanced."
    ],
    "evidence_relations": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts"
  },
  {
    "id": "Medical-62a9b979",
    "source": "Medical",
    "question": "Which blood cell type is produced in increased numbers in CML?",
    "answer": "Myeloid progenitor cells are produced in increased numbers in CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Myeloid progenitor cells are produced in increased numbers in CML."
    ],
    "evidence_relations": "CML arises from blood stem cells producing increased myeloid progenitor cells"
  },
  {
    "id": "Medical-61ec9250",
    "source": "Medical",
    "question": "Which treatment strategy targets the abnormal protein in CML?",
    "answer": "BCR::ABL1 protein inhibition is the treatment strategy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1 protein inhibition is the treatment strategy for CML."
    ],
    "evidence_relations": "Treatment: BCR::ABL1 protein inhibition"
  },
  {
    "id": "Medical-e2848d7f",
    "source": "Medical",
    "question": "Which blood cell types may show abnormal counts in CML?",
    "answer": "White blood cells (granulocytes) and platelets (PLTs) may show abnormal counts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "White blood cells may show abnormal counts in CML.",
      "Granulocytes may show abnormal counts in CML.",
      "Platelets may show abnormal counts in CML."
    ],
    "evidence_relations": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts"
  },
  {
    "id": "Medical-ea3d4859",
    "source": "Medical",
    "question": "Which chromosomes are specifically mentioned as being involved in CML pathogenesis?",
    "answer": "Chromosome 9 and chromosome 22 are involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chromosome 9 is involved in CML pathogenesis.",
      "Chromosome 22 is involved in CML pathogenesis."
    ],
    "evidence_relations": "Chromosomal Abnormality: chromosome 9, chromosome 22"
  },
  {
    "id": "Medical-8109c3aa",
    "source": "Medical",
    "question": "What is the function of BCR::ABL1 protein inhibition in CML treatment?",
    "answer": "It is the primary treatment approach for CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1 protein inhibition is the primary treatment approach for CML."
    ],
    "evidence_relations": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-8be16d47",
    "source": "Medical",
    "question": "Which cells do squamous cell carcinoma originate from?",
    "answer": "Squamous cell carcinoma forms from cells that line the bronchi.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma forms from cells that line the bronchi."
    ],
    "evidence_relations": "Squamous cell carcinoma forms from cells that line the bronchi"
  },
  {
    "id": "Medical-9e7500a0",
    "source": "Medical",
    "question": "What is the origin of large cell carcinoma in NSCLC?",
    "answer": "Large cell carcinoma forms from large cells found throughout the airways.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Large cell carcinoma forms from large cells.",
      "Large cells are found throughout the airways."
    ],
    "evidence_relations": "Large cell carcinoma forms from large cells found throughout the airways"
  },
  {
    "id": "Medical-a61abd42",
    "source": "Medical",
    "question": "How is Stage 1 NSCLC classified?",
    "answer": "Stage 1 NSCLC is considered early stage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage 1 NSCLC is considered early stage."
    ],
    "evidence_relations": "Stage 1 NSCLC is considered early stage"
  },
  {
    "id": "Medical-83b8a631",
    "source": "Medical",
    "question": "Which treatment is used for some early NSCLC cases?",
    "answer": "Radiation therapy is used for some early NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy is used for some early NSCLC cases."
    ],
    "evidence_relations": "Radiation therapy is used for some early NSCLC cases"
  },
  {
    "id": "Medical-2c702150",
    "source": "Medical",
    "question": "What treatment is used for some locally advanced NSCLC cases?",
    "answer": "Chemoradiation is used for some locally advanced NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemoradiation is used for some locally advanced NSCLC cases."
    ],
    "evidence_relations": "Chemoradiation is used for some locally advanced NSCLC cases"
  },
  {
    "id": "Medical-5bae1c96",
    "source": "Medical",
    "question": "What type of care extends and enhances life for people with lung cancer?",
    "answer": "Supportive care extends and enhances life for people with lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care extends life for people with lung cancer.",
      "Supportive care enhances life for people with lung cancer."
    ],
    "evidence_relations": "Supportive care extends and enhances life for people with lung cancer"
  },
  {
    "id": "Medical-64042235",
    "source": "Medical",
    "question": "List environmental risk factors for lung cancer besides tobacco.",
    "answer": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Exposure to radon is a risk factor for lung cancer.",
      "Exposure to asbestos is a risk factor for lung cancer.",
      "Exposure to arsenic is a risk factor for lung cancer.",
      "Exposure to beryllium is a risk factor for lung cancer.",
      "Exposure to cadmium is a risk factor for lung cancer.",
      "Exposure to chromium is a risk factor for lung cancer.",
      "Exposure to nickel is a risk factor for lung cancer.",
      "Exposure to coal smoke is a risk factor for lung cancer.",
      "Exposure to soot is a risk factor for lung cancer.",
      "Exposure to silica is a risk factor for lung cancer.",
      "Exposure to diesel fumes is a risk factor for lung cancer.",
      "Air pollution is a risk factor for lung cancer."
    ],
    "evidence_relations": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer"
  },
  {
    "id": "Medical-61cf41ee",
    "source": "Medical",
    "question": "What does follow-up care after lung cancer treatment include?",
    "answer": "Follow-up care is planned after treatment and includes surveillance for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up care is planned after lung cancer treatment.",
      "Follow-up care includes surveillance for recurrence."
    ],
    "evidence_relations": "Follow-up care is planned after treatment and includes surveillance for recurrence"
  },
  {
    "id": "Medical-1b7a0e02",
    "source": "Medical",
    "question": "How are lung nodules assessed for malignancy?",
    "answer": "Lung nodules are assessed by biopsy and lung cancer screening.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lung nodules are assessed by biopsy.",
      "Lung nodules are assessed by lung cancer screening."
    ],
    "evidence_relations": "Lung nodules may be detected by imaging and require further assessment to determine malignancy"
  },
  {
    "id": "Medical-d2746bf8",
    "source": "Medical",
    "question": "What is the most common subtype of nasopharyngeal cancer?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer."
    ],
    "evidence_relations": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer"
  },
  {
    "id": "Medical-4196794d",
    "source": "Medical",
    "question": "Which geographic regions have higher rates of nasopharyngeal carcinoma?",
    "answer": "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nasopharyngeal carcinoma most often occurs in people from parts of Asia.",
      "Nasopharyngeal carcinoma most often occurs in Native Americans.",
      "Nasopharyngeal carcinoma most often occurs in people from North Africa."
    ],
    "evidence_relations": "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
  },
  {
    "id": "Medical-c5bc82ff",
    "source": "Medical",
    "question": "What are two common symptoms of nasopharyngeal carcinoma?",
    "answer": "Enlarged lymph nodes and hearing loss are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Enlarged lymph nodes are a common symptom of nasopharyngeal carcinoma.",
      "Hearing loss is a common symptom of nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Symptom: [\"Enlarged lymph nodes\", \"Hearing loss\", \"Symptoms may be absent until advanced stage\"]"
  },
  {
    "id": "Medical-8f64cf43",
    "source": "Medical",
    "question": "Which biomarker tests are recommended for nasopharyngeal carcinoma?",
    "answer": "EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden are recommended biomarker tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA is a recommended biomarker test for nasopharyngeal carcinoma.",
      "MSI-H/dMMR is a recommended biomarker test for nasopharyngeal carcinoma.",
      "PD-L1 is a recommended biomarker test for nasopharyngeal carcinoma.",
      "HPV is a recommended biomarker test for nasopharyngeal carcinoma.",
      "Tumor mutational burden is a recommended biomarker test for nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden"
  },
  {
    "id": "Medical-49ff508e",
    "source": "Medical",
    "question": "Which performance measure is considered in NPC treatment planning?",
    "answer": "Performance status is considered in NPC treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is considered in nasopharyngeal carcinoma treatment planning."
    ],
    "evidence_relations": "Performance status is considered in NPC treatment planning"
  },
  {
    "id": "Medical-debec9f1",
    "source": "Medical",
    "question": "What are the possible classifications of nasopharyngeal carcinoma based on extent of disease?",
    "answer": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nasopharyngeal carcinoma can be classified as resectable.",
      "Nasopharyngeal carcinoma can be classified as unresectable.",
      "Nasopharyngeal carcinoma can be classified as locoregional.",
      "Nasopharyngeal carcinoma can be classified as locally advanced.",
      "Nasopharyngeal carcinoma can be classified as metastatic."
    ],
    "evidence_relations": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease"
  },
  {
    "id": "Medical-b696a6b5",
    "source": "Medical",
    "question": "What is the purpose of EBV DNA testing in NPC?",
    "answer": "EBV DNA testing is performed before and after treatment for NPC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA testing is performed before treatment for nasopharyngeal carcinoma.",
      "EBV DNA testing is performed after treatment for nasopharyngeal carcinoma."
    ],
    "evidence_relations": "EBV DNA testing is performed before and after treatment for NPC"
  },
  {
    "id": "Medical-41723902",
    "source": "Medical",
    "question": "How is the cancer subtype determined in NPC?",
    "answer": "Biopsy determines cancer subtype in NPC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biopsy determines cancer subtype in nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Biopsy confirms diagnosis and determines cancer subtype"
  },
  {
    "id": "Medical-0155c059",
    "source": "Medical",
    "question": "Which factors are considered prognostic in NPC?",
    "answer": "EBV DNA level and performance status are prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA level is a prognostic factor in nasopharyngeal carcinoma.",
      "Performance status is a prognostic factor in nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Prognostic Factor: [\"EBV DNA level\", \"Performance status\"]"
  },
  {
    "id": "Medical-4482bd32",
    "source": "Medical",
    "question": "Which assessments are recommended before starting NPC treatment?",
    "answer": "Dental exam, nutrition assessment, and speech and swallowing assessment are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Dental exam is recommended before starting nasopharyngeal carcinoma treatment.",
      "Nutrition assessment is recommended before starting nasopharyngeal carcinoma treatment.",
      "Speech and swallowing assessment is recommended before starting nasopharyngeal carcinoma treatment."
    ],
    "evidence_relations": "Diagnostic Method: [\"Dental exam\", \"Nutrition assessment\", \"Speech and swallowing assessment\"]"
  },
  {
    "id": "Medical-adb77b8f",
    "source": "Medical",
    "question": "What is the role of imaging in NPC management?",
    "answer": "Imaging is used for staging and surveillance of NPC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging is used for staging of NPC.",
      "Imaging is used for surveillance of NPC."
    ],
    "evidence_relations": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance"
  },
  {
    "id": "Medical-6b0b36c7",
    "source": "Medical",
    "question": "Which populations are at increased risk for NPC due to geographic origin?",
    "answer": "People from Asia, Native America, and North Africa are at increased risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "People from Asia are at increased risk for NPC.",
      "Native Americans are at increased risk for NPC.",
      "People from North Africa are at increased risk for NPC."
    ],
    "evidence_relations": "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
  },
  {
    "id": "Medical-06ecaea9",
    "source": "Medical",
    "question": "Which two lifestyle factors increase the risk of head and neck cancer?",
    "answer": "Tobacco and alcohol use are risk factors for head and neck cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tobacco use is a risk factor for head and neck cancer.",
      "Alcohol use is a risk factor for head and neck cancer."
    ],
    "evidence_relations": "Tobacco and alcohol use are risk factors for head and neck cancer"
  },
  {
    "id": "Medical-35f3815e",
    "source": "Medical",
    "question": "From which type of polyp do most colon cancers originate?",
    "answer": "Most colon cancers start in polyps, especially adenomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Most colon cancers start in polyps.",
      "Most colon cancers especially start in adenomas."
    ],
    "evidence_relations": "Most colon cancers start in polyps, especially adenomas"
  },
  {
    "id": "Medical-5b005bba",
    "source": "Medical",
    "question": "Which system is used to stage colon cancer?",
    "answer": "AJCC TNM system is used to stage colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AJCC TNM system is used to stage colon cancer."
    ],
    "evidence_relations": "AJCC TNM system is used to stage colon cancer"
  },
  {
    "id": "Medical-2360f9dd",
    "source": "Medical",
    "question": "What defines Stage 0 colon cancer?",
    "answer": "Stage 0 colon cancer is carcinoma in situ.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage 0 colon cancer is carcinoma in situ."
    ],
    "evidence_relations": "Stage 0 colon cancer is carcinoma in situ"
  },
  {
    "id": "Medical-c8d26f3e",
    "source": "Medical",
    "question": "How is Stage 2 colon cancer described?",
    "answer": "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage 2 colon cancer invades or passes the fourth layer.",
      "Stage 2 colon cancer has no lymph node involvement."
    ],
    "evidence_relations": "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement"
  },
  {
    "id": "Medical-879889ee",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for all colon cancers?",
    "answer": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All colon cancers should be tested for mismatch repair deficiency (dMMR).",
      "All colon cancers should be tested for microsatellite instability-high (MSI-H)."
    ],
    "evidence_relations": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)"
  },
  {
    "id": "Medical-a77dafa9",
    "source": "Medical",
    "question": "Which biomarker guides immunotherapy in colon cancer?",
    "answer": "dMMR/MSI-H is a biomarker guiding immunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "dMMR/MSI-H is a biomarker that guides immunotherapy in colon cancer."
    ],
    "evidence_relations": "dMMR/MSI-H is a biomarker guiding immunotherapy"
  },
  {
    "id": "Medical-973bc3d0",
    "source": "Medical",
    "question": "How are pMMR/MSS colon cancers generally treated?",
    "answer": "pMMR/MSS cancers are treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "pMMR/MSS colon cancers are generally treated with chemotherapy."
    ],
    "evidence_relations": "pMMR/MSS cancers are treated with chemotherapy"
  },
  {
    "id": "Medical-13fbbea3",
    "source": "Medical",
    "question": "What blood tests are recommended for initial evaluation of colon cancer?",
    "answer": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests recommended for initial evaluation of colon cancer include CBC.",
      "Blood tests recommended for initial evaluation of colon cancer include chemistry profile.",
      "Blood tests recommended for initial evaluation of colon cancer include CEA."
    ],
    "evidence_relations": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing"
  },
  {
    "id": "Medical-6f2d6386",
    "source": "Medical",
    "question": "When is MRI used in the evaluation of colon cancer?",
    "answer": "MRI may be used for further evaluation of liver or rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MRI may be used for further evaluation of the liver in colon cancer.",
      "MRI may be used for further evaluation of the rectum in colon cancer."
    ],
    "evidence_relations": "MRI may be used for further evaluation of liver or rectum"
  },
  {
    "id": "Medical-80328029",
    "source": "Medical",
    "question": "What is the current role of ctDNA testing in colon cancer?",
    "answer": "ctDNA testing is investigational and recommended only in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ctDNA testing is investigational in colon cancer.",
      "ctDNA testing is recommended only in clinical trials for colon cancer."
    ],
    "evidence_relations": "ctDNA testing is investigational and recommended only in clinical trials"
  },
  {
    "id": "Medical-babf4510",
    "source": "Medical",
    "question": "What chemotherapy regimens are commonly used for colon cancer?",
    "answer": "Capecitabine, 5-fluorouracil (5-FU), leucovorin, FOLFOX, and CAPEOX are chemotherapy regimens used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Capecitabine is a chemotherapy regimen used for colon cancer.",
      "5-fluorouracil (5-FU) is a chemotherapy regimen used for colon cancer.",
      "Leucovorin is a chemotherapy regimen used for colon cancer.",
      "FOLFOX is a chemotherapy regimen used for colon cancer.",
      "CAPEOX is a chemotherapy regimen used for colon cancer."
    ],
    "evidence_relations": "Capecitabine, 5-fluorouracil (5-FU), Leucovorin, FOLFOX, CAPEOX"
  },
  {
    "id": "Medical-1e78dd0f",
    "source": "Medical",
    "question": "Which checkpoint inhibitors are used in immunotherapy for colon cancer?",
    "answer": "Pembrolizumab (Keytruda), Nivolumab (Opdivo), and Ipilimumab (Yervoy) are checkpoint inhibitors used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pembrolizumab (Keytruda) is a checkpoint inhibitor used in immunotherapy for colon cancer.",
      "Nivolumab (Opdivo) is a checkpoint inhibitor used in immunotherapy for colon cancer.",
      "Ipilimumab (Yervoy) is a checkpoint inhibitor used in immunotherapy for colon cancer."
    ],
    "evidence_relations": "Pembrolizumab (Keytruda), Nivolumab (Opdivo), Ipilimumab (Yervoy)"
  },
  {
    "id": "Medical-611ac003",
    "source": "Medical",
    "question": "What anatomical locations are associated with esophageal squamous cell carcinoma?",
    "answer": "Upper, middle, and lower esophagus are associated locations.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Upper esophagus is associated with esophageal squamous cell carcinoma.",
      "Middle esophagus is associated with esophageal squamous cell carcinoma.",
      "Lower esophagus is associated with esophageal squamous cell carcinoma."
    ],
    "evidence_relations": "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus"
  },
  {
    "id": "Medical-04e27815",
    "source": "Medical",
    "question": "Which anatomical sites are included for esophageal cancer in general?",
    "answer": "Esophagus and esophagogastric junction are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Esophagus is included as an anatomical site for esophageal cancer.",
      "Esophagogastric junction is included as an anatomical site for esophageal cancer."
    ],
    "evidence_relations": "Anatomical Location: Esophagus, Esophagogastric junction"
  },
  {
    "id": "Medical-bb0fe530",
    "source": "Medical",
    "question": "What is a precancerous condition for esophageal adenocarcinoma?",
    "answer": "Barrett esophagus is a precancerous condition.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Barrett esophagus is a precancerous condition."
    ],
    "evidence_relations": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-08144fc9",
    "source": "Medical",
    "question": "Which risk factor increases the likelihood of developing esophageal adenocarcinoma?",
    "answer": "Barrett esophagus increases the risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Barrett esophagus increases the risk of developing esophageal adenocarcinoma."
    ],
    "evidence_relations": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-c06a99a5",
    "source": "Medical",
    "question": "What additional assessments are included in esophageal cancer diagnosis beyond imaging and biopsy?",
    "answer": "Nutritional assessment and performance status are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nutritional assessment is included in esophageal cancer diagnosis.",
      "Performance status is included in esophageal cancer diagnosis."
    ],
    "evidence_relations": "Diagnostic Method: Nutritional assessment, Performance status"
  },
  {
    "id": "Medical-5c1a382a",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for esophageal cancer?",
    "answer": "Cancer type, location, stage, and Siewert types (for EGJ tumors) are considered.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cancer type is considered in treatment planning for esophageal cancer.",
      "Location is considered in treatment planning for esophageal cancer.",
      "Stage is considered in treatment planning for esophageal cancer.",
      "Siewert types are considered in treatment planning for esophageal cancer for EGJ tumors."
    ],
    "evidence_relations": "Treatment planning is based on cancer type, location, and stage"
  },
  {
    "id": "Medical-0f576b9d",
    "source": "Medical",
    "question": "Which genetic assessments are part of esophageal cancer diagnosis?",
    "answer": "Biomarker testing and genetic risk testing are part of the diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing is part of the diagnosis for esophageal cancer.",
      "Genetic risk testing is part of the diagnosis for esophageal cancer."
    ],
    "evidence_relations": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-6b811802",
    "source": "Medical",
    "question": "What are the main stages of esophageal cancer described in the ontology?",
    "answer": "Early-stage, locoregional, and metastatic are the main stages.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Early-stage is one of the main stages of esophageal cancer.",
      "Locoregional is one of the main stages of esophageal cancer.",
      "Metastatic is one of the main stages of esophageal cancer."
    ],
    "evidence_relations": "Disease Stage: Early-stage, Locoregional, Metastatic"
  },
  {
    "id": "Medical-21c7cd3c",
    "source": "Medical",
    "question": "How are tumors at the esophagogastric junction staged?",
    "answer": "They are staged using Siewert types.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumors at the esophagogastric junction are staged using Siewert types."
    ],
    "evidence_relations": "Siewert types are used to stage tumors at the esophagogastric junction"
  },
  {
    "id": "Medical-9ba19145",
    "source": "Medical",
    "question": "Which assessments help determine performance status in esophageal cancer patients?",
    "answer": "Performance status assessment is used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status assessment is used to determine performance status in esophageal cancer patients."
    ],
    "evidence_relations": "Diagnostic Method: Performance status"
  },
  {
    "id": "Medical-465ca672",
    "source": "Medical",
    "question": "What is a key factor in planning treatment for esophageal cancer located at the esophagogastric junction?",
    "answer": "Siewert types are a key factor for EGJ tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Siewert types are a key factor in planning treatment for esophageal cancer located at the esophagogastric junction."
    ],
    "evidence_relations": "Treatment Planning: Based on: Siewert types (for EGJ tumors)"
  },
  {
    "id": "Medical-ad0123e9",
    "source": "Medical",
    "question": "What is the main cancer type discussed in this dataset?",
    "answer": "Gray zone lymphoma is the main cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gray zone lymphoma is the main cancer type discussed in this dataset."
    ],
    "evidence_relations": "Gray zone lymphoma is listed as a Cancer Type in the ontology."
  },
  {
    "id": "Medical-cf8b52e2",
    "source": "Medical",
    "question": "Which histopathological feature is characteristic of MGZL?",
    "answer": "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Reed-Sternberg cells are characteristic histopathological features in MGZL."
    ],
    "evidence_relations": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-e875d9cd",
    "source": "Medical",
    "question": "What is the recommended initial treatment for MGZL?",
    "answer": "MGZL is usually treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL is usually treated with chemotherapy."
    ],
    "evidence_relations": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-c0ac21ce",
    "source": "Medical",
    "question": "Which immunotherapy agent may be added to chemotherapy for MGZL?",
    "answer": "Rituximab may be added to chemotherapy for chemoimmunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Rituximab may be added to chemotherapy for chemoimmunotherapy."
    ],
    "evidence_relations": "Rituximab may be added to chemotherapy for chemoimmunotherapy"
  },
  {
    "id": "Medical-afb11f97",
    "source": "Medical",
    "question": "What type of radiation therapy may be used in localized MGZL?",
    "answer": "Involved-site radiation therapy (ISRT) may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL."
    ],
    "evidence_relations": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-0cbbd549",
    "source": "Medical",
    "question": "What diagnostic method is required for MGZL?",
    "answer": "Diagnosis of MGZL requires expert hematopathologist review.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of MGZL requires expert hematopathologist review."
    ],
    "evidence_relations": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-aed3f61c",
    "source": "Medical",
    "question": "Which age group is most commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals aged 20 to 40 years.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL commonly affects individuals aged 20 to 40 years."
    ],
    "evidence_relations": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-3c1265b5",
    "source": "Medical",
    "question": "Which sex assigned at birth is more commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals assigned male at birth.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL commonly affects individuals assigned male at birth."
    ],
    "evidence_relations": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-368307ba",
    "source": "Medical",
    "question": "Which sites are typically involved in mediastinal gray zone lymphoma?",
    "answer": "The mediastinum and lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The mediastinum is typically involved in MGZL.",
      "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL."
    ],
    "evidence_relations": "Sites of involvement for MGZL include Mediastinum and Lymph nodes above the collar bone (supraclavicular)"
  },
  {
    "id": "Medical-30e1cf9c",
    "source": "Medical",
    "question": "What is a common presenting symptom of MGZL?",
    "answer": "A large mediastinal mass is a common presenting symptom of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A large mediastinal mass is a common presenting symptom of MGZL."
    ],
    "evidence_relations": "MGZL is characterized by a large mediastinal mass"
  },
  {
    "id": "Medical-9086efa3",
    "source": "Medical",
    "question": "What is the relationship between gray zone lymphoma and Hodgkin lymphoma?",
    "answer": "Gray zone lymphomas have overlapping features with Hodgkin lymphoma (HL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gray zone lymphomas have overlapping features with Hodgkin lymphoma (HL)."
    ],
    "evidence_relations": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-8a80ec5c",
    "source": "Medical",
    "question": "What is a distinguishing feature of non-mediastinal gray zone lymphomas compared to MGZL?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons.",
      "Non-mediastinal gray zone lymphomas have higher rates of bone marrow involvement.",
      "Non-mediastinal gray zone lymphomas have higher rates of extranodal involvement."
    ],
    "evidence_relations": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
  },
  {
    "id": "Medical-e9a8741e",
    "source": "Medical",
    "question": "Which sites are more commonly involved in non-mediastinal gray zone lymphomas?",
    "answer": "Bone marrow and extranodal disease are more commonly involved in non-mediastinal gray zone lymphomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone marrow disease is more commonly involved in non-mediastinal gray zone lymphomas.",
      "Extranodal disease is more commonly involved in non-mediastinal gray zone lymphomas."
    ],
    "evidence_relations": "Sites of involvement for non-mediastinal gray zone lymphoma include Bone marrow involvement and Extranodal disease"
  },
  {
    "id": "Medical-60151004",
    "source": "Medical",
    "question": "Which professional is required for the diagnosis of MGZL?",
    "answer": "Expert hematopathologist review is required for diagnosis of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "An expert hematopathologist review is required for the diagnosis of MGZL."
    ],
    "evidence_relations": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-1b949b50",
    "source": "Medical",
    "question": "Name two related entities to gray zone lymphoma.",
    "answer": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) are related entities.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary mediastinal B-cell lymphoma (PMBL) is a related entity to gray zone lymphoma.",
      "Hodgkin lymphoma (HL) is a related entity to gray zone lymphoma."
    ],
    "evidence_relations": "Related Entities: Primary mediastinal B-cell lymphoma (PMBL), Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-f83e84a2",
    "source": "Medical",
    "question": "What kind of therapy may be considered for MGZL in addition to chemotherapy?",
    "answer": "Chemoimmunotherapy and radiation therapy may be considered for MGZL in addition to chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemoimmunotherapy may be considered for MGZL in addition to chemotherapy.",
      "Radiation therapy may be considered for MGZL in addition to chemotherapy."
    ],
    "evidence_relations": "Treatment for MGZL includes Chemotherapy, Chemoimmunotherapy (Rituximab), and Radiation Therapy (ISRT)"
  },
  {
    "id": "Medical-e84ba674",
    "source": "Medical",
    "question": "Which cells are a histopathological hallmark of MGZL?",
    "answer": "Reed-Sternberg cells are a histopathological hallmark of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Reed-Sternberg cells are a histopathological hallmark of MGZL."
    ],
    "evidence_relations": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-47995a35",
    "source": "Medical",
    "question": "What is the epidemiological profile of non-mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons."
    ],
    "evidence_relations": "Non-mediastinal gray zone lymphomas occur in older persons"
  },
  {
    "id": "Medical-4dcf4539",
    "source": "Medical",
    "question": "Which lymphoma is diagnosed if gray zone lymphoma presents with extra-mediastinal disease?",
    "answer": "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if there is extra-mediastinal disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if gray zone lymphoma presents with extra-mediastinal disease."
    ],
    "evidence_relations": "If extra-mediastinal disease: Diagnose as DLBCL-NOS"
  },
  {
    "id": "Medical-efc035f3",
    "source": "Medical",
    "question": "What is the purpose of involved-site radiation therapy (ISRT) in MGZL?",
    "answer": "ISRT may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL."
    ],
    "evidence_relations": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-b6d5f2ae",
    "source": "Medical",
    "question": "Which lymph nodes are typically involved in MGZL?",
    "answer": "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL."
    ],
    "evidence_relations": "Sites of involvement for MGZL include Lymph nodes above the collar bone (supraclavicular)"
  },
  {
    "id": "Medical-5f5a35d2",
    "source": "Medical",
    "question": "What is the main diagnostic method for gray zone lymphoma?",
    "answer": "Expert hematopathologist review is the main diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Expert hematopathologist review is the main diagnostic method for gray zone lymphoma."
    ],
    "evidence_relations": "Diagnostic Method for MGZL: Expert hematopathologist review"
  },
  {
    "id": "Medical-5a4056c3",
    "source": "Medical",
    "question": "Name two cancer types related to gray zone lymphoma.",
    "answer": "Classical Hodgkin lymphoma (CHL) and Non-Hodgkin lymphoma are related to gray zone lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Classical Hodgkin lymphoma (CHL) is related to gray zone lymphoma.",
      "Non-Hodgkin lymphoma is related to gray zone lymphoma."
    ],
    "evidence_relations": "Related Entities: Classical Hodgkin lymphoma (CHL), Non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-b4916c72",
    "source": "Medical",
    "question": "What is the standard chemotherapy regimen for MGZL?",
    "answer": "Chemotherapy is the standard treatment for MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy is the standard treatment for MGZL."
    ],
    "evidence_relations": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-14497bbd",
    "source": "Medical",
    "question": "What is the primary diagnostic method for cervical cancer?",
    "answer": "Cervical biopsy is the primary diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cervical biopsy is the primary diagnostic method for cervical cancer."
    ],
    "evidence_relations": "Cervical biopsy is the primary diagnostic method for cervical cancer"
  },
  {
    "id": "Medical-4262873a",
    "source": "Medical",
    "question": "Which surgical procedure can be both diagnostic and therapeutic for early-stage cervical cancer?",
    "answer": "Cone biopsy can be both diagnostic and therapeutic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cone biopsy can be both diagnostic for early-stage cervical cancer.",
      "Cone biopsy can be therapeutic for early-stage cervical cancer."
    ],
    "evidence_relations": "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer"
  },
  {
    "id": "Medical-bb870733",
    "source": "Medical",
    "question": "Which fertility-sparing surgical option is available for selected early-stage cervical cancer cases?",
    "answer": "Trachelectomy is an option for selected early-stage cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Trachelectomy is a fertility-sparing surgical option.",
      "Trachelectomy is available for selected early-stage cervical cancer cases."
    ],
    "evidence_relations": "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases"
  },
  {
    "id": "Medical-e8a07389",
    "source": "Medical",
    "question": "Which radiation therapies are used for local control in cervical cancer?",
    "answer": "External beam radiation therapy (EBRT) and brachytherapy are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "External beam radiation therapy (EBRT) is used for local control in cervical cancer.",
      "Brachytherapy is used for local control in cervical cancer."
    ],
    "evidence_relations": "External beam radiation therapy (EBRT) and brachytherapy are used for local control"
  },
  {
    "id": "Medical-e3419109",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for recurrent or metastatic cervical cancer?",
    "answer": "Biomarker testing for PD-L1, MSI, TMB, MMR, HER2, RET, and NTRK is recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing for PD-L1 is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for MSI is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for TMB is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for MMR is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for HER2 is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for RET is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for NTRK is recommended for recurrent or metastatic cervical cancer."
    ],
    "evidence_relations": "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer"
  },
  {
    "id": "Medical-bc97fb7b",
    "source": "Medical",
    "question": "What biomarker guides the use of pembrolizumab in cervical cancer?",
    "answer": "PD-L1 positivity guides the use of pembrolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-L1 positivity guides the use of pembrolizumab in cervical cancer."
    ],
    "evidence_relations": "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)"
  },
  {
    "id": "Medical-5c0cc4b2",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy for metastatic cervical cancer?",
    "answer": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bevacizumab may be added to chemotherapy for metastatic cervical cancer."
    ],
    "evidence_relations": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer"
  },
  {
    "id": "Medical-2bbad791",
    "source": "Medical",
    "question": "Which factors increase the risk of cervical cancer?",
    "answer": "HPV infection, smoking, immunosuppression, and HIV increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV infection increases the risk of cervical cancer.",
      "Smoking increases the risk of cervical cancer.",
      "Immunosuppression increases the risk of cervical cancer.",
      "HIV increases the risk of cervical cancer."
    ],
    "evidence_relations": "Risk factors include HPV infection, smoking, immunosuppression (e.g., HIV infection)"
  },
  {
    "id": "Medical-15dda38d",
    "source": "Medical",
    "question": "How does smoking affect cervical cancer risk?",
    "answer": "Smoking increases the risk of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Smoking increases the risk of cervical cancer."
    ],
    "evidence_relations": "Smoking increases the risk of cervical cancer"
  },
  {
    "id": "Medical-bfa6e03a",
    "source": "Medical",
    "question": "What corresponds to a low-grade squamous intraepithelial lesion (LSIL) in cervical pathology?",
    "answer": "LSIL corresponds to CIN 1.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "LSIL corresponds to CIN 1."
    ],
    "evidence_relations": "Low-grade squamous intraepithelial lesion (LSIL) corresponds to CIN 1"
  },
  {
    "id": "Medical-c6f1ea93",
    "source": "Medical",
    "question": "What is the main purpose of surveillance after cervical cancer treatment?",
    "answer": "Surveillance includes regular physical exams and imaging as indicated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance includes regular physical exams.",
      "Surveillance includes imaging as indicated."
    ],
    "evidence_relations": "Surveillance after treatment includes regular physical exams and imaging as indicated"
  },
  {
    "id": "Medical-4a5f5e62",
    "source": "Medical",
    "question": "Which rare and aggressive subtype of cervical cancer is noted in the ontology?",
    "answer": "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Neuroendocrine carcinoma of the cervix (NECC) is a rare subtype.",
      "Neuroendocrine carcinoma of the cervix (NECC) is an aggressive subtype."
    ],
    "evidence_relations": "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype"
  },
  {
    "id": "Medical-38ee28b6",
    "source": "Medical",
    "question": "What is the relationship between cervical dysplasia and cervical cancer?",
    "answer": "Cervical dysplasia (CIN) can progress to cervical cancer if untreated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated."
    ],
    "evidence_relations": "Cervical dysplasia (CIN) can progress to cervical cancer if untreated"
  },
  {
    "id": "Medical-5eeca870",
    "source": "Medical",
    "question": "Which physical examination methods are included in the diagnostic process for cervical cancer?",
    "answer": "Physical exam, cystoscopy, and proctoscopy are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Physical examination methods for cervical cancer include physical exam.",
      "Physical examination methods for cervical cancer include cystoscopy.",
      "Physical examination methods for cervical cancer include proctoscopy."
    ],
    "evidence_relations": "Other diagnostic methods include cystoscopy, proctoscopy, and physical exam"
  },
  {
    "id": "Medical-7eb90c51",
    "source": "Medical",
    "question": "What fertility preservation options are available for cervical cancer patients?",
    "answer": "Options include fertility-sparing surgery, ovarian transposition, egg freezing, and surrogacy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation options for cervical cancer patients include fertility-sparing surgery.",
      "Fertility preservation options for cervical cancer patients include ovarian transposition.",
      "Fertility preservation options for cervical cancer patients include egg freezing.",
      "Fertility preservation options for cervical cancer patients include surrogacy."
    ],
    "evidence_relations": "Fertility preservation options include fertility-sparing surgery, ovarian transposition, egg freezing, and surrogacy"
  },
  {
    "id": "Medical-c6e9519c",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in cervical cancer for biomarker testing?",
    "answer": "Relevant genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, and NTRK fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Relevant genetic alterations for cervical cancer biomarker testing include PD-L1 positivity.",
      "Relevant genetic alterations for cervical cancer biomarker testing include MSI-H.",
      "Relevant genetic alterations for cervical cancer biomarker testing include dMMR.",
      "Relevant genetic alterations for cervical cancer biomarker testing include TMB-H.",
      "Relevant genetic alterations for cervical cancer biomarker testing include HER2 amplification.",
      "Relevant genetic alterations for cervical cancer biomarker testing include RET fusion.",
      "Relevant genetic alterations for cervical cancer biomarker testing include NTRK fusion."
    ],
    "evidence_relations": "Genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, NTRK fusion"
  },
  {
    "id": "Medical-56084fb4",
    "source": "Medical",
    "question": "Which cell type characterizes Classic Hodgkin lymphoma (CHL)?",
    "answer": "CHL is characterized by Reed-Sternberg cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL) is characterized by Reed-Sternberg cells."
    ],
    "evidence_relations": "CHL is characterized by Reed-Sternberg cells"
  },
  {
    "id": "Medical-d81ad4db",
    "source": "Medical",
    "question": "Which cell type is characteristic of NLPHL?",
    "answer": "NLPHL is characterized by popcorn-shaped cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is characterized by popcorn-shaped cells."
    ],
    "evidence_relations": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-41eb01ac",
    "source": "Medical",
    "question": "Into which disease can NLPHL transform?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-620a1582",
    "source": "Medical",
    "question": "What is the primary diagnostic method for Hodgkin lymphoma?",
    "answer": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary diagnostic method for Hodgkin lymphoma is excisional lymph node biopsy."
    ],
    "evidence_relations": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy"
  },
  {
    "id": "Medical-45b14e2d",
    "source": "Medical",
    "question": "Which biopsy method may be used for Hodgkin lymphoma diagnosis in some cases?",
    "answer": "Core needle biopsy may be used for diagnosis in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Core needle biopsy may be used for Hodgkin lymphoma diagnosis in some cases."
    ],
    "evidence_relations": "Core needle biopsy may be used for diagnosis in some cases"
  },
  {
    "id": "Medical-d3a58aef",
    "source": "Medical",
    "question": "Which diagnostic procedures are part of the initial workup for Hodgkin lymphoma?",
    "answer": "Health history and physical exam are part of the diagnostic process.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Health history is part of the diagnostic process for Hodgkin lymphoma.",
      "Physical exam is part of the diagnostic process for Hodgkin lymphoma."
    ],
    "evidence_relations": "Health history and physical exam are part of the diagnostic process"
  },
  {
    "id": "Medical-49e5ee6e",
    "source": "Medical",
    "question": "What laboratory and imaging tests are used in the diagnostic workup for Hodgkin lymphoma?",
    "answer": "Blood tests and imaging tests are used in the diagnostic workup.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used in the diagnostic workup for Hodgkin lymphoma.",
      "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-3b688fe1",
    "source": "Medical",
    "question": "Which age groups are most commonly diagnosed with Hodgkin lymphoma?",
    "answer": "Most people are diagnosed between ages 15 to 30 or after age 55.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Most people diagnosed with Hodgkin lymphoma are between ages 15 to 30.",
      "Most people diagnosed with Hodgkin lymphoma are over age 55."
    ],
    "evidence_relations": "Most people are diagnosed between ages 15 to 30 or after age 55"
  },
  {
    "id": "Medical-140a1830",
    "source": "Medical",
    "question": "What are the common sites involved in Hodgkin lymphoma?",
    "answer": "Common sites include lymph nodes in the upper body.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common sites involved in Hodgkin lymphoma include lymph nodes.",
      "Common sites involved in Hodgkin lymphoma include lymph nodes in the upper body."
    ],
    "evidence_relations": "Common Sites: lymph nodes in upper body"
  },
  {
    "id": "Medical-9b5a2b0a",
    "source": "Medical",
    "question": "Which two biopsy methods are listed for diagnosing CHL?",
    "answer": "Excisional lymph node biopsy and core needle biopsy are listed for CHL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Excisional lymph node biopsy is listed for diagnosing CHL.",
      "Core needle biopsy is listed for diagnosing CHL."
    ],
    "evidence_relations": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy"
  },
  {
    "id": "Medical-e39fe71c",
    "source": "Medical",
    "question": "What cell type is associated with Classic Hodgkin lymphoma according to the ontology?",
    "answer": "Reed-Sternberg cells are associated with Classic Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Reed-Sternberg cells are associated with Classic Hodgkin lymphoma."
    ],
    "evidence_relations": "Cell Type: Reed-Sternberg cells"
  },
  {
    "id": "Medical-8f34d47a",
    "source": "Medical",
    "question": "What cell type is associated with NLPHL according to the ontology?",
    "answer": "Popcorn-shaped cells are associated with NLPHL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Popcorn-shaped cells are associated with NLPHL."
    ],
    "evidence_relations": "Cell Type: popcorn-shaped cells"
  },
  {
    "id": "Medical-e9c535e5",
    "source": "Medical",
    "question": "What disease transformation is noted for NLPHL?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "Disease Transformation: diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-9d5ac399",
    "source": "Medical",
    "question": "What is the main cell type that distinguishes NLPHL from CHL?",
    "answer": "Popcorn-shaped cells distinguish NLPHL from CHL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Popcorn-shaped cells distinguish NLPHL from CHL."
    ],
    "evidence_relations": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-59a9ad6d",
    "source": "Medical",
    "question": "What are two age-related risk factors for Hodgkin lymphoma?",
    "answer": "Ages 15 to 30 and age 55 are risk factors for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ages 15 to 30 are a risk factor for Hodgkin lymphoma.",
      "Age 55 is a risk factor for Hodgkin lymphoma."
    ],
    "evidence_relations": "Risk Factor: ages 15 to 30, age 55"
  },
  {
    "id": "Medical-3306e2b6",
    "source": "Medical",
    "question": "What is the role of blood tests in Hodgkin lymphoma diagnosis?",
    "answer": "Blood tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-15c48832",
    "source": "Medical",
    "question": "Which imaging techniques are part of the diagnostic methods for Hodgkin lymphoma?",
    "answer": "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-0e5e7e44",
    "source": "Medical",
    "question": "Which anatomical structures are covered by a thin, moist epithelial layer?",
    "answer": "The gallbladder and bile ducts are covered by a thin, moist epithelial layer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The gallbladder is covered by a thin, moist epithelial layer.",
      "The bile ducts are covered by a thin, moist epithelial layer."
    ],
    "evidence_relations": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer"
  },
  {
    "id": "Medical-a0ee92b3",
    "source": "Medical",
    "question": "What is the outermost membrane covering the gallbladder and bile ducts?",
    "answer": "Serosa is the outer membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Serosa is the outer membrane covering the gallbladder.",
      "Serosa is the outer membrane covering the bile ducts."
    ],
    "evidence_relations": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-aa283616",
    "source": "Medical",
    "question": "What histological layers are found in the bile duct wall?",
    "answer": "The bile duct wall contains epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The bile duct wall contains epithelium.",
      "The bile duct wall contains lamina propria.",
      "The bile duct wall contains muscularis.",
      "The bile duct wall contains perimuscular fibrous tissue.",
      "The bile duct wall contains serosa."
    ],
    "evidence_relations": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-5136f646",
    "source": "Medical",
    "question": "Which connective tissue is located under the epithelium in the gallbladder and bile duct?",
    "answer": "Lamina propria is the connective tissue found under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lamina propria is the connective tissue found under the epithelium in the gallbladder.",
      "Lamina propria is the connective tissue found under the epithelium in the bile duct."
    ],
    "evidence_relations": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-7d67a49f",
    "source": "Medical",
    "question": "What is the function of the muscularis layer in the bile duct wall?",
    "answer": "Muscularis is a soft tissue layer in the bile duct wall.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Muscularis is a soft tissue layer in the bile duct wall."
    ],
    "evidence_relations": "Muscularis is a soft tissue layer in the bile duct wall"
  },
  {
    "id": "Medical-0535a6b1",
    "source": "Medical",
    "question": "What tissue surrounds the muscle layer in the bile duct and gallbladder?",
    "answer": "Perimuscular fibrous tissue surrounds the muscle layer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perimuscular fibrous tissue surrounds the muscle layer in the bile duct.",
      "Perimuscular fibrous tissue surrounds the muscle layer in the gallbladder."
    ],
    "evidence_relations": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-14c841bc",
    "source": "Medical",
    "question": "On what basis is bile duct cancer staging determined?",
    "answer": "Bile duct cancer staging is based on tumor size and extent of spread.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bile duct cancer staging is based on tumor size.",
      "Bile duct cancer staging is based on extent of spread."
    ],
    "evidence_relations": "Bile duct cancer staging is based on tumor size and extent of spread"
  },
  {
    "id": "Medical-ebc2ff97",
    "source": "Medical",
    "question": "Which structures can bile duct cancer invade as it progresses?",
    "answer": "Cancer can invade nearby blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bile duct cancer can invade nearby blood vessels.",
      "Bile duct cancer can invade the liver.",
      "Bile duct cancer can invade structures outside the liver."
    ],
    "evidence_relations": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-da181948",
    "source": "Medical",
    "question": "What are the histological layers present in the gallbladder?",
    "answer": "The gallbladder contains epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The gallbladder contains epithelium.",
      "The gallbladder contains lamina propria.",
      "The gallbladder contains muscularis.",
      "The gallbladder contains perimuscular fibrous tissue.",
      "The gallbladder contains serosa."
    ],
    "evidence_relations": "gallbladder has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-1060f44f",
    "source": "Medical",
    "question": "Which cancer type is classified under the anatomical structure of the bile duct?",
    "answer": "Intrahepatic bile duct cancer is classified under the bile duct.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intrahepatic bile duct cancer is classified under the bile duct."
    ],
    "evidence_relations": "Cancer Type: intrahepatic bile duct cancer under bile duct"
  },
  {
    "id": "Medical-5c7974c9",
    "source": "Medical",
    "question": "Which layer directly covers the muscularis in the gallbladder and bile duct?",
    "answer": "Perimuscular fibrous tissue directly covers the muscularis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perimuscular fibrous tissue directly covers the muscularis in the gallbladder.",
      "Perimuscular fibrous tissue directly covers the muscularis in the bile duct."
    ],
    "evidence_relations": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-340cdb40",
    "source": "Medical",
    "question": "What are examples of tumor spread in intrahepatic bile duct cancer?",
    "answer": "Tumor can spread to blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor can spread to blood vessels.",
      "Tumor can spread to the liver.",
      "Tumor can spread to structures outside the liver."
    ],
    "evidence_relations": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-306b4531",
    "source": "Medical",
    "question": "What is an intraductal tumor in the context of cancer staging?",
    "answer": "An intraductal tumor is a carcinoma in situ confined to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "An intraductal tumor is a carcinoma in situ.",
      "An intraductal tumor is confined to the epithelium."
    ],
    "evidence_relations": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-d70b14a4",
    "source": "Medical",
    "question": "Which anatomical structures are included in the ontology for intrahepatic bile duct cancer?",
    "answer": "Bile duct and gallbladder are included as anatomical structures.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bile duct is included as an anatomical structure for intrahepatic bile duct cancer.",
      "Gallbladder is included as an anatomical structure for intrahepatic bile duct cancer."
    ],
    "evidence_relations": "Anatomical Structure: bile duct, gallbladder"
  },
  {
    "id": "Medical-2ebac5e5",
    "source": "Medical",
    "question": "Which tumor characteristic involves the measurement in centimeters or millimeters?",
    "answer": "Primary tumor size (cm or mm) is a tumor characteristic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary tumor size is a tumor characteristic.",
      "Primary tumor size is measured in centimeters or millimeters."
    ],
    "evidence_relations": "Tumor Characteristic: primary tumor size (cm or mm)"
  },
  {
    "id": "Medical-edc4f2c6",
    "source": "Medical",
    "question": "What is the relationship between the muscularis and perimuscular fibrous tissue?",
    "answer": "Perimuscular fibrous tissue surrounds the muscularis layer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perimuscular fibrous tissue surrounds the muscularis layer."
    ],
    "evidence_relations": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-af5dbcb0",
    "source": "Medical",
    "question": "What anatomical layers must a tumor penetrate to reach the serosa in the bile duct?",
    "answer": "A tumor must penetrate the epithelium, lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A tumor must penetrate the epithelium to reach the serosa.",
      "A tumor must penetrate the lamina propria to reach the serosa.",
      "A tumor must penetrate the muscularis to reach the serosa.",
      "A tumor must penetrate the perimuscular fibrous tissue to reach the serosa."
    ],
    "evidence_relations": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-e79c55d4",
    "source": "Medical",
    "question": "Which layer is described as a membrane in the anatomical structure of the gallbladder and bile ducts?",
    "answer": "Serosa is described as a membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Serosa is described as a membrane.",
      "Serosa covers the gallbladder.",
      "Serosa covers the bile ducts."
    ],
    "evidence_relations": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-e4d47909",
    "source": "Medical",
    "question": "What type of lymphoma is follicular lymphoma (FL)?",
    "answer": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma."
    ],
    "evidence_relations": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-c2568161",
    "source": "Medical",
    "question": "What are the main disease sites for follicular lymphoma (FL)?",
    "answer": "FL affects lymph nodes, bone marrow, spleen, and extranodal sites.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follicular lymphoma (FL) affects lymph nodes.",
      "Follicular lymphoma (FL) affects bone marrow.",
      "Follicular lymphoma (FL) affects the spleen.",
      "Follicular lymphoma (FL) affects extranodal sites."
    ],
    "evidence_relations": "Disease sites for FL include lymph node, bone marrow, spleen, and extranodal sites"
  },
  {
    "id": "Medical-7ed82690",
    "source": "Medical",
    "question": "How is grade 3B follicular lymphoma treated?",
    "answer": "Grade 3B FL is treated as diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Grade 3B follicular lymphoma is treated as diffuse large B-cell lymphoma."
    ],
    "evidence_relations": "Grade 3B FL is treated as DLBCL"
  },
  {
    "id": "Medical-4be4d916",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in uncommon FL (uFL)?",
    "answer": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is t(14;18)-negative.",
      "Uncommon follicular lymphoma has uncommon pathologic features."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features"
  },
  {
    "id": "Medical-2e05b3f3",
    "source": "Medical",
    "question": "How is uncommon FL (uFL) treated?",
    "answer": "Uncommon FL (uFL) is treated as classic FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is treated as classic follicular lymphoma."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL"
  },
  {
    "id": "Medical-f3e4ed65",
    "source": "Medical",
    "question": "What is the typical presentation of pediatric-type follicular lymphoma (PTFL)?",
    "answer": "PTFL usually presents with a single enlarged lymph node in the head and neck and minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pediatric-type follicular lymphoma usually presents with a single enlarged lymph node.",
      "The single enlarged lymph node in pediatric-type follicular lymphoma is located in the head and neck.",
      "Pediatric-type follicular lymphoma usually presents with minimal symptoms."
    ],
    "evidence_relations": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-2d90241b",
    "source": "Medical",
    "question": "What are common symptoms of follicular lymphoma (FL)?",
    "answer": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of follicular lymphoma include swollen lymph nodes.",
      "Common symptoms of follicular lymphoma include enlarged spleen.",
      "Common symptoms of follicular lymphoma include fever.",
      "Common symptoms of follicular lymphoma include night sweats.",
      "Common symptoms of follicular lymphoma include fatigue.",
      "Common symptoms of follicular lymphoma include weight loss."
    ],
    "evidence_relations": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-44af5ecf",
    "source": "Medical",
    "question": "What guides treatment decisions in follicular lymphoma (FL)?",
    "answer": "The type of cells in FL determines the grade, which guides treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The type of cells in follicular lymphoma determines the grade.",
      "The grade of follicular lymphoma guides treatment decisions."
    ],
    "evidence_relations": "The type of cells in FL determines the grade, which guides treatment decisions"
  },
  {
    "id": "Medical-9b28edf9",
    "source": "Medical",
    "question": "What are the main cell types found in follicular lymphoma (FL)?",
    "answer": "The main cell types in FL are centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The main cell types in follicular lymphoma are centrocytes.",
      "The main cell types in follicular lymphoma are centroblasts."
    ],
    "evidence_relations": "FL is graded based on the proportion of centrocytes and centroblasts"
  },
  {
    "id": "Medical-8a166224",
    "source": "Medical",
    "question": "Which biomarker is commonly associated with follicular lymphoma (FL)?",
    "answer": "BCL2 protein is a biomarker commonly associated with FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCL2 protein is a biomarker commonly associated with follicular lymphoma."
    ],
    "evidence_relations": "Biomarker: BCL2 protein"
  },
  {
    "id": "Medical-bf9805af",
    "source": "Medical",
    "question": "What genetic alteration is associated with FL besides t(14;18)?",
    "answer": "Chromosome translocation is associated with FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chromosome translocation is associated with follicular lymphoma."
    ],
    "evidence_relations": "Genetic Alteration: chromosome translocation"
  },
  {
    "id": "Medical-9410dd14",
    "source": "Medical",
    "question": "Which FL subtype is defined by t(14;18)-negativity?",
    "answer": "Uncommon FL (uFL) is defined by t(14;18)-negativity.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is defined by t(14;18)-negativity."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative"
  },
  {
    "id": "Medical-2876eea3",
    "source": "Medical",
    "question": "What is the classification of grade 3A FL?",
    "answer": "Grade 3A FL may be classified as classic FL or as DLBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Grade 3A follicular lymphoma may be classified as classic follicular lymphoma.",
      "Grade 3A follicular lymphoma may be classified as DLBCL."
    ],
    "evidence_relations": "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-43e5c06b",
    "source": "Medical",
    "question": "Which FL subtype is associated with minimal symptoms?",
    "answer": "Pediatric-type FL (PTFL) is associated with minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pediatric-type follicular lymphoma is associated with minimal symptoms."
    ],
    "evidence_relations": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-4392ee71",
    "source": "Medical",
    "question": "Which diagnostic method is used to assess bone marrow involvement in FL?",
    "answer": "Bone marrow aspirate and biopsy are used to assess bone marrow involvement in FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone marrow aspirate and biopsy are used to assess bone marrow involvement in follicular lymphoma."
    ],
    "evidence_relations": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping"
  },
  {
    "id": "Medical-08098847",
    "source": "Medical",
    "question": "What is the main clinical management consideration for FL?",
    "answer": "Not all patients with FL require immediate treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Not all patients with FL require immediate treatment."
    ],
    "evidence_relations": "Not all patients with FL require immediate treatment"
  },
  {
    "id": "Medical-3fb59b05",
    "source": "Medical",
    "question": "What is the disease site for extranodal FL?",
    "answer": "Extranodal FL occurs in tissues outside the lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Extranodal FL occurs in tissues outside the lymph nodes."
    ],
    "evidence_relations": "FL can present as nodal or extranodal disease"
  },
  {
    "id": "Medical-cd57cf13",
    "source": "Medical",
    "question": "Which lymphoma subtype can FL transform into?",
    "answer": "FL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "FL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "FL can transform into DLBCL, a more aggressive lymphoma"
  },
  {
    "id": "Medical-ffc96616",
    "source": "Medical",
    "question": "Which organ is commonly enlarged in FL patients?",
    "answer": "The spleen is commonly enlarged in FL patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The spleen is commonly enlarged in FL patients."
    ],
    "evidence_relations": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-fcc037cd",
    "source": "Medical",
    "question": "What defines a mixed-type liver tumor?",
    "answer": "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mixed-type liver tumors contain hepatocellular carcinoma components.",
      "Mixed-type liver tumors contain cholangiocarcinoma components."
    ],
    "evidence_relations": "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components"
  },
  {
    "id": "Medical-4664e4cf",
    "source": "Medical",
    "question": "What is a major risk factor for developing liver cancer?",
    "answer": "Cirrhosis is a major risk factor for developing liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cirrhosis is a major risk factor for developing liver cancer."
    ],
    "evidence_relations": "Cirrhosis is a major risk factor for developing liver cancer"
  },
  {
    "id": "Medical-135a7719",
    "source": "Medical",
    "question": "How does chronic hepatitis B infection affect liver cancer risk?",
    "answer": "Chronic hepatitis B infection increases the risk of liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chronic hepatitis B infection increases the risk of liver cancer."
    ],
    "evidence_relations": "Chronic hepatitis B infection increases the risk of liver cancer"
  },
  {
    "id": "Medical-33eeb504",
    "source": "Medical",
    "question": "How does chronic hepatitis C infection affect liver cancer risk?",
    "answer": "Chronic hepatitis C infection increases the risk of liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chronic hepatitis C infection increases the risk of liver cancer."
    ],
    "evidence_relations": "Chronic hepatitis C infection increases the risk of liver cancer"
  },
  {
    "id": "Medical-0c921721",
    "source": "Medical",
    "question": "What screening methods are used for liver cancer?",
    "answer": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Liver cancer screening includes ultrasound.",
      "Liver cancer screening includes alpha-fetoprotein (AFP) test.",
      "Liver cancer screening is done every 6 months."
    ],
    "evidence_relations": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
  },
  {
    "id": "Medical-73945218",
    "source": "Medical",
    "question": "How can liver cancer spread within the body?",
    "answer": "Liver cancer can spread directly through the liver or to distant sites such as lung or bone.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Liver cancer can spread directly through the liver.",
      "Liver cancer can spread to distant sites such as the lung.",
      "Liver cancer can spread to distant sites such as bone."
    ],
    "evidence_relations": "Liver cancer can spread directly through the liver or to distant sites such as lung or bone"
  },
  {
    "id": "Medical-f4ba3ee9",
    "source": "Medical",
    "question": "What are common sites of liver cancer metastasis?",
    "answer": "Liver cancer most often metastasizes to the lung or bone.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Liver cancer most often metastasizes to the lung.",
      "Liver cancer most often metastasizes to bone."
    ],
    "evidence_relations": "Liver cancer most often metastasizes to the lung or bone"
  },
  {
    "id": "Medical-aece5feb",
    "source": "Medical",
    "question": "Which genetic alteration is a risk factor for liver cancer?",
    "answer": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic hemochromatosis is a risk factor for cirrhosis.",
      "Genetic hemochromatosis is a risk factor for liver cancer."
    ],
    "evidence_relations": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-8c555476",
    "source": "Medical",
    "question": "What is the origin of secondary liver cancer?",
    "answer": "Secondary liver cancer originates from other primary cancers such as colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Secondary liver cancer originates from other primary cancers.",
      "Colon cancer can be a primary cancer that leads to secondary liver cancer."
    ],
    "evidence_relations": "Secondary liver cancer is cancer that has spread to the liver from another organ; Other primary cancers (e.g., colon cancer) are the origin"
  },
  {
    "id": "Medical-3c025533",
    "source": "Medical",
    "question": "Which diagnostic methods are listed for liver cancer in the ontology?",
    "answer": "Imaging tests and biopsy are diagnostic methods for liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are diagnostic methods for liver cancer.",
      "Biopsy is a diagnostic method for liver cancer."
    ],
    "evidence_relations": "Diagnosis of liver cancer is usually confirmed with imaging tests; Biopsy may be needed to confirm liver cancer"
  },
  {
    "id": "Medical-9671d373",
    "source": "Medical",
    "question": "What is another name for oncocytic carcinoma?",
    "answer": "Oncocytic carcinoma is also known as Hrthle cell carcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Oncocytic carcinoma is also known as Hrthle cell carcinoma."
    ],
    "evidence_relations": "Oncocytic carcinoma is also known as Hrthle cell carcinoma"
  },
  {
    "id": "Medical-63709f72",
    "source": "Medical",
    "question": "Which thyroid cancer subtype is the rarest and most aggressive?",
    "answer": "Anaplastic thyroid cancer is the most aggressive and rarest subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Anaplastic thyroid cancer is the rarest subtype of thyroid cancer.",
      "Anaplastic thyroid cancer is the most aggressive subtype of thyroid cancer."
    ],
    "evidence_relations": "Anaplastic thyroid cancer is the most aggressive and rarest subtype"
  },
  {
    "id": "Medical-1068c5b7",
    "source": "Medical",
    "question": "Which inherited syndromes are linked to increased thyroid cancer risk?",
    "answer": "FAP, Carney complex, Cowden syndrome, and MEN are inherited syndromes linked to increased thyroid cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "FAP is an inherited syndrome linked to increased thyroid cancer risk.",
      "Carney complex is an inherited syndrome linked to increased thyroid cancer risk.",
      "Cowden syndrome is an inherited syndrome linked to increased thyroid cancer risk.",
      "MEN is an inherited syndrome linked to increased thyroid cancer risk."
    ],
    "evidence_relations": "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk"
  },
  {
    "id": "Medical-e21aceef",
    "source": "Medical",
    "question": "What symptoms can large thyroid nodules cause?",
    "answer": "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Large thyroid nodules can cause a visible neck lump.",
      "Large thyroid nodules can cause neck pain.",
      "Large thyroid nodules can cause voice changes.",
      "Large thyroid nodules can cause trouble breathing.",
      "Large thyroid nodules can cause swallowing problems."
    ],
    "evidence_relations": "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems"
  },
  {
    "id": "Medical-3226c376",
    "source": "Medical",
    "question": "Which tests are recommended for evaluating thyroid nodules?",
    "answer": "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "TSH blood test is recommended for evaluating thyroid nodules.",
      "Neck ultrasound is recommended for evaluating thyroid nodules."
    ],
    "evidence_relations": "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules"
  },
  {
    "id": "Medical-420f3886",
    "source": "Medical",
    "question": "What procedure is used to sample suspicious thyroid nodules?",
    "answer": "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules."
    ],
    "evidence_relations": "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
  },
  {
    "id": "Medical-06892ea0",
    "source": "Medical",
    "question": "When is lobectomy considered for thyroid cancer?",
    "answer": "Lobectomy is an option for small, low-risk differentiated thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lobectomy is considered for small, low-risk differentiated thyroid cancers."
    ],
    "evidence_relations": "Lobectomy is an option for small, low-risk differentiated thyroid cancers"
  },
  {
    "id": "Medical-2e96fdbb",
    "source": "Medical",
    "question": "What is the standard medication for thyroid hormone replacement?",
    "answer": "Levothyroxine is the standard thyroid hormone replacement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Levothyroxine is the standard thyroid hormone replacement."
    ],
    "evidence_relations": "Levothyroxine is the standard thyroid hormone replacement"
  },
  {
    "id": "Medical-dffcdcf8",
    "source": "Medical",
    "question": "What treatment is used for anaplastic, recurrent, or metastatic thyroid cancers not amenable to surgery or RAI?",
    "answer": "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "External beam radiation therapy is used for anaplastic thyroid cancers.",
      "External beam radiation therapy is used for recurrent thyroid cancers.",
      "External beam radiation therapy is used for metastatic thyroid cancers not amenable to surgery or RAI."
    ],
    "evidence_relations": "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI"
  },
  {
    "id": "Medical-130e07e9",
    "source": "Medical",
    "question": "When is targeted therapy indicated in thyroid cancer?",
    "answer": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Targeted therapy is used for thyroid cancers not responsive to surgery.",
      "Targeted therapy is used for thyroid cancers not responsive to RAI.",
      "Targeted therapy is used for thyroid cancers with metastasis."
    ],
    "evidence_relations": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis"
  },
  {
    "id": "Medical-dc537cd7",
    "source": "Medical",
    "question": "What is the role of chemotherapy in thyroid cancer?",
    "answer": "Chemotherapy is rarely effective and mainly used for anaplastic thyroid cancer with radiation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy is rarely effective in thyroid cancer.",
      "Chemotherapy is mainly used for anaplastic thyroid cancer with radiation."
    ],
    "evidence_relations": "Chemotherapy is rarely effective, mainly used for anaplastic thyroid cancer with radiation"
  },
  {
    "id": "Medical-af243069",
    "source": "Medical",
    "question": "What biomarkers are recommended for testing in recurrent, advanced, or metastatic thyroid cancers not treatable with RAI?",
    "answer": "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, and TMB-H.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarkers recommended for testing in recurrent thyroid cancers include ALK fusion.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include NTRK fusion.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include BRAF mutation.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include RET fusion.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include dMMR.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include MSI-H.",
      "Biomarkers recommended for testing in recurrent thyroid cancers include TMB-H."
    ],
    "evidence_relations": "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H"
  },
  {
    "id": "Medical-8a22c205",
    "source": "Medical",
    "question": "What follow-up is recommended after total thyroidectomy?",
    "answer": "Follow-up after total thyroidectomy includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up after total thyroidectomy includes a physical exam.",
      "Follow-up after total thyroidectomy includes blood tests for TSH.",
      "Follow-up after total thyroidectomy includes blood tests for Tg.",
      "Follow-up after total thyroidectomy includes blood tests for Tg ab.",
      "Follow-up after total thyroidectomy includes a neck ultrasound."
    ],
    "evidence_relations": "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound"
  },
  {
    "id": "Medical-880faffb",
    "source": "Medical",
    "question": "What laboratory tests are included in the follow-up of thyroid cancer?",
    "answer": "Laboratory tests include TSH, thyroglobulin (Tg), and anti-thyroglobulin antibodies (Tg ab).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Laboratory tests include TSH.",
      "Laboratory tests include thyroglobulin (Tg).",
      "Laboratory tests include anti-thyroglobulin antibodies (Tg ab)."
    ],
    "evidence_relations": "Laboratory: [\"TSH test\", \"Thyroglobulin (Tg)\", \"Anti-thyroglobulin antibodies (Tg ab)\"]"
  },
  {
    "id": "Medical-666afa8e",
    "source": "Medical",
    "question": "What is the purpose of molecular tests in thyroid cancer diagnosis?",
    "answer": "Molecular tests can help determine malignancy and need for surgery.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Molecular tests can help determine malignancy.",
      "Molecular tests can help determine the need for surgery."
    ],
    "evidence_relations": "Molecular tests can help determine malignancy and need for surgery"
  },
  {
    "id": "Medical-d184bb36",
    "source": "Medical",
    "question": "What is the recommended treatment for regional thyroid cancer with lymph node involvement?",
    "answer": "Treatment includes surgery with neck dissection and RAI therapy if indicated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment for regional thyroid cancer with lymph node involvement includes surgery.",
      "Surgery for regional thyroid cancer may include neck dissection.",
      "RAI therapy may be indicated for regional thyroid cancer with lymph node involvement."
    ],
    "evidence_relations": "Regional (lymph node involvement): {\"Treatment\": [\"Surgery with neck dissection\", \"RAI therapy (if indicated)\"]}"
  },
  {
    "id": "Medical-4e0348b9",
    "source": "Medical",
    "question": "What are the treatment options for thyroid cancer with distant metastasis?",
    "answer": "Treatment options for distant metastasis include RAI therapy (if iodine-avid), targeted therapy, external beam radiation therapy, chemotherapy (for anaplastic), and clinical trial.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment options for distant metastasis include RAI therapy if iodine-avid.",
      "Treatment options for distant metastasis include targeted therapy.",
      "Treatment options for distant metastasis include external beam radiation therapy.",
      "Treatment options for distant metastasis include chemotherapy for anaplastic thyroid cancer.",
      "Treatment options for distant metastasis include clinical trial."
    ],
    "evidence_relations": "Distant metastasis: {\"Treatment\": [\"RAI therapy (if iodine-avid)\", \"Targeted therapy\", \"External beam radiation therapy\", \"Chemotherapy (for anaplastic)\", \"Clinical trial\"]}"
  },
  {
    "id": "Medical-35f5fbd3",
    "source": "Medical",
    "question": "Which gene mutations are considered actionable biomarkers in thyroid cancer?",
    "answer": "Actionable biomarkers include BRAF gene mutation, RET gene fusion, ALK gene fusion, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Actionable biomarkers in thyroid cancer include BRAF gene mutation.",
      "Actionable biomarkers in thyroid cancer include RET gene fusion.",
      "Actionable biomarkers in thyroid cancer include ALK gene fusion.",
      "Actionable biomarkers in thyroid cancer include NTRK gene fusion."
    ],
    "evidence_relations": "Biomarker: [\"BRAF gene mutation\", \"RET gene fusion\", \"ALK gene fusion\", \"NTRK gene fusion\"]"
  },
  {
    "id": "Medical-f8d40959",
    "source": "Medical",
    "question": "What is the primary method for detecting recurrence in thyroid cancer?",
    "answer": "Detection of recurrence is primarily by rising thyroglobulin, neck ultrasound, and imaging (CT, MRI).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary method for detecting recurrence in thyroid cancer is rising thyroglobulin.",
      "Neck ultrasound is a method for detecting recurrence in thyroid cancer.",
      "Imaging methods such as CT and MRI are used to detect recurrence in thyroid cancer."
    ],
    "evidence_relations": "Recurrence: {\"Detection\": [\"Rising thyroglobulin\", \"Neck ultrasound\", \"Imaging (CT, MRI)\"]}"
  },
  {
    "id": "Medical-edb040bb",
    "source": "Medical",
    "question": "What is the origin of primary bone cancer?",
    "answer": "Primary bone cancer originates in bone or cartilage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary bone cancer originates in bone.",
      "Primary bone cancer originates in cartilage."
    ],
    "evidence_relations": "Primary bone cancer originates in bone or cartilage"
  },
  {
    "id": "Medical-0cac50ed",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in Ewing sarcoma?",
    "answer": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions.",
      "The most common gene fusion in Ewing sarcoma is EWSR1-FLI1."
    ],
    "evidence_relations": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1"
  },
  {
    "id": "Medical-6ded047c",
    "source": "Medical",
    "question": "Where does giant cell tumor of bone often occur?",
    "answer": "Giant cell tumor of bone often occurs in the metaphysis and epiphysis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Giant cell tumor of bone often occurs in the metaphysis.",
      "Giant cell tumor of bone often occurs in the epiphysis."
    ],
    "evidence_relations": "Giant cell tumor of bone often occurs in the metaphysis and epiphysis"
  },
  {
    "id": "Medical-c39b1031",
    "source": "Medical",
    "question": "How is the diagnosis of bone cancer confirmed?",
    "answer": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of bone cancer is confirmed by core needle biopsy.",
      "Diagnosis of bone cancer is confirmed by surgical biopsy."
    ],
    "evidence_relations": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy"
  },
  {
    "id": "Medical-38953b85",
    "source": "Medical",
    "question": "What blood tests are used in the evaluation of bone cancer?",
    "answer": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests used in the evaluation of bone cancer include alkaline phosphatase.",
      "Blood tests used in the evaluation of bone cancer include CBC.",
      "Blood tests used in the evaluation of bone cancer include CMP.",
      "Blood tests used in the evaluation of bone cancer include LDH."
    ],
    "evidence_relations": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation"
  },
  {
    "id": "Medical-0fcdee63",
    "source": "Medical",
    "question": "What is the purpose of genetic cancer risk testing in bone cancer?",
    "answer": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic cancer risk testing identifies germline mutations.",
      "Germline mutations are associated with increased cancer risk."
    ],
    "evidence_relations": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk"
  },
  {
    "id": "Medical-7dd6e939",
    "source": "Medical",
    "question": "What treatments are available for tumor mutational burden-high (TMB-H) bone cancers?",
    "answer": "TMB-H may be treated with pembrolizumab, nivolumab, or ipilimumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "TMB-H may be treated with pembrolizumab.",
      "TMB-H may be treated with nivolumab.",
      "TMB-H may be treated with ipilimumab."
    ],
    "evidence_relations": "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab"
  },
  {
    "id": "Medical-142025a5",
    "source": "Medical",
    "question": "What system is used for staging bone cancer?",
    "answer": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Staging of bone cancer uses the TNM system.",
      "The TNM system includes T for tumor size/location.",
      "The TNM system includes N for lymph node involvement.",
      "The TNM system includes M for metastasis."
    ],
    "evidence_relations": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)"
  },
  {
    "id": "Medical-8f43b36b",
    "source": "Medical",
    "question": "How is the stage of bone cancer determined?",
    "answer": "Stage is determined by combining T, N, M, and G scores.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage of bone cancer is determined by combining T scores.",
      "Stage of bone cancer is determined by combining N scores.",
      "Stage of bone cancer is determined by combining M scores.",
      "Stage of bone cancer is determined by combining G scores."
    ],
    "evidence_relations": "Stage is determined by combining T, N, M, and G scores"
  },
  {
    "id": "Medical-712b02a6",
    "source": "Medical",
    "question": "Which performance status scales are used in bone cancer treatment planning?",
    "answer": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ECOG performance status is used in bone cancer treatment planning.",
      "Karnofsky Performance Status (KPS) is used in bone cancer treatment planning."
    ],
    "evidence_relations": "Performance status (ECOG or KPS) is considered in treatment planning"
  },
  {
    "id": "Medical-7ced180c",
    "source": "Medical",
    "question": "What metabolic complication can bone cancer cause?",
    "answer": "Bone cancer can cause hypercalcemia due to bone destruction.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone cancer can cause hypercalcemia.",
      "Hypercalcemia is due to bone destruction."
    ],
    "evidence_relations": "Bone cancer can cause hypercalcemia due to bone destruction"
  },
  {
    "id": "Medical-45b7e7da",
    "source": "Medical",
    "question": "Where can bone cancer spread?",
    "answer": "Bone cancer can spread to lungs, other bones, or distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone cancer can spread to the lungs.",
      "Bone cancer can spread to other bones.",
      "Bone cancer can spread to distant organs."
    ],
    "evidence_relations": "Bone cancer can spread to lungs, other bones, or distant organs"
  },
  {
    "id": "Medical-9418792b",
    "source": "Medical",
    "question": "Which diagnostic methods are used for bone sarcomas?",
    "answer": "Diagnostic methods for bone sarcomas include X-ray, bone scan, CT scan, MRI, PET scan, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "X-ray is a diagnostic method for bone sarcomas.",
      "Bone scan is a diagnostic method for bone sarcomas.",
      "CT scan is a diagnostic method for bone sarcomas.",
      "MRI is a diagnostic method for bone sarcomas.",
      "PET scan is a diagnostic method for bone sarcomas.",
      "Biopsy is a diagnostic method for bone sarcomas."
    ],
    "evidence_relations": "Osteosarcoma: Diagnostic Method: [X-ray, Bone scan, CT scan, MRI, PET scan, Biopsy]"
  },
  {
    "id": "Medical-7a495600",
    "source": "Medical",
    "question": "What are the main risk factors for bone cancer?",
    "answer": "Family history of cancer and germline mutations are risk factors for bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history of cancer is a risk factor for bone cancer.",
      "Germline mutations are a risk factor for bone cancer."
    ],
    "evidence_relations": "Risk Factor: [Family history of cancer, Germline mutations]"
  },
  {
    "id": "Medical-836b4146",
    "source": "Medical",
    "question": "What are alternative names for mouth cancer?",
    "answer": "Mouth cancer is also known as oral cavity cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mouth cancer is also known as oral cavity cancer."
    ],
    "evidence_relations": "Mouth cancer: Also known as Oral cavity cancer"
  },
  {
    "id": "Medical-bb448a1f",
    "source": "Medical",
    "question": "Which anatomic sites can be affected by mouth cancer?",
    "answer": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mouth cancer can develop in the lips.",
      "Mouth cancer can develop in the gums.",
      "Mouth cancer can develop in the buccal mucosa.",
      "Mouth cancer can develop in the tongue.",
      "Mouth cancer can develop in the hard palate.",
      "Mouth cancer can develop in the alveolar ridge.",
      "Mouth cancer can develop in the floor of mouth.",
      "Mouth cancer can develop in the retromolar trigone."
    ],
    "evidence_relations": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone"
  },
  {
    "id": "Medical-92eb2c34",
    "source": "Medical",
    "question": "What is the basis for cancer staging in mouth cancer?",
    "answer": "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cancer staging in mouth cancer is based on the TNM system.",
      "The TNM system includes tumor size and depth (T).",
      "The TNM system includes lymph node involvement (N).",
      "The TNM system includes distant metastasis (M)."
    ],
    "evidence_relations": "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)"
  },
  {
    "id": "Medical-dbfb3406",
    "source": "Medical",
    "question": "How is T2 defined in mouth cancer TNM classification?",
    "answer": "T2 is a tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T2 is a tumor 2 cm with DOI >5 mm.",
      "T2 is a tumor 24 cm with DOI 10 mm."
    ],
    "evidence_relations": "T2: Tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm"
  },
  {
    "id": "Medical-97502e67",
    "source": "Medical",
    "question": "What characterizes a T3 tumor in mouth cancer?",
    "answer": "T3 is a 24 cm tumor with DOI >10 mm or >4 cm tumor with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A T3 tumor in mouth cancer is 24 cm in size.",
      "A T3 tumor in mouth cancer has a depth of invasion (DOI) greater than 10 mm.",
      "A T3 tumor in mouth cancer can also be greater than 4 cm in size with a DOI of 10 mm or less."
    ],
    "evidence_relations": "T3: 24 cm with DOI >10 mm or >4 cm with DOI 10 mm"
  },
  {
    "id": "Medical-4eefc14f",
    "source": "Medical",
    "question": "Which diagnostic methods may be used for mouth cancer besides imaging?",
    "answer": "Diagnostic methods include panoramic dental x-ray (Panorex), fine-needle aspiration (FNA), core needle biopsy (CNB), dental exam, speech and swallowing assessment, and nutrition assessment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Panoramic dental x-ray (Panorex) may be used as a diagnostic method for mouth cancer.",
      "Fine-needle aspiration (FNA) may be used as a diagnostic method for mouth cancer.",
      "Core needle biopsy (CNB) may be used as a diagnostic method for mouth cancer.",
      "A dental exam may be used as a diagnostic method for mouth cancer.",
      "Speech and swallowing assessment may be used as a diagnostic method for mouth cancer.",
      "Nutrition assessment may be used as a diagnostic method for mouth cancer."
    ],
    "evidence_relations": "Diagnostic Method: [CT scan, MRI, PET/CT, Ultrasound, Panoramic dental x-ray (Panorex), Biopsy, Fine-needle aspiration (FNA), Core needle biopsy (CNB), Dental exam, Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-6f5dcba9",
    "source": "Medical",
    "question": "What biomarkers may be tested in mouth cancer?",
    "answer": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing in mouth cancer may include PD-L1.",
      "Biomarker testing in mouth cancer may include MSI-H/dMMR.",
      "Biomarker testing in mouth cancer may include tumor mutational burden (TMB)."
    ],
    "evidence_relations": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-dde9c1e8",
    "source": "Medical",
    "question": "Which risk factors are associated with mouth cancer?",
    "answer": "Tobacco use and alcohol use are risk factors for mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tobacco use is a risk factor for mouth cancer.",
      "Alcohol use is a risk factor for mouth cancer."
    ],
    "evidence_relations": "Tobacco and alcohol use are risk factors for mouth cancer"
  },
  {
    "id": "Medical-9e29cae8",
    "source": "Medical",
    "question": "Which clinical assessment is important for treatment selection in mouth cancer?",
    "answer": "Performance status (ECOG) is considered in treatment selection.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status (ECOG) is considered in treatment selection for mouth cancer."
    ],
    "evidence_relations": "Performance status (ECOG) is considered in treatment selection"
  },
  {
    "id": "Medical-015910ee",
    "source": "Medical",
    "question": "How can cancer and its treatment impact fertility in mouth cancer patients?",
    "answer": "Cancer and its treatment can affect fertility.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cancer can affect fertility in mouth cancer patients.",
      "Treatment can affect fertility in mouth cancer patients."
    ],
    "evidence_relations": "Cancer and its treatment can affect fertility"
  },
  {
    "id": "Medical-ab04c717",
    "source": "Medical",
    "question": "What symptoms may indicate mouth cancer?",
    "answer": "Symptoms may include changes in the mouth, tongue, or neck area.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of mouth cancer may include changes in the mouth.",
      "Symptoms of mouth cancer may include changes in the tongue.",
      "Symptoms of mouth cancer may include changes in the neck area."
    ],
    "evidence_relations": "Symptoms may include changes in the mouth, tongue, or neck area"
  },
  {
    "id": "Medical-f41a6eed",
    "source": "Medical",
    "question": "What is the purpose of a dental exam in mouth cancer management?",
    "answer": "Dental exam is a diagnostic method used in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A dental exam is a diagnostic method used in mouth cancer."
    ],
    "evidence_relations": "Diagnostic Method: [Dental exam]"
  },
  {
    "id": "Medical-7f529715",
    "source": "Medical",
    "question": "Which assessments are included in the clinical evaluation of mouth cancer patients?",
    "answer": "Speech and swallowing assessment and nutrition assessment are included in clinical evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Speech and swallowing assessment is included in the clinical evaluation of mouth cancer patients.",
      "Nutrition assessment is included in the clinical evaluation of mouth cancer patients."
    ],
    "evidence_relations": "Diagnostic Method: [Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-25024e4e",
    "source": "Medical",
    "question": "What is the significance of performance status (ECOG) in mouth cancer?",
    "answer": "Performance status (ECOG) is used as a clinical assessment in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status (ECOG) is used as a clinical assessment in mouth cancer."
    ],
    "evidence_relations": "Clinical Assessment: [Performance status (ECOG)]"
  },
  {
    "id": "Medical-f598e40d",
    "source": "Medical",
    "question": "What fertility consideration should be addressed in mouth cancer patients?",
    "answer": "Fertility preservation is a fertility consideration in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation is a fertility consideration in mouth cancer."
    ],
    "evidence_relations": "Fertility Consideration: [Fertility preservation]"
  },
  {
    "id": "Medical-f2c54ca8",
    "source": "Medical",
    "question": "Which genetic alterations may be evaluated in mouth cancer biomarker testing?",
    "answer": "MSI-H/dMMR and tumor mutational burden (TMB) may be evaluated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MSI-H/dMMR may be evaluated in mouth cancer biomarker testing.",
      "Tumor mutational burden (TMB) may be evaluated in mouth cancer biomarker testing."
    ],
    "evidence_relations": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-79a34cfc",
    "source": "Medical",
    "question": "Which stomach adenocarcinoma subtype forms tube- and gland-shaped structures?",
    "answer": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures."
    ],
    "evidence_relations": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures"
  },
  {
    "id": "Medical-50852ffa",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma consists of scattered cells and is less common?",
    "answer": "Diffuse type adenocarcinoma consists of scattered cells and is less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diffuse type adenocarcinoma consists of scattered cells.",
      "Diffuse type adenocarcinoma is less common."
    ],
    "evidence_relations": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-442b042c",
    "source": "Medical",
    "question": "To which organs can stomach cancer spread?",
    "answer": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stomach cancer can spread to lymph nodes.",
      "Stomach cancer can spread to veins.",
      "Stomach cancer can spread to arteries.",
      "Stomach cancer can spread to the liver.",
      "Stomach cancer can spread to the pancreas.",
      "Stomach cancer can spread to the spleen."
    ],
    "evidence_relations": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen"
  },
  {
    "id": "Medical-d8dd3085",
    "source": "Medical",
    "question": "What is a risk factor for stomach cancer related to infection?",
    "answer": "H. pylori infection is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer."
    ],
    "evidence_relations": "H. pylori infection is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-e77a80c7",
    "source": "Medical",
    "question": "Is family history a risk factor for stomach cancer?",
    "answer": "Family history is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history is a risk factor for stomach cancer."
    ],
    "evidence_relations": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5778d49d",
    "source": "Medical",
    "question": "What symptoms can stomach cancer cause?",
    "answer": "Symptoms can include ulcer or mass formation in the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stomach cancer can cause ulcer formation in the stomach.",
      "Stomach cancer can cause mass formation in the stomach."
    ],
    "evidence_relations": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-ed553dca",
    "source": "Medical",
    "question": "What is the role of biomarker testing in stomach cancer diagnosis?",
    "answer": "Biomarker testing is used as part of the diagnostic process for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing is used as part of the diagnostic process for stomach cancer."
    ],
    "evidence_relations": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-fc8c1f25",
    "source": "Medical",
    "question": "What genetic risk factor is listed for stomach cancer?",
    "answer": "Family history is listed as a genetic risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history is listed as a genetic risk factor for stomach cancer."
    ],
    "evidence_relations": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5470aded",
    "source": "Medical",
    "question": "Which stomach cancer subtype is less common?",
    "answer": "Diffuse type adenocarcinoma is less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diffuse type adenocarcinoma is a less common subtype of stomach cancer."
    ],
    "evidence_relations": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-e18d2c7f",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma is more likely to benefit from targeted therapy?",
    "answer": "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy."
    ],
    "evidence_relations": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy"
  },
  {
    "id": "Medical-e542c70c",
    "source": "Medical",
    "question": "What are two main symptoms of stomach cancer listed in the ontology?",
    "answer": "Ulcer and mass are two main symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ulcer is a main symptom of stomach cancer.",
      "Mass is a main symptom of stomach cancer."
    ],
    "evidence_relations": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-5724612b",
    "source": "Medical",
    "question": "What are the most common subtypes of glioma?",
    "answer": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Astrocytoma is a common subtype of glioma.",
      "Oligodendroglioma is a common subtype of glioma.",
      "Glioblastoma is a common subtype of glioma."
    ],
    "evidence_relations": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma"
  },
  {
    "id": "Medical-e84e4ea0",
    "source": "Medical",
    "question": "Which glioma subtype is the most aggressive?",
    "answer": "Glioblastoma is the most aggressive subtype of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Glioblastoma is the most aggressive subtype of glioma."
    ],
    "evidence_relations": "Glioblastoma is the most aggressive subtype of glioma"
  },
  {
    "id": "Medical-d272b033",
    "source": "Medical",
    "question": "What biomarker is used to classify gliomas?",
    "answer": "IDH mutation is a biomarker used to classify gliomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "IDH mutation is a biomarker used to classify gliomas."
    ],
    "evidence_relations": "IDH mutation is a biomarker used to classify gliomas"
  },
  {
    "id": "Medical-981edc6b",
    "source": "Medical",
    "question": "What is recommended for follow-up after glioma treatment?",
    "answer": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Periodic imaging (MRI) is recommended for follow-up after glioma treatment.",
      "The purpose of follow-up imaging is to monitor for recurrence."
    ],
    "evidence_relations": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence"
  },
  {
    "id": "Medical-28389677",
    "source": "Medical",
    "question": "What is assessed to determine treatment eligibility for glioma?",
    "answer": "Performance status is assessed to determine treatment eligibility.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is assessed to determine treatment eligibility for glioma."
    ],
    "evidence_relations": "Performance status is assessed to determine treatment eligibility"
  },
  {
    "id": "Medical-7b37919a",
    "source": "Medical",
    "question": "In which age group are gliomas more common?",
    "answer": "Gliomas are more common in adults than children.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gliomas are more common in adults than in children."
    ],
    "evidence_relations": "Gliomas are more common in adults than children"
  },
  {
    "id": "Medical-3c7e7363",
    "source": "Medical",
    "question": "What performance status assessment is used in glioma diagnosis?",
    "answer": "Performance status is assessed as part of the clinical evaluation for glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is assessed as part of the clinical evaluation for glioma."
    ],
    "evidence_relations": "Clinical evaluation for glioma includes performance status assessment"
  },
  {
    "id": "Medical-bf9e60be",
    "source": "Medical",
    "question": "Which imaging methods are used for glioma diagnosis according to the ontology?",
    "answer": "MRI and CT scan are imaging methods used for glioma diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MRI is an imaging method used for glioma diagnosis.",
      "CT scan is an imaging method used for glioma diagnosis."
    ],
    "evidence_relations": "Imaging for glioma diagnosis includes MRI and CT scan"
  },
  {
    "id": "Medical-86e59474",
    "source": "Medical",
    "question": "What laboratory tests are conducted for glioma diagnosis?",
    "answer": "Laboratory testing for glioma includes molecular testing and histology.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Laboratory testing for glioma includes molecular testing.",
      "Laboratory testing for glioma includes histology."
    ],
    "evidence_relations": "Laboratory testing for glioma includes molecular testing and histology"
  },
  {
    "id": "Medical-2db59cde",
    "source": "Medical",
    "question": "What are the risk factors for glioma?",
    "answer": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for glioma include age.",
      "Glioma is more common in adults.",
      "Risk factors for glioma include non-hereditary mutation."
    ],
    "evidence_relations": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation"
  },
  {
    "id": "Medical-96567841",
    "source": "Medical",
    "question": "What type of cancer is AML?",
    "answer": "AML is a type of blood cancer that starts in the stem cells of bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AML is a type of blood cancer.",
      "AML starts in the stem cells of bone marrow."
    ],
    "evidence_relations": "AML is a type of blood cancer that starts in the stem cells of bone marrow"
  },
  {
    "id": "Medical-78c160d3",
    "source": "Medical",
    "question": "How is AML diagnosed?",
    "answer": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow.",
      "AML is diagnosed by the presence of 20% myeloblasts in blood."
    ],
    "evidence_relations": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood"
  },
  {
    "id": "Medical-44f40835",
    "source": "Medical",
    "question": "What is Blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
    "answer": "BPDCN is an aggressive subtype of AML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of acute myeloid leukemia (AML)."
    ],
    "evidence_relations": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML"
  },
  {
    "id": "Medical-93bdac1d",
    "source": "Medical",
    "question": "What causes low counts of healthy blood cells in AML?",
    "answer": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute myeloid leukemia (AML) causes a buildup of blasts in bone marrow.",
      "Acute myeloid leukemia (AML) causes a buildup of blasts in blood.",
      "The buildup of blasts in AML leads to low counts of healthy red blood cells.",
      "The buildup of blasts in AML leads to low counts of healthy platelets.",
      "The buildup of blasts in AML leads to low counts of healthy white blood cells."
    ],
    "evidence_relations": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells"
  },
  {
    "id": "Medical-98aa1f14",
    "source": "Medical",
    "question": "Which laboratory tests are used for AML diagnosis?",
    "answer": "Complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complete blood count (CBC) is used for AML diagnosis.",
      "Comprehensive metabolic panel (CMP) is used for AML diagnosis.",
      "Lactate dehydrogenase (LDH) is used for AML diagnosis.",
      "Blood clotting tests are used for AML diagnosis."
    ],
    "evidence_relations": "Laboratory tests used for AML diagnosis include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests"
  },
  {
    "id": "Medical-6d25f354",
    "source": "Medical",
    "question": "What bone marrow evaluations are performed for AML diagnosis?",
    "answer": "Bone marrow aspirate, bone marrow biopsy, and histopathology are performed.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone marrow aspirate is performed for AML diagnosis.",
      "Bone marrow biopsy is performed for AML diagnosis.",
      "Histopathology is performed for AML diagnosis."
    ],
    "evidence_relations": "Bone marrow evaluation for AML includes bone marrow aspirate, bone marrow biopsy, and histopathology"
  },
  {
    "id": "Medical-722f609c",
    "source": "Medical",
    "question": "What molecular and cytogenetic tests are used in AML workup?",
    "answer": "Karyotype, FISH, next-generation sequencing (NGS), and PCR are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Karyotype testing is used in AML workup.",
      "FISH testing is used in AML workup.",
      "Next-generation sequencing (NGS) is used in AML workup.",
      "PCR testing is used in AML workup."
    ],
    "evidence_relations": "Molecular and cytogenetic testing for AML includes karyotype, FISH, next-generation sequencing (NGS), and PCR"
  },
  {
    "id": "Medical-1345f015",
    "source": "Medical",
    "question": "Which chemotherapy agents are commonly used in AML?",
    "answer": "Chemotherapy regimens may include cytarabine, daunorubicin, idarubicin, and hypomethylating agents such as azacitidine and decitabine.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy regimens for AML may include cytarabine.",
      "Chemotherapy regimens for AML may include daunorubicin.",
      "Chemotherapy regimens for AML may include idarubicin.",
      "Chemotherapy regimens for AML may include hypomethylating agents such as azacitidine.",
      "Chemotherapy regimens for AML may include hypomethylating agents such as decitabine."
    ],
    "evidence_relations": "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine)"
  },
  {
    "id": "Medical-5cd1d09f",
    "source": "Medical",
    "question": "What are common genetic alterations found in AML?",
    "answer": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common genetic alterations in AML include FLT3-ITD.",
      "Common genetic alterations in AML include FLT3-TKD.",
      "Common genetic alterations in AML include inv(16).",
      "Common genetic alterations in AML include inv(3).",
      "Common genetic alterations in AML include t(8;21).",
      "Common genetic alterations in AML include del(5q).",
      "Common genetic alterations in AML include PML::RARA."
    ],
    "evidence_relations": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA"
  },
  {
    "id": "Medical-284507d2",
    "source": "Medical",
    "question": "What is the goal of AML treatment phases?",
    "answer": "The goal of AML treatment phases is achieving remission.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The goal of AML treatment phases is achieving remission."
    ],
    "evidence_relations": "Treatment for AML is delivered in phases with the goal of achieving remission"
  },
  {
    "id": "Medical-514e9bd7",
    "source": "Medical",
    "question": "When is hematopoietic cell transplant considered in AML?",
    "answer": "Hematopoietic cell transplant is considered for eligible patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hematopoietic cell transplant is considered for eligible patients."
    ],
    "evidence_relations": "Hematopoietic cell transplant is considered for eligible patients"
  },
  {
    "id": "Medical-393eabb5",
    "source": "Medical",
    "question": "What supportive care measures are provided in AML?",
    "answer": "Supportive care includes transfusions, infection prevention, and management of side effects.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care in AML includes transfusions.",
      "Supportive care in AML includes infection prevention.",
      "Supportive care in AML includes management of side effects."
    ],
    "evidence_relations": "Supportive care includes transfusions, infection prevention, and management of side effects"
  },
  {
    "id": "Medical-70d75840",
    "source": "Medical",
    "question": "What are risk factors for developing AML?",
    "answer": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history of leukemia is a risk factor for developing AML.",
      "Hereditary predisposition syndromes are risk factors for developing AML."
    ],
    "evidence_relations": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML"
  },
  {
    "id": "Medical-5d792183",
    "source": "Medical",
    "question": "What is the cell of origin for AML?",
    "answer": "AML originates from myeloid blasts and bone marrow stem cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AML originates from myeloid blasts.",
      "AML originates from bone marrow stem cells."
    ],
    "evidence_relations": "Cell of Origin for AML includes myeloid blasts and bone marrow stem cells"
  },
  {
    "id": "Medical-bb057eb6",
    "source": "Medical",
    "question": "Which AML subtype commonly involves the skin?",
    "answer": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) commonly involves the skin.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) commonly involves the skin."
    ],
    "evidence_relations": "BPDCN is a subtype of AML with sites of involvement including skin"
  },
  {
    "id": "Medical-67b8e0a9",
    "source": "Medical",
    "question": "What fertility preservation options are recommended in AML?",
    "answer": "Fertility preservation counseling and referral to a reproductive specialist are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation counseling is recommended in AML.",
      "Referral to a reproductive specialist is recommended in AML."
    ],
    "evidence_relations": "Fertility Preservation in AML includes fertility preservation counseling and referral to reproductive specialist"
  },
  {
    "id": "Medical-78cecf8c",
    "source": "Medical",
    "question": "What is the most common type of ovarian cancer?",
    "answer": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ovarian cancer is most commonly an epithelial cancer.",
      "Epithelial cancer arises from the ovary surface epithelium."
    ],
    "evidence_relations": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium"
  },
  {
    "id": "Medical-1bb1f1db",
    "source": "Medical",
    "question": "What are some less common subtypes of ovarian cancer?",
    "answer": "Less common ovarian cancers include low-grade serous carcinoma, low-grade endometrioid carcinoma, carcinosarcoma, clear cell carcinoma, mucinous carcinoma, borderline epithelial tumor, malignant sex-cord stromal tumors, and malignant germ cell tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Less common ovarian cancers include low-grade serous carcinoma.",
      "Less common ovarian cancers include low-grade endometrioid carcinoma.",
      "Less common ovarian cancers include carcinosarcoma.",
      "Less common ovarian cancers include clear cell carcinoma.",
      "Less common ovarian cancers include mucinous carcinoma.",
      "Less common ovarian cancers include borderline epithelial tumor.",
      "Less common ovarian cancers include malignant sex-cord stromal tumors.",
      "Less common ovarian cancers include malignant germ cell tumors."
    ],
    "evidence_relations": "Less common ovarian cancers include low-grade serous carcinoma, low-grade endometrioid carcinoma, carcinosarcoma, clear cell carcinoma, mucinous carcinoma, borderline epithelial tumor, malignant sex-cord stromal tumors, and malignant germ cell tumors"
  },
  {
    "id": "Medical-ceb6a99b",
    "source": "Medical",
    "question": "Which cancers are managed similarly to ovarian cancer?",
    "answer": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary peritoneal cancer is managed similarly to ovarian cancer.",
      "Fallopian tube cancer is managed similarly to ovarian cancer."
    ],
    "evidence_relations": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer"
  },
  {
    "id": "Medical-1a736b11",
    "source": "Medical",
    "question": "What are the common symptoms of ovarian cancer?",
    "answer": "Common symptoms include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of ovarian cancer include bloating.",
      "Common symptoms of ovarian cancer include pelvic or abdominal pain.",
      "Common symptoms of ovarian cancer include trouble eating or feeling full quickly.",
      "Common symptoms of ovarian cancer include urinary urgency or frequency.",
      "Common symptoms of ovarian cancer include pain during sex."
    ],
    "evidence_relations": "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex"
  },
  {
    "id": "Medical-d8149b81",
    "source": "Medical",
    "question": "Which hereditary syndromes are major risk factors for ovarian cancer?",
    "answer": "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BRCA1 mutations are a major hereditary risk factor for ovarian cancer.",
      "BRCA2 mutations are a major hereditary risk factor for ovarian cancer.",
      "Lynch syndrome is a major hereditary risk factor for ovarian cancer."
    ],
    "evidence_relations": "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer"
  },
  {
    "id": "Medical-40918a31",
    "source": "Medical",
    "question": "Who should receive genetic testing for BRCA and other syndromes in ovarian cancer?",
    "answer": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer."
    ],
    "evidence_relations": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer"
  },
  {
    "id": "Medical-1043deff",
    "source": "Medical",
    "question": "What tumor biomarker tests are performed in ovarian cancer?",
    "answer": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor biomarker testing includes BRCA mutation.",
      "Tumor biomarker testing includes HRD status.",
      "Tumor biomarker testing includes MSI.",
      "Tumor biomarker testing includes MMR.",
      "Tumor biomarker testing includes HER2 expression.",
      "Tumor biomarker testing includes TMB.",
      "Tumor biomarker testing includes BRAF V600E.",
      "Tumor biomarker testing includes FR.",
      "Tumor biomarker testing includes RET mutations.",
      "Tumor biomarker testing includes NTRK gene fusion."
    ],
    "evidence_relations": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion"
  },
  {
    "id": "Medical-cd6393dc",
    "source": "Medical",
    "question": "What staging system is used for ovarian cancer?",
    "answer": "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Staging of ovarian cancer is based on the FIGO system.",
      "The FIGO system has stages I-IV.",
      "Surgical staging is required for ovarian cancer."
    ],
    "evidence_relations": "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging"
  },
  {
    "id": "Medical-cf87aed7",
    "source": "Medical",
    "question": "What is the standard initial treatment for most ovarian cancers?",
    "answer": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgery is the standard initial treatment for most ovarian cancers.",
      "The standard initial surgery is a hysterectomy with bilateral salpingo-oophorectomy."
    ],
    "evidence_relations": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers"
  },
  {
    "id": "Medical-ae9a09e0",
    "source": "Medical",
    "question": "What chemotherapy regimen is typically recommended after surgery for ovarian cancer?",
    "answer": "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy is typically recommended after surgery for ovarian cancer.",
      "Paclitaxel is a chemotherapy drug recommended after surgery for ovarian cancer.",
      "Carboplatin is a chemotherapy drug recommended after surgery for ovarian cancer.",
      "Chemotherapy is recommended for most stages of ovarian cancer."
    ],
    "evidence_relations": "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages"
  },
  {
    "id": "Medical-2ca3a0ac",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy in some ovarian cancer cases?",
    "answer": "Bevacizumab may be added to chemotherapy in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bevacizumab may be added to chemotherapy in some ovarian cancer cases."
    ],
    "evidence_relations": "Bevacizumab may be added to chemotherapy in some cases"
  },
  {
    "id": "Medical-0ce3e959",
    "source": "Medical",
    "question": "What are the treatment options for platinum-resistant ovarian cancer?",
    "answer": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy.",
      "Bevacizumab is a treatment option for platinum-resistant ovarian cancer.",
      "Targeted therapies are treatment options for platinum-resistant ovarian cancer.",
      "Mirvetuximab soravtansine-gynx is a targeted therapy for FR-positive tumors."
    ],
    "evidence_relations": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors"
  },
  {
    "id": "Medical-41491cb3",
    "source": "Medical",
    "question": "When are clinical trials recommended for ovarian cancer?",
    "answer": "Clinical trials are recommended for recurrent or persistent ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are recommended for recurrent ovarian cancer.",
      "Clinical trials are recommended for persistent ovarian cancer."
    ],
    "evidence_relations": "Clinical trials are recommended for recurrent or persistent ovarian cancer"
  },
  {
    "id": "Medical-fcbaf737",
    "source": "Medical",
    "question": "Which tumor markers are used in ovarian cancer diagnosis?",
    "answer": "Tumor markers include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, and HE4.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor markers used in ovarian cancer diagnosis include CA-125.",
      "Tumor markers used in ovarian cancer diagnosis include Inhibin.",
      "Tumor markers used in ovarian cancer diagnosis include Beta-human chorionic gonadotropin (-hCG).",
      "Tumor markers used in ovarian cancer diagnosis include Alpha-fetoprotein (AFP).",
      "Tumor markers used in ovarian cancer diagnosis include Lactate dehydrogenase (LDH).",
      "Tumor markers used in ovarian cancer diagnosis include Carcinoembryonic antigen (CEA).",
      "Tumor markers used in ovarian cancer diagnosis include CA 19-9.",
      "Tumor markers used in ovarian cancer diagnosis include HE4."
    ],
    "evidence_relations": "Tumor marker tests include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, HE4"
  },
  {
    "id": "Medical-6b4b11a7",
    "source": "Medical",
    "question": "Which diagnostic procedures are available for ovarian cancer?",
    "answer": "Diagnostic methods include abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, FNA, core biopsy, paracentesis, colonoscopy, upper endoscopy, CBC, blood chemistry profile, and liver function tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for ovarian cancer include abdominal exams.",
      "Diagnostic methods for ovarian cancer include pelvic exams.",
      "Diagnostic methods for ovarian cancer include ultrasound.",
      "Diagnostic methods for ovarian cancer include CT scan.",
      "Diagnostic methods for ovarian cancer include MRI.",
      "Diagnostic methods for ovarian cancer include PET scan.",
      "Diagnostic methods for ovarian cancer include chest x-ray.",
      "Diagnostic methods for ovarian cancer include diagnostic laparoscopy.",
      "Diagnostic methods for ovarian cancer include biopsy.",
      "Diagnostic methods for ovarian cancer include FNA.",
      "Diagnostic methods for ovarian cancer include core biopsy.",
      "Diagnostic methods for ovarian cancer include paracentesis.",
      "Diagnostic methods for ovarian cancer include colonoscopy.",
      "Diagnostic methods for ovarian cancer include upper endoscopy.",
      "Diagnostic methods for ovarian cancer include CBC.",
      "Diagnostic methods for ovarian cancer include blood chemistry profile.",
      "Diagnostic methods for ovarian cancer include liver function tests."
    ],
    "evidence_relations": "Diagnostic Method includes abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, fine-needle aspiration (FNA), core biopsy, paracentesis, colonoscopy, upper endoscopy, complete blood count (CBC), blood chemistry profile, liver function tests"
  },
  {
    "id": "Medical-476ca8b6",
    "source": "Medical",
    "question": "What surgical procedures are included in the treatment of ovarian cancer?",
    "answer": "Surgical procedures include hysterectomy, bilateral salpingo-oophorectomy, unilateral salpingo-oophorectomy, debulking surgery, cytoreductive surgery, interval cytoreductive surgery, laparotomy, laparoscopy, and peritoneal washing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgical procedures for ovarian cancer include hysterectomy.",
      "Surgical procedures for ovarian cancer include bilateral salpingo-oophorectomy.",
      "Surgical procedures for ovarian cancer include unilateral salpingo-oophorectomy.",
      "Surgical procedures for ovarian cancer include debulking surgery.",
      "Surgical procedures for ovarian cancer include cytoreductive surgery.",
      "Surgical procedures for ovarian cancer include interval cytoreductive surgery.",
      "Surgical procedures for ovarian cancer include laparotomy.",
      "Surgical procedures for ovarian cancer include laparoscopy.",
      "Surgical procedures for ovarian cancer include peritoneal washing."
    ],
    "evidence_relations": "Surgical Procedure includes hysterectomy, bilateral salpingo-oophorectomy (BSO), unilateral salpingo-oophorectomy (USO), debulking surgery, cytoreductive surgery, interval cytoreductive surgery (ICS), laparotomy, laparoscopy, peritoneal washing"
  },
  {
    "id": "Medical-451efc66",
    "source": "Medical",
    "question": "Which chemotherapy drugs are commonly used in ovarian cancer?",
    "answer": "Common chemotherapy drugs include paclitaxel, carboplatin, cisplatin, oxaliplatin, docetaxel, and bevacizumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common chemotherapy drugs for ovarian cancer include paclitaxel.",
      "Common chemotherapy drugs for ovarian cancer include carboplatin.",
      "Common chemotherapy drugs for ovarian cancer include cisplatin.",
      "Common chemotherapy drugs for ovarian cancer include oxaliplatin.",
      "Common chemotherapy drugs for ovarian cancer include docetaxel.",
      "Common chemotherapy drugs for ovarian cancer include bevacizumab."
    ],
    "evidence_relations": "Chemotherapy Regimen includes paclitaxel, carboplatin, cisplatin, oxaliplatin, docetaxel, bevacizumab (Avastin)"
  },
  {
    "id": "Medical-365a0e76",
    "source": "Medical",
    "question": "Which maintenance therapies are available for ovarian cancer?",
    "answer": "Maintenance therapies include olaparib, niraparib, rucaparib, bevacizumab, and mirvetuximab soravtansine-gynx.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Maintenance therapies for ovarian cancer include olaparib.",
      "Maintenance therapies for ovarian cancer include niraparib.",
      "Maintenance therapies for ovarian cancer include rucaparib.",
      "Maintenance therapies for ovarian cancer include bevacizumab.",
      "Maintenance therapies for ovarian cancer include mirvetuximab soravtansine-gynx."
    ],
    "evidence_relations": "Maintenance Therapy includes olaparib (Lynparza), niraparib (Zejula), rucaparib (Rubraca), bevacizumab (Avastin), mirvetuximab soravtansine-gynx (Elahere)"
  },
  {
    "id": "Medical-181dd442",
    "source": "Medical",
    "question": "What genetic alterations are tested for in ovarian cancer?",
    "answer": "Genetic alterations tested include BRCA1 mutation, BRCA2 mutation, HRD, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutation, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic alterations tested for ovarian cancer include BRCA1 mutation.",
      "Genetic alterations tested for ovarian cancer include BRCA2 mutation.",
      "Genetic alterations tested for ovarian cancer include HRD.",
      "Genetic alterations tested for ovarian cancer include MSI.",
      "Genetic alterations tested for ovarian cancer include MMR.",
      "Genetic alterations tested for ovarian cancer include HER2 expression.",
      "Genetic alterations tested for ovarian cancer include TMB.",
      "Genetic alterations tested for ovarian cancer include BRAF V600E.",
      "Genetic alterations tested for ovarian cancer include FR.",
      "Genetic alterations tested for ovarian cancer include RET mutation.",
      "Genetic alterations tested for ovarian cancer include NTRK gene fusion."
    ],
    "evidence_relations": "Genetic Alteration includes BRCA1 mutation, BRCA2 mutation, homologous recombination deficiency (HRD), microsatellite instability (MSI), mismatch repair (MMR), HER2 expression, tumor mutational burden (TMB), BRAF V600E mutation, folate receptor alpha (FR), RET mutation, NTRK gene fusion"
  },
  {
    "id": "Medical-fbef0cd8",
    "source": "Medical",
    "question": "What are the main risk factors for ovarian cancer?",
    "answer": "Risk factors include BRCA1 mutation, BRCA2 mutation, Lynch syndrome, and family history.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Main risk factors for ovarian cancer include BRCA1 mutation.",
      "Main risk factors for ovarian cancer include BRCA2 mutation.",
      "Main risk factors for ovarian cancer include Lynch syndrome.",
      "Main risk factors for ovarian cancer include family history."
    ],
    "evidence_relations": "Risk Factor includes BRCA1 mutation, BRCA2 mutation, Lynch syndrome, Family history"
  },
  {
    "id": "Medical-070e0d62",
    "source": "Medical",
    "question": "What are the stages of ovarian cancer according to the FIGO system?",
    "answer": "The stages are Stage I (IA, IB, IC1, IC2, IC3), Stage II (IIA, IIB), Stage III (IIIA1(i), IIIA1(ii), IIIA2, IIIB, IIIC), and Stage IV (IVA, IVB).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The stages of ovarian cancer according to the FIGO system include Stage I.",
      "Stage I includes IA, IB, IC1, IC2, and IC3.",
      "The stages of ovarian cancer according to the FIGO system include Stage II.",
      "Stage II includes IIA and IIB.",
      "The stages of ovarian cancer according to the FIGO system include Stage III.",
      "Stage III includes IIIA1(i), IIIA1(ii), IIIA2, IIIB, and IIIC.",
      "The stages of ovarian cancer according to the FIGO system include Stage IV.",
      "Stage IV includes IVA and IVB."
    ],
    "evidence_relations": "Stage includes Stage I (IA, IB, IC1, IC2, IC3), Stage II (IIA, IIB), Stage III (IIIA1(i), IIIA1(ii), IIIA2, IIIB, IIIC), Stage IV (IVA, IVB)"
  },
  {
    "id": "Medical-adf818a2",
    "source": "Medical",
    "question": "What are common symptoms of ovarian cancer listed in the ontology?",
    "answer": "Common symptoms include persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, and constipation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of ovarian cancer include persistent bloating.",
      "Common symptoms of ovarian cancer include pelvic pain.",
      "Common symptoms of ovarian cancer include abdominal pain.",
      "Common symptoms of ovarian cancer include trouble eating.",
      "Common symptoms of ovarian cancer include feeling full quickly.",
      "Common symptoms of ovarian cancer include urinary urgency.",
      "Common symptoms of ovarian cancer include urinary frequency.",
      "Common symptoms of ovarian cancer include pain during sex.",
      "Common symptoms of ovarian cancer include fatigue.",
      "Common symptoms of ovarian cancer include unexplained weight loss.",
      "Common symptoms of ovarian cancer include constipation."
    ],
    "evidence_relations": "Symptom includes persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, constipation"
  },
  {
    "id": "Medical-e7671bff",
    "source": "Medical",
    "question": "What is the recommended management for recurrent or persistent ovarian cancer?",
    "answer": "Clinical trial enrollment is recommended for recurrent or persistent disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trial enrollment is recommended for recurrent ovarian cancer.",
      "Clinical trial enrollment is recommended for persistent ovarian cancer."
    ],
    "evidence_relations": "Clinical trial enrollment for recurrent or persistent disease"
  },
  {
    "id": "Medical-150e36b6",
    "source": "Medical",
    "question": "How is CLL/SLL diagnosed?",
    "answer": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CLL/SLL is diagnosed by a blood test.",
      "The blood test shows 5,000 monoclonal B lymphocytes per microliter."
    ],
    "evidence_relations": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter"
  },
  {
    "id": "Medical-cdfc9ecd",
    "source": "Medical",
    "question": "What are common symptoms of CLL?",
    "answer": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of CLL include swollen glands.",
      "Common symptoms of CLL include fatigue.",
      "Common symptoms of CLL include night sweats.",
      "Common symptoms of CLL include fever.",
      "Common symptoms of CLL include recurrent infections.",
      "Common symptoms of CLL include early satiety.",
      "Common symptoms of CLL include unintentional weight loss."
    ],
    "evidence_relations": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-4f070485",
    "source": "Medical",
    "question": "What are risk factors for developing CLL?",
    "answer": "Risk factors for CLL include older age and family history of CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for developing CLL include older age.",
      "Risk factors for developing CLL include family history of CLL."
    ],
    "evidence_relations": "Risk factors for CLL include older age and family history of CLL"
  },
  {
    "id": "Medical-e33e6d40",
    "source": "Medical",
    "question": "What surface proteins are identified in CLL cells by immunophenotyping?",
    "answer": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping identifies CLL cells by surface proteins.",
      "Surface proteins identified in CLL cells include CD20.",
      "Surface proteins identified in CLL cells include CD200.",
      "Surface proteins identified in CLL cells include LEF1."
    ],
    "evidence_relations": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1"
  },
  {
    "id": "Medical-e773a3cf",
    "source": "Medical",
    "question": "What are the treatment options for CLL/SLL?",
    "answer": "Treatment options include oral medications, IV infusions, and combination therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment options for CLL/SLL include oral medications.",
      "Treatment options for CLL/SLL include IV infusions.",
      "Treatment options for CLL/SLL include combination therapies."
    ],
    "evidence_relations": "Treatment options include oral medications, IV infusions, and combination therapies"
  },
  {
    "id": "Medical-b31acd9a",
    "source": "Medical",
    "question": "What factors are considered in CLL treatment planning?",
    "answer": "Performance status and comprehensive metabolic panel are used in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is considered in CLL treatment planning.",
      "Comprehensive metabolic panel is used in CLL treatment planning."
    ],
    "evidence_relations": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-3d64f92a",
    "source": "Medical",
    "question": "What is the treatment goal regarding minimal residual disease in CLL?",
    "answer": "Minimal residual disease is a treatment goal indicating mostly healthy blood cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Minimal residual disease is a treatment goal in CLL.",
      "Minimal residual disease indicates mostly healthy blood cells."
    ],
    "evidence_relations": "Minimal residual disease is a treatment goal indicating mostly healthy blood cells"
  },
  {
    "id": "Medical-7bc6693e",
    "source": "Medical",
    "question": "What considerations are needed before starting CLL treatment in women of reproductive age?",
    "answer": "Pregnancy testing and fertility preservation are considered before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pregnancy testing is considered before starting CLL treatment in women of reproductive age.",
      "Fertility preservation is considered before starting CLL treatment in women of reproductive age."
    ],
    "evidence_relations": "Pregnancy testing and fertility preservation are considered before starting treatment"
  },
  {
    "id": "Medical-92b44036",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in CLL biomarker testing?",
    "answer": "Relevant genetic alterations include 17p deletion, TP53 mutation, and IGHV mutation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "17p deletion is a relevant genetic alteration in CLL biomarker testing.",
      "TP53 mutation is a relevant genetic alteration in CLL biomarker testing.",
      "IGHV mutation is a relevant genetic alteration in CLL biomarker testing."
    ],
    "evidence_relations": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-7197a18d",
    "source": "Medical",
    "question": "What is the primary site of CLL?",
    "answer": "The primary site of CLL is the blood and bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary site of CLL is the blood.",
      "The primary site of CLL is the bone marrow."
    ],
    "evidence_relations": "The primary site of CLL is the blood and bone marrow"
  },
  {
    "id": "Medical-9f87cac2",
    "source": "Medical",
    "question": "What is the purpose of a comprehensive metabolic panel in CLL management?",
    "answer": "A comprehensive metabolic panel is used in treatment planning for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A comprehensive metabolic panel is used in treatment planning for CLL."
    ],
    "evidence_relations": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-f7b0cf01",
    "source": "Medical",
    "question": "What is the function of supportive care in CLL follow-up?",
    "answer": "Supportive care is part of follow-up strategies for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care is part of follow-up strategies for CLL."
    ],
    "evidence_relations": "Follow-up strategies include watch and wait, regular monitoring, and supportive care"
  },
  {
    "id": "Medical-ccd3b472",
    "source": "Medical",
    "question": "What is the significance of complex karyotype in CLL?",
    "answer": "Complex karyotype is a biomarker assessed in CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complex karyotype is a biomarker assessed in CLL."
    ],
    "evidence_relations": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-2621de32",
    "source": "Medical",
    "question": "Which symptoms may indicate advanced CLL?",
    "answer": "Symptoms such as early satiety and unintentional weight loss may indicate advanced CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms such as early satiety may indicate advanced CLL.",
      "Unintentional weight loss may indicate advanced CLL."
    ],
    "evidence_relations": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-a6860279",
    "source": "Medical",
    "question": "What diagnostic method is required for definitive diagnosis and biomarker testing in throat cancer?",
    "answer": "Biopsy is required for definitive diagnosis and biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A biopsy is required for definitive diagnosis in throat cancer.",
      "A biopsy is required for biomarker testing in throat cancer."
    ],
    "evidence_relations": "Biopsy is required for definitive diagnosis and biomarker testing"
  },
  {
    "id": "Medical-20454e30",
    "source": "Medical",
    "question": "Which factors are considered risk factors for head and neck cancers?",
    "answer": "Tobacco and alcohol use are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tobacco use is a risk factor for head and neck cancers.",
      "Alcohol use is a risk factor for head and neck cancers."
    ],
    "evidence_relations": "Tobacco and alcohol use are risk factors for head and neck cancers"
  },
  {
    "id": "Medical-c99a29ae",
    "source": "Medical",
    "question": "Which symptoms may indicate throat cancer?",
    "answer": "Symptoms may include difficulty swallowing, sore throat, and changes in voice.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Difficulty swallowing may indicate throat cancer.",
      "Sore throat may indicate throat cancer.",
      "Changes in voice may indicate throat cancer."
    ],
    "evidence_relations": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-cea4d8ff",
    "source": "Medical",
    "question": "Which system is used for staging throat cancer?",
    "answer": "Cancer staging uses the AJCC TNM system.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The AJCC TNM system is used for staging throat cancer."
    ],
    "evidence_relations": "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)"
  },
  {
    "id": "Medical-5bf6c470",
    "source": "Medical",
    "question": "What tumor size corresponds to T1 in the AJCC TNM staging?",
    "answer": "T1 is a tumor 2 cm or less.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T1 in the AJCC TNM staging corresponds to a tumor 2 cm or less."
    ],
    "evidence_relations": "T1: Tumor 2 cm"
  },
  {
    "id": "Medical-c808d555",
    "source": "Medical",
    "question": "Which biomarker expressions may guide immunotherapy treatment decisions in throat cancer?",
    "answer": "PD-L1 expression may guide immunotherapy treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-L1 expression may guide immunotherapy treatment decisions in throat cancer."
    ],
    "evidence_relations": "PD-L1 expression may guide immunotherapy treatment decisions"
  },
  {
    "id": "Medical-930c4439",
    "source": "Medical",
    "question": "Which biomarker tests are included in throat cancer biomarker testing?",
    "answer": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing in throat cancer includes p16 (HPV).",
      "Biomarker testing in throat cancer includes PD-L1.",
      "Biomarker testing in throat cancer includes MSI-H/dMMR.",
      "Biomarker testing in throat cancer includes tumor mutational burden."
    ],
    "evidence_relations": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden"
  },
  {
    "id": "Medical-49e7d093",
    "source": "Medical",
    "question": "What are the common sites of metastasis for throat cancer?",
    "answer": "Common sites of metastasis are the lungs, liver, or spine.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common sites of metastasis for throat cancer include the lungs.",
      "Common sites of metastasis for throat cancer include the liver.",
      "Common sites of metastasis for throat cancer include the spine."
    ],
    "evidence_relations": "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine"
  },
  {
    "id": "Medical-43965a1c",
    "source": "Medical",
    "question": "What is used to determine clinical stage before treatment in throat cancer?",
    "answer": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical stage of throat cancer is determined before treatment.",
      "Physical exam is used to determine clinical stage before treatment in throat cancer.",
      "Imaging is used to determine clinical stage before treatment in throat cancer.",
      "Biopsy is used to determine clinical stage before treatment in throat cancer."
    ],
    "evidence_relations": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy"
  },
  {
    "id": "Medical-c89d3c38",
    "source": "Medical",
    "question": "How is pathologic stage determined in throat cancer?",
    "answer": "Pathologic stage is determined after surgery based on tissue examination.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pathologic stage of throat cancer is determined after surgery.",
      "Pathologic stage is based on tissue examination."
    ],
    "evidence_relations": "Pathologic stage is determined after surgery based on tissue examination"
  },
  {
    "id": "Medical-d8127f85",
    "source": "Medical",
    "question": "Which assessment is important before treatment of throat cancer?",
    "answer": "Dental health assessment is important before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Dental health assessment is important before treatment of throat cancer."
    ],
    "evidence_relations": "Dental health assessment is important before treatment"
  },
  {
    "id": "Medical-26d2ebbd",
    "source": "Medical",
    "question": "Which performance status is considered a prognostic factor in throat cancer treatment planning?",
    "answer": "ECOG performance status is a prognostic factor considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ECOG performance status is a prognostic factor in throat cancer treatment planning."
    ],
    "evidence_relations": "Performance status (ECOG) is a prognostic factor considered in treatment planning"
  },
  {
    "id": "Medical-5e15bf0c",
    "source": "Medical",
    "question": "Which scoping procedures are used as diagnostic methods for throat cancer?",
    "answer": "Endoscopy, laryngoscopy, nasolaryngoscopy, esophagoscopy, bronchoscopy, and panendoscopy are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Endoscopy is used as a diagnostic method for throat cancer.",
      "Laryngoscopy is used as a diagnostic method for throat cancer.",
      "Nasolaryngoscopy is used as a diagnostic method for throat cancer.",
      "Esophagoscopy is used as a diagnostic method for throat cancer.",
      "Bronchoscopy is used as a diagnostic method for throat cancer.",
      "Panendoscopy is used as a diagnostic method for throat cancer."
    ],
    "evidence_relations": "Scoping procedures: [\"Endoscopy\", \"Laryngoscopy\", \"Nasolaryngoscopy\", \"Esophagoscopy\", \"Bronchoscopy\", \"Panendoscopy\"]"
  },
  {
    "id": "Medical-f5e27a80",
    "source": "Medical",
    "question": "Which genetic alterations are associated with squamous cell carcinoma of the throat?",
    "answer": "HPV-mediated, p16-positive, and p16-negative are associated genetic alterations.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV-mediated genetic alterations are associated with squamous cell carcinoma of the throat.",
      "p16-positive genetic alterations are associated with squamous cell carcinoma of the throat.",
      "p16-negative genetic alterations are associated with squamous cell carcinoma of the throat."
    ],
    "evidence_relations": "Genetic Alteration: [\"HPV-mediated\", \"p16-positive\", \"p16-negative\"]"
  },
  {
    "id": "Medical-75107d1d",
    "source": "Medical",
    "question": "What surveillance methods are used for patients after throat cancer treatment?",
    "answer": "Surveillance includes dental health assessment, imaging follow-up, and physical exam.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance methods after throat cancer treatment include dental health assessment.",
      "Surveillance methods after throat cancer treatment include imaging follow-up.",
      "Surveillance methods after throat cancer treatment include physical exam."
    ],
    "evidence_relations": "Surveillance: [\"Dental health assessment\", \"Imaging follow-up\", \"Physical exam\"]"
  },
  {
    "id": "Medical-dd68e8b3",
    "source": "Medical",
    "question": "What symptoms are commonly associated with throat cancer?",
    "answer": "Difficulty swallowing, sore throat, and voice changes are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms associated with throat cancer include difficulty swallowing.",
      "Common symptoms associated with throat cancer include sore throat.",
      "Common symptoms associated with throat cancer include voice changes."
    ],
    "evidence_relations": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-fde1ce46",
    "source": "Medical",
    "question": "What are the main prognostic factors considered for squamous cell carcinoma of the throat?",
    "answer": "ECOG performance status, tumor grade, and HPV/p16 status are main prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ECOG performance status is a main prognostic factor for squamous cell carcinoma of the throat.",
      "Tumor grade is a main prognostic factor for squamous cell carcinoma of the throat.",
      "HPV/p16 status is a main prognostic factor for squamous cell carcinoma of the throat."
    ],
    "evidence_relations": "Prognostic Factor: [\"ECOG performance status\", \"Tumor grade\", \"HPV/p16 status\"]"
  },
  {
    "id": "Medical-d1271e37",
    "source": "Medical",
    "question": "What are common symptoms of cutaneous B-cell lymphoma?",
    "answer": "Symptoms include skin nodules and papules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of cutaneous B-cell lymphoma include skin nodules.",
      "Common symptoms of cutaneous B-cell lymphoma include papules."
    ],
    "evidence_relations": "Symptoms of CBCL include skin nodules and papules"
  },
  {
    "id": "Medical-4c260a72",
    "source": "Medical",
    "question": "Which test is used to assess biomarkers and genetic changes in CBCL?",
    "answer": "Testing for CBCL includes assessment of biomarkers and genetic changes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Testing for CBCL includes assessment of biomarkers.",
      "Testing for CBCL includes assessment of genetic changes."
    ],
    "evidence_relations": "Testing for CBCL includes assessment of biomarkers and genetic changes"
  },
  {
    "id": "Medical-a40a55aa",
    "source": "Medical",
    "question": "Which subtypes are included under cutaneous B-cell lymphoma in the ontology?",
    "answer": "Primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type) are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary cutaneous marginal zone lymphoma (PCMZL) is included under cutaneous B-cell lymphoma.",
      "Primary cutaneous follicle center lymphoma (PCFCL) is included under cutaneous B-cell lymphoma.",
      "Primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type) is included under cutaneous B-cell lymphoma."
    ],
    "evidence_relations": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-5d17dd81",
    "source": "Medical",
    "question": "What is the role of lymphocytes in the body?",
    "answer": "Lymphocytes help fight infection.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lymphocytes help fight infection."
    ],
    "evidence_relations": "Lymphocytes are a type of white blood cell that help fight infection"
  },
  {
    "id": "Medical-c7d5764f",
    "source": "Medical",
    "question": "What are examples of diagnostic imaging tests for CBCL?",
    "answer": "Imaging tests are used for diagnosis of CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are used for the diagnosis of CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-1295f7a6",
    "source": "Medical",
    "question": "Which test is used to analyze cell surface proteins in CBCL diagnosis?",
    "answer": "Immunophenotyping is used to analyze cell surface proteins.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping is used to analyze cell surface proteins."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-6c304dfe",
    "source": "Medical",
    "question": "What laboratory test is commonly performed for CBCL diagnosis?",
    "answer": "Blood test is commonly performed for CBCL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A blood test is commonly performed for CBCL diagnosis."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-9b559ea7",
    "source": "Medical",
    "question": "What type of lymphoma is cutaneous T-cell lymphoma (CTCL)?",
    "answer": "CTCL is a cancer subtype of primary cutaneous lymphoma derived from T lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CTCL is a cancer subtype of primary cutaneous lymphoma.",
      "CTCL is derived from T lymphocytes."
    ],
    "evidence_relations": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-6a57de34",
    "source": "Medical",
    "question": "Which diagnostic method involves examining the skin for CBCL?",
    "answer": "Skin exam is a diagnostic method for CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A skin exam is a diagnostic method for CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-8bfc6705",
    "source": "Medical",
    "question": "Which categories of biomarkers are assessed in CBCL testing?",
    "answer": "Assessment includes both biomarkers and genetic changes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Assessment includes biomarkers.",
      "Assessment includes genetic changes."
    ],
    "evidence_relations": "Testing for CBCL includes assessment of biomarkers and genetic changes"
  },
  {
    "id": "Medical-4c444d45",
    "source": "Medical",
    "question": "Which diagnostic method is used to identify genetic changes in CBCL?",
    "answer": "Immunophenotyping is used to identify genetic changes in CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping is used to identify genetic changes in CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-ca48819b",
    "source": "Medical",
    "question": "What are the three named subtypes of CBCL in the ontology?",
    "answer": "The three named subtypes are PCMZL, PCFCL, and PC-DLBCL, leg type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The three named subtypes of CBCL are PCMZL.",
      "The three named subtypes of CBCL are PCFCL.",
      "The three named subtypes of CBCL are PC-DLBCL, leg type."
    ],
    "evidence_relations": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-1b7da7b8",
    "source": "Medical",
    "question": "What are the two main subtypes of ALL?",
    "answer": "The two main subtypes of ALL are B-cell ALL (B-ALL) and T-cell ALL (T-ALL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The two main subtypes of ALL are B-cell ALL (B-ALL).",
      "The two main subtypes of ALL are T-cell ALL (T-ALL)."
    ],
    "evidence_relations": "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)"
  },
  {
    "id": "Medical-fe91b005",
    "source": "Medical",
    "question": "What rare subtype of B-ALL is treated differently?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL.",
      "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL."
    ],
    "evidence_relations": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-a413ecf5",
    "source": "Medical",
    "question": "What is B-cell lymphoblastic lymphoma also called?",
    "answer": "B-cell lymphoblastic lymphoma is also called B-LL or B-LBL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "B-cell lymphoblastic lymphoma is also called B-LL.",
      "B-cell lymphoblastic lymphoma is also called B-LBL."
    ],
    "evidence_relations": "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
  },
  {
    "id": "Medical-5a825e05",
    "source": "Medical",
    "question": "What is the minimum percentage of lymphoblasts in bone marrow required for ALL diagnosis?",
    "answer": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow."
    ],
    "evidence_relations": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow"
  },
  {
    "id": "Medical-b3af6970",
    "source": "Medical",
    "question": "What are the possible disease sites for ALL?",
    "answer": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL can be found in bone marrow.",
      "ALL can be found in blood.",
      "ALL can be found in testicles.",
      "ALL can be found in the central nervous system (CNS)."
    ],
    "evidence_relations": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)"
  },
  {
    "id": "Medical-53b40877",
    "source": "Medical",
    "question": "Which subtype of ALL can cause an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) can cause an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell ALL (T-ALL) can cause an enlarged thymus."
    ],
    "evidence_relations": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-e31f34b7",
    "source": "Medical",
    "question": "What are the components of ALL treatment besides chemotherapy and steroids?",
    "answer": "Systemic therapy and supportive care are part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Systemic therapy is part of ALL treatment.",
      "Supportive care is part of ALL treatment."
    ],
    "evidence_relations": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-bff01916",
    "source": "Medical",
    "question": "Which subtype of B-ALL requires intensive systemic therapies?",
    "answer": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies."
    ],
    "evidence_relations": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
  },
  {
    "id": "Medical-b63d5b37",
    "source": "Medical",
    "question": "For which cases are clinical trials preferred in ALL?",
    "answer": "Clinical trials are preferred for certain B-ALL and T-ALL cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are preferred for certain B-ALL cases.",
      "Clinical trials are preferred for certain T-ALL cases."
    ],
    "evidence_relations": "Clinical trials are preferred for certain B-ALL and T-ALL cases"
  },
  {
    "id": "Medical-85d1a489",
    "source": "Medical",
    "question": "How is infant ALL (under 12 months) treated compared to other age groups?",
    "answer": "Infant ALL (under 12 months) is treated differently than other age groups.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Infant ALL (under 12 months) is treated differently than other age groups."
    ],
    "evidence_relations": "Infant ALL (under 12 months) is treated differently than other age groups"
  },
  {
    "id": "Medical-1d62116d",
    "source": "Medical",
    "question": "What is the purpose of a lumbar puncture in ALL diagnosis?",
    "answer": "A lumbar puncture is used as a diagnostic method for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A lumbar puncture is used as a diagnostic method for ALL."
    ],
    "evidence_relations": "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture"
  },
  {
    "id": "Medical-0c88cd2e",
    "source": "Medical",
    "question": "What is the standard supportive care for ALL?",
    "answer": "Supportive care is part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care is part of ALL treatment."
    ],
    "evidence_relations": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-4cb346cb",
    "source": "Medical",
    "question": "What is the main treatment protocol for both B-ALL and T-ALL?",
    "answer": "Steroids, multiagent chemotherapy, systemic therapy, and clinical trial are main treatments.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Steroids are a main treatment for both B-ALL and T-ALL.",
      "Multiagent chemotherapy is a main treatment for both B-ALL and T-ALL.",
      "Systemic therapy is a main treatment for both B-ALL and T-ALL.",
      "Clinical trial is a main treatment for both B-ALL and T-ALL."
    ],
    "evidence_relations": "B-cell ALL (B-ALL): Treatment: [steroids, multiagent chemotherapy, systemic therapy, clinical trial]; T-cell ALL (T-ALL): Treatment: [steroids, multiagent chemotherapy, systemic therapy, clinical trial]"
  },
  {
    "id": "Medical-efdf2abc",
    "source": "Medical",
    "question": "What cancer type is characterized by fast growth and origin in lymphocytes?",
    "answer": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer.",
      "ALL starts in lymphocytes."
    ],
    "evidence_relations": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-45dbe22b",
    "source": "Medical",
    "question": "Which site is affected in T-cell lymphoblastic lymphoma?",
    "answer": "T-cell lymphoblastic lymphoma involves the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell lymphoblastic lymphoma involves the thymus."
    ],
    "evidence_relations": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)"
  },
  {
    "id": "Medical-a685f7fb",
    "source": "Medical",
    "question": "Which age group requires a different treatment approach for ALL?",
    "answer": "Infants (under 12 months) require a different treatment approach for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Infants under 12 months require a different treatment approach for ALL."
    ],
    "evidence_relations": "Infant ALL (under 12 months) is treated differently than other age groups"
  },
  {
    "id": "Medical-49bb5694",
    "source": "Medical",
    "question": "Which polyps rarely become cancerous in the rectum?",
    "answer": "Hyperplastic and inflammatory polyps rarely turn into cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hyperplastic polyps rarely turn into cancer.",
      "Inflammatory polyps rarely turn into cancer."
    ],
    "evidence_relations": "Hyperplastic and inflammatory polyps rarely turn into cancer"
  },
  {
    "id": "Medical-6b8d3af0",
    "source": "Medical",
    "question": "What are the recommended biomarkers to test in all rectal tumors?",
    "answer": "All rectal tumors should be tested for dMMR or MSI-H.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All rectal tumors should be tested for dMMR.",
      "All rectal tumors should be tested for MSI-H."
    ],
    "evidence_relations": "All rectal tumors should be tested for dMMR or MSI-H"
  },
  {
    "id": "Medical-63846367",
    "source": "Medical",
    "question": "Which biomarkers are associated with rectal cancer?",
    "answer": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mismatch repair deficiency (dMMR) is a biomarker in rectal cancer.",
      "Microsatellite instability-high (MSI-H) is a biomarker in rectal cancer."
    ],
    "evidence_relations": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer"
  },
  {
    "id": "Medical-4418f730",
    "source": "Medical",
    "question": "Which scan is used to detect metastasis in rectal cancer?",
    "answer": "CT scan of chest and abdomen is used to detect metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CT scan of chest and abdomen is used to detect metastasis in rectal cancer."
    ],
    "evidence_relations": "CT scan of chest and abdomen is used to detect metastasis"
  },
  {
    "id": "Medical-58b16818",
    "source": "Medical",
    "question": "Which surgical procedure is an option for T1 tumors at the end of the rectum?",
    "answer": "Transanal local excision is an option for T1 tumors at the end of the rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Transanal local excision is an option for T1 tumors at the end of the rectum."
    ],
    "evidence_relations": "Transanal local excision is an option for T1 tumors at the end of the rectum"
  },
  {
    "id": "Medical-40a89900",
    "source": "Medical",
    "question": "What surgical treatment is recommended for T2 and some T1/T3 rectal tumors?",
    "answer": "Transabdominal surgery is recommended for T2 and some T1/T3 tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Transabdominal surgery is recommended for T2 rectal tumors.",
      "Transabdominal surgery is recommended for some T1/T3 rectal tumors."
    ],
    "evidence_relations": "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
  },
  {
    "id": "Medical-64d6964d",
    "source": "Medical",
    "question": "What is the surveillance strategy after local excision or ESD for rectal cancer?",
    "answer": "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance after local excision or ESD for rectal cancer includes regular sigmoidoscopy.",
      "Surveillance after local excision or ESD for rectal cancer includes imaging."
    ],
    "evidence_relations": "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
  },
  {
    "id": "Medical-c02f01c8",
    "source": "Medical",
    "question": "Which procedure is recommended after surgery for surveillance of rectal cancer?",
    "answer": "Colonoscopy is recommended after surgery for surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Colonoscopy is recommended after surgery for surveillance of rectal cancer."
    ],
    "evidence_relations": "Colonoscopy is recommended after surgery for surveillance"
  },
  {
    "id": "Medical-3677b386",
    "source": "Medical",
    "question": "What are the fertility preservation options for rectal cancer patients?",
    "answer": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation options for rectal cancer patients include sperm banking.",
      "Fertility preservation options for rectal cancer patients include egg freezing.",
      "Fertility preservation options for rectal cancer patients include ovarian tissue banking.",
      "Fertility preservation options for rectal cancer patients include ovarian transposition."
    ],
    "evidence_relations": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition"
  },
  {
    "id": "Medical-f7e69032",
    "source": "Medical",
    "question": "Which genetic alterations are risk factors for rectal cancer?",
    "answer": "Lynch syndrome and familial adenomatous polyposis (FAP) are risk factors for rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lynch syndrome is a risk factor for rectal cancer.",
      "Familial adenomatous polyposis (FAP) is a risk factor for rectal cancer."
    ],
    "evidence_relations": "Lynch syndrome is a genetic risk factor for rectal cancer; Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
  },
  {
    "id": "Medical-4361d3ae",
    "source": "Medical",
    "question": "What surveillance methods are used after T1 rectal tumor resection?",
    "answer": "Flexible sigmoidoscopy every 6 months for 5 years and imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5 are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Flexible sigmoidoscopy is performed every 6 months for 5 years after T1 rectal tumor resection.",
      "Imaging (EUS or MRI) is performed every 3-6 months for 2 years after T1 rectal tumor resection.",
      "Imaging (EUS or MRI) is performed every 6 months through year 5 after T1 rectal tumor resection."
    ],
    "evidence_relations": "Flexible sigmoidoscopy every 6 months for 5 years; Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5"
  },
  {
    "id": "Medical-43c23661",
    "source": "Medical",
    "question": "Which diagnostic methods are listed for rectal cancer?",
    "answer": "Diagnostic methods include MRI, endorectal ultrasound (EUS), CT scan, flexible sigmoidoscopy, colonoscopy, and CEA blood test.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for rectal cancer include MRI.",
      "Diagnostic methods for rectal cancer include endorectal ultrasound (EUS).",
      "Diagnostic methods for rectal cancer include CT scan.",
      "Diagnostic methods for rectal cancer include flexible sigmoidoscopy.",
      "Diagnostic methods for rectal cancer include colonoscopy.",
      "Diagnostic methods for rectal cancer include CEA blood test."
    ],
    "evidence_relations": "MRI, Endorectal ultrasound (EUS), CT scan, Flexible sigmoidoscopy, Colonoscopy, CEA blood test"
  },
  {
    "id": "Medical-15f8d40a",
    "source": "Medical",
    "question": "Which surgical procedures are included in rectal cancer treatment?",
    "answer": "Surgical procedures include polypectomy, transanal local excision, transabdominal surgery, low anterior resection (LAR), and abdominoperineal resection (APR).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgical procedures for rectal cancer treatment include polypectomy.",
      "Surgical procedures for rectal cancer treatment include transanal local excision.",
      "Surgical procedures for rectal cancer treatment include transabdominal surgery.",
      "Surgical procedures for rectal cancer treatment include low anterior resection (LAR).",
      "Surgical procedures for rectal cancer treatment include abdominoperineal resection (APR)."
    ],
    "evidence_relations": "Surgical Procedure: Polypectomy, Transanal local excision, Transabdominal surgery, Low anterior resection (LAR), Abdominoperineal resection (APR)"
  },
  {
    "id": "Medical-9a4565c5",
    "source": "Medical",
    "question": "What is the recommended imaging for surveillance after local excision of rectal cancer?",
    "answer": "Imaging with EUS or MRI is recommended for surveillance after local excision.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging with EUS is recommended for surveillance after local excision of rectal cancer.",
      "Imaging with MRI is recommended for surveillance after local excision of rectal cancer."
    ],
    "evidence_relations": "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5"
  },
  {
    "id": "Medical-b7f57756",
    "source": "Medical",
    "question": "Which cancer subtypes are less common in bladder cancer?",
    "answer": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma is a less common subtype of bladder cancer.",
      "Adenocarcinoma is a less common subtype of bladder cancer.",
      "Small cell carcinoma is a less common subtype of bladder cancer."
    ],
    "evidence_relations": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer"
  },
  {
    "id": "Medical-aeb19c82",
    "source": "Medical",
    "question": "What is the greatest risk factor for bladder cancer?",
    "answer": "Smoking is the greatest risk factor for bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Smoking is the greatest risk factor for bladder cancer."
    ],
    "evidence_relations": "Smoking is the greatest risk factor for bladder cancer"
  },
  {
    "id": "Medical-7171cb7e",
    "source": "Medical",
    "question": "List other risk factors for bladder cancer besides smoking.",
    "answer": "Other risk factors include age, family history, Lynch syndrome, and chemical exposure.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Other risk factors for bladder cancer include age.",
      "Other risk factors for bladder cancer include family history.",
      "Other risk factors for bladder cancer include Lynch syndrome.",
      "Other risk factors for bladder cancer include chemical exposure."
    ],
    "evidence_relations": "Other risk factors include age, family history, Lynch syndrome, and chemical exposure"
  },
  {
    "id": "Medical-03cb5164",
    "source": "Medical",
    "question": "Name additional symptoms of bladder cancer.",
    "answer": "Other symptoms include frequent urination, urgency, painful urination, and back pain.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Other symptoms of bladder cancer include frequent urination.",
      "Other symptoms of bladder cancer include urgency.",
      "Other symptoms of bladder cancer include painful urination.",
      "Other symptoms of bladder cancer include back pain."
    ],
    "evidence_relations": "Other symptoms include frequent urination, urgency, painful urination, and back pain"
  },
  {
    "id": "Medical-5d4c9987",
    "source": "Medical",
    "question": "Which diagnostic methods are used for bladder cancer?",
    "answer": "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of bladder cancer involves cystoscopy.",
      "Diagnosis of bladder cancer involves urine cytology.",
      "Diagnosis of bladder cancer involves biopsy.",
      "Diagnosis of bladder cancer involves imaging.",
      "Imaging methods for bladder cancer diagnosis include CT.",
      "Imaging methods for bladder cancer diagnosis include MRI.",
      "Imaging methods for bladder cancer diagnosis include PET/CT.",
      "Imaging methods for bladder cancer diagnosis include ultrasound.",
      "Imaging methods for bladder cancer diagnosis include pyelogram.",
      "Imaging methods for bladder cancer diagnosis include urogram."
    ],
    "evidence_relations": "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)"
  },
  {
    "id": "Medical-a14ecb5b",
    "source": "Medical",
    "question": "What is the role of biomarker tests in bladder cancer?",
    "answer": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer."
    ],
    "evidence_relations": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer"
  },
  {
    "id": "Medical-7c3827b8",
    "source": "Medical",
    "question": "Which genetic alterations are associated with bladder cancer?",
    "answer": "Mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mutations in CDKN2A are associated with bladder cancer.",
      "Mutations in FGFR3 are associated with bladder cancer.",
      "Mutations in PIK3CA are associated with bladder cancer.",
      "Mutations in ERBB genes are associated with bladder cancer."
    ],
    "evidence_relations": "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer"
  },
  {
    "id": "Medical-87a9ce2a",
    "source": "Medical",
    "question": "What is the standard surgery for muscle-invasive bladder cancer?",
    "answer": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radical cystectomy is the standard surgery.",
      "Radical cystectomy is used for muscle-invasive bladder cancer."
    ],
    "evidence_relations": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer"
  },
  {
    "id": "Medical-a605930d",
    "source": "Medical",
    "question": "Name immunotherapy agents used in bladder cancer treatment.",
    "answer": "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunotherapy agents include pembrolizumab.",
      "Immunotherapy agents include nivolumab.",
      "Immunotherapy agents include avelumab.",
      "Immunotherapy agents include atezolizumab."
    ],
    "evidence_relations": "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab"
  },
  {
    "id": "Medical-b0dbdd5a",
    "source": "Medical",
    "question": "Which targeted therapies are available for bladder cancer?",
    "answer": "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev).",
      "Targeted therapies include erdafitinib (Balversa).",
      "Targeted therapies include sacituzumab govitecan-hziy (Trodelvy)."
    ],
    "evidence_relations": "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)"
  },
  {
    "id": "Medical-f14367b4",
    "source": "Medical",
    "question": "Are clinical trials available for bladder cancer patients?",
    "answer": "Clinical trials are available at all stages of bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are available for bladder cancer patients.",
      "Clinical trials are available at all stages of bladder cancer."
    ],
    "evidence_relations": "Clinical trials are available at all stages of bladder cancer"
  },
  {
    "id": "Medical-5c1d4e51",
    "source": "Medical",
    "question": "What are common side effects of bladder cancer treatment?",
    "answer": "Common side effects include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common side effects of bladder cancer treatment include bleeding.",
      "Common side effects of bladder cancer treatment include infection.",
      "Common side effects of bladder cancer treatment include sexual dysfunction.",
      "Common side effects of bladder cancer treatment include urinary incontinence.",
      "Common side effects of bladder cancer treatment include fatigue.",
      "Common side effects of bladder cancer treatment include nausea.",
      "Common side effects of bladder cancer treatment include diarrhea."
    ],
    "evidence_relations": "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea"
  },
  {
    "id": "Medical-0a1eb649",
    "source": "Medical",
    "question": "Which procedures are included in follow-up and surveillance for bladder cancer?",
    "answer": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are included in follow-up and surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Regular cystoscopy is included in follow-up and surveillance for bladder cancer.",
      "Urine cytology is included in follow-up and surveillance for bladder cancer.",
      "Imaging is included in follow-up and surveillance for bladder cancer.",
      "Biomarker surveillance is included in follow-up and surveillance for bladder cancer."
    ],
    "evidence_relations": "Follow-up/Surveillance: [Regular cystoscopy, Urine cytology, Imaging, Biomarker surveillance]"
  },
  {
    "id": "Medical-d44eb527",
    "source": "Medical",
    "question": "What are the main non-clear cell subtypes of RCC?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma are the main non-clear cell RCC subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Papillary RCC is a main non-clear cell subtype of RCC.",
      "Chromophobe RCC is a main non-clear cell subtype of RCC.",
      "Collecting duct RCC is a main non-clear cell subtype of RCC.",
      "Renal medullary carcinoma is a main non-clear cell subtype of RCC."
    ],
    "evidence_relations": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-37dbfdeb",
    "source": "Medical",
    "question": "Which kidney cancer type starts in the renal pelvis and ureter?",
    "answer": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Urothelial carcinoma starts in the cells lining the renal pelvis.",
      "Urothelial carcinoma starts in the cells lining the ureter."
    ],
    "evidence_relations": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter"
  },
  {
    "id": "Medical-490d56f2",
    "source": "Medical",
    "question": "What kidney cancer type arises from the blood vessels or connective tissue?",
    "answer": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Renal sarcoma starts in the blood vessels of the kidney.",
      "Renal sarcoma starts in the connective tissue of the kidney."
    ],
    "evidence_relations": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
  },
  {
    "id": "Medical-10f571cf",
    "source": "Medical",
    "question": "Name two anatomical structures in the kidney where cancer can spread locally.",
    "answer": "Kidney cancer can spread locally to surrounding fat and blood vessels.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Kidney cancer can spread locally to surrounding fat.",
      "Kidney cancer can spread locally to blood vessels."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-b8dfd72f",
    "source": "Medical",
    "question": "Which factors determine the treatment approach for RCC?",
    "answer": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment for RCC is based on histology.",
      "Treatment for RCC is based on tumor size.",
      "Treatment for RCC is based on tumor location.",
      "Treatment for RCC is based on presence of metastasis."
    ],
    "evidence_relations": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis"
  },
  {
    "id": "Medical-1e2c5da7",
    "source": "Medical",
    "question": "How are multiple tumors in one or both kidneys classified?",
    "answer": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Multiple tumors in one kidney are treated as separate primary tumors.",
      "Multiple tumors in both kidneys are treated as separate primary tumors.",
      "Multiple tumors in one or both kidneys are not considered metastasis."
    ],
    "evidence_relations": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis"
  },
  {
    "id": "Medical-a11058f1",
    "source": "Medical",
    "question": "Which anatomical structure is the origin of RCC according to the ontology?",
    "answer": "RCC originates from the renal tubules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "RCC originates from the renal tubules."
    ],
    "evidence_relations": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-a7da5e0d",
    "source": "Medical",
    "question": "What is a histological subtype of non-clear cell RCC?",
    "answer": "Papillary RCC is a histological subtype of non-clear cell RCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Papillary RCC is a histological subtype of non-clear cell RCC."
    ],
    "evidence_relations": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-823c7c4f",
    "source": "Medical",
    "question": "Which anatomical structure surrounds the kidney and can be invaded by cancer?",
    "answer": "Gerotas fascia surrounds the kidney and can be invaded by cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gerotas fascia surrounds the kidney.",
      "Gerotas fascia can be invaded by cancer."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-794ec19c",
    "source": "Medical",
    "question": "What is a potential local spread site for kidney cancer besides fat and vessels?",
    "answer": "Adrenal glands are a potential local spread site for kidney cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adrenal glands are a potential local spread site for kidney cancer."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-f0243613",
    "source": "Medical",
    "question": "Which RCC subtype can show sarcomatoid features?",
    "answer": "Sarcomatoid features can occur in any RCC subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Sarcomatoid features can occur in any RCC subtype."
    ],
    "evidence_relations": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
  },
  {
    "id": "Medical-974e88ba",
    "source": "Medical",
    "question": "Which cancer subtype is called nephroblastoma?",
    "answer": "Wilms tumor is also known as nephroblastoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Wilms tumor is also known as nephroblastoma."
    ],
    "evidence_relations": "Wilms tumor (nephroblastoma) is listed in the ontology"
  },
  {
    "id": "Medical-10a38986",
    "source": "Medical",
    "question": "Which kidney cancer arises from the connective tissue?",
    "answer": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Renal sarcoma starts in the blood vessels of the kidney.",
      "Renal sarcoma starts in the connective tissue of the kidney."
    ],
    "evidence_relations": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
  },
  {
    "id": "Medical-c7f55e00",
    "source": "Medical",
    "question": "What is the main anatomical structure involved in the origin of RCC?",
    "answer": "The renal tubules are the main anatomical structure involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The renal tubules are the main anatomical structure involved in the origin of RCC."
    ],
    "evidence_relations": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-d1937844",
    "source": "Medical",
    "question": "Which anatomical structure is a common site of distant metastasis from kidney cancer?",
    "answer": "The lungs are a common site of distant metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The lungs are a common site of distant metastasis from kidney cancer."
    ],
    "evidence_relations": "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain"
  },
  {
    "id": "Medical-ebc2f755",
    "source": "Medical",
    "question": "What is the relationship between tumor location and RCC treatment?",
    "answer": "Tumor location is a treatment factor for RCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor location is a treatment factor for RCC."
    ],
    "evidence_relations": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis"
  },
  {
    "id": "Medical-a653aa5d",
    "source": "Medical",
    "question": "What is the most common subtype of anal cancer?",
    "answer": "Anal squamous cell carcinoma is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Anal squamous cell carcinoma is the most common subtype of anal cancer."
    ],
    "evidence_relations": "Anal squamous cell carcinoma is the most common subtype of anal cancer"
  },
  {
    "id": "Medical-97813815",
    "source": "Medical",
    "question": "What chemotherapy regimens are recommended with radiation for anal cancer?",
    "answer": "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mitomycin and capecitabine are recommended chemotherapy regimens with radiation for anal cancer.",
      "Mitomycin and 5-FU are recommended chemotherapy regimens with radiation for anal cancer.",
      "5-FU and cisplatin are recommended chemotherapy regimens with radiation for anal cancer."
    ],
    "evidence_relations": "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin"
  },
  {
    "id": "Medical-0c7cb4ef",
    "source": "Medical",
    "question": "Which risk factor is shared by patients with a history of cervical, vulvar, or vaginal cancer or precancer?",
    "answer": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A history of cervical cancer increases anal cancer risk.",
      "A history of vulvar cancer increases anal cancer risk.",
      "A history of vaginal cancer increases anal cancer risk.",
      "A history of precancer increases anal cancer risk."
    ],
    "evidence_relations": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk"
  },
  {
    "id": "Medical-5fed2a2c",
    "source": "Medical",
    "question": "What is the recommended follow-up for complete remission after anal cancer treatment?",
    "answer": "Follow-up includes DRE and inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years (stage II/III).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for complete remission after anal cancer treatment includes DRE every 3-6 months for 5 years.",
      "Follow-up for complete remission after anal cancer treatment includes inguinal lymph node exam every 3-6 months for 5 years.",
      "Follow-up for complete remission after anal cancer treatment includes anoscopy every 6-12 months for 3 years.",
      "Follow-up for complete remission after anal cancer treatment includes imaging yearly for 3 years for stage II/III."
    ],
    "evidence_relations": "Complete remission: DRE every 3-6 months for 5 years, inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, imaging yearly for 3 years (stage II/III)"
  },
  {
    "id": "Medical-506ba6ee",
    "source": "Medical",
    "question": "Which chemotherapy regimens are used for metastatic anal cancer?",
    "answer": "Carboplatin and paclitaxel, FOLFOX, FOLFCIS, modified DCF, and 5-FU and cisplatin are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Carboplatin and paclitaxel are used for metastatic anal cancer.",
      "FOLFOX is used for metastatic anal cancer.",
      "FOLFCIS is used for metastatic anal cancer.",
      "Modified DCF is used for metastatic anal cancer.",
      "5-FU and cisplatin are used for metastatic anal cancer."
    ],
    "evidence_relations": "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)"
  },
  {
    "id": "Medical-63d09604",
    "source": "Medical",
    "question": "What precancerous lesions are associated with anal squamous cell carcinoma?",
    "answer": "AIN, LSIL, HSIL, and Stage 0 are precancerous lesions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AIN is a precancerous lesion associated with anal squamous cell carcinoma.",
      "LSIL is a precancerous lesion associated with anal squamous cell carcinoma.",
      "HSIL is a precancerous lesion associated with anal squamous cell carcinoma.",
      "Stage 0 is a precancerous lesion associated with anal squamous cell carcinoma."
    ],
    "evidence_relations": "Anal squamous cell carcinoma: Precancerous Lesion: [AIN, LSIL, HSIL, Stage 0]"
  },
  {
    "id": "Medical-481c27a3",
    "source": "Medical",
    "question": "What are the consequences of abdominoperineal resection (APR)?",
    "answer": "APR results in a permanent colostomy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Abdominoperineal resection (APR) results in a permanent colostomy."
    ],
    "evidence_relations": "APR results in a permanent colostomy"
  },
  {
    "id": "Medical-86f3ab3d",
    "source": "Medical",
    "question": "What is the definition of Stage I anal cancer according to the AJCC TNM system?",
    "answer": "Stage I: tumor 2 cm, no lymph node or distant spread.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage I anal cancer is defined as a tumor that is 2 cm or smaller.",
      "Stage I anal cancer has no lymph node spread.",
      "Stage I anal cancer has no distant spread."
    ],
    "evidence_relations": "Stage I: tumor 2 cm, no lymph node or distant spread"
  },
  {
    "id": "Medical-73b1e8c2",
    "source": "Medical",
    "question": "What is the indication for groin dissection in anal cancer?",
    "answer": "Groin dissection is indicated for lymph node recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Groin dissection is indicated for lymph node recurrence in anal cancer."
    ],
    "evidence_relations": "Groin dissection: Indication: Lymph node recurrence"
  },
  {
    "id": "Medical-912613b8",
    "source": "Medical",
    "question": "Which supportive care measures are provided for anal cancer patients?",
    "answer": "Supportive care includes pelvic floor physical therapy, dietary counseling, vaginal dilator therapy, ostomy care, mental health support, and peer-to-peer support.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care for anal cancer patients includes pelvic floor physical therapy.",
      "Supportive care for anal cancer patients includes dietary counseling.",
      "Supportive care for anal cancer patients includes vaginal dilator therapy.",
      "Supportive care for anal cancer patients includes ostomy care.",
      "Supportive care for anal cancer patients includes mental health support.",
      "Supportive care for anal cancer patients includes peer-to-peer support."
    ],
    "evidence_relations": "Supportive Care: [Pelvic floor physical therapy, Dietary counseling, Vaginal dilator therapy, Ostomy care, Mental health support, Peer-to-peer support]"
  },
  {
    "id": "Medical-ea7aec7d",
    "source": "Medical",
    "question": "What are common side effects of anal cancer treatment?",
    "answer": "Common side effects include infertility, bowel dysfunction, urinary incontinence, sexual dysfunction, hand-foot syndrome, nausea, vomiting, diarrhea, fatigue, skin irritation, mucositis, low blood cell counts, hearing loss (cisplatin), and neuropathy (oxaliplatin).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common side effects of anal cancer treatment include infertility.",
      "Common side effects of anal cancer treatment include bowel dysfunction.",
      "Common side effects of anal cancer treatment include urinary incontinence.",
      "Common side effects of anal cancer treatment include sexual dysfunction.",
      "Common side effects of anal cancer treatment include hand-foot syndrome.",
      "Common side effects of anal cancer treatment include nausea.",
      "Common side effects of anal cancer treatment include vomiting.",
      "Common side effects of anal cancer treatment include diarrhea.",
      "Common side effects of anal cancer treatment include fatigue.",
      "Common side effects of anal cancer treatment include skin irritation.",
      "Common side effects of anal cancer treatment include mucositis.",
      "Common side effects of anal cancer treatment include low blood cell counts.",
      "Common side effects of anal cancer treatment include hearing loss due to cisplatin.",
      "Common side effects of anal cancer treatment include neuropathy due to oxaliplatin."
    ],
    "evidence_relations": "Side Effect: [Infertility, Bowel dysfunction, Urinary incontinence, Sexual dysfunction, Hand-foot syndrome, Nausea, Vomiting, Diarrhea, Fatigue, Skin irritation, Mucositis, Low blood cell counts, Hearing loss (cisplatin), Neuropathy (oxaliplatin)]"
  },
  {
    "id": "Medical-4c1f9dd4",
    "source": "Medical",
    "question": "Which patients are eligible for clinical trials in anal cancer?",
    "answer": "All patients are encouraged to consider enrollment in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All patients are encouraged to consider enrollment in clinical trials for anal cancer."
    ],
    "evidence_relations": "Clinical trials are recommended for all patients if available"
  },
  {
    "id": "Medical-f3817e3b",
    "source": "Medical",
    "question": "What is the standard method for diagnosing anal cancer after abnormal DRE or anoscopy?",
    "answer": "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE.",
      "Anal cancer is diagnosed by biopsy after abnormal findings on anoscopy."
    ],
    "evidence_relations": "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy"
  },
  {
    "id": "Medical-0eed4fb2",
    "source": "Medical",
    "question": "What is the primary cancer type described in this context?",
    "answer": "Acute lymphoblastic leukemia (ALL) is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary cancer type described is acute lymphoblastic leukemia (ALL)."
    ],
    "evidence_relations": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-abe5fc71",
    "source": "Medical",
    "question": "Which cells are the origin of ALL?",
    "answer": "ALL arises from lymphoid progenitor cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute lymphoblastic leukemia (ALL) arises from lymphoid progenitor cells."
    ],
    "evidence_relations": "ALL arises from lymphoid progenitor cells"
  },
  {
    "id": "Medical-e87faed8",
    "source": "Medical",
    "question": "Which ALL subtype is more common?",
    "answer": "B-cell ALL (B-ALL) is more common than T-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "B-cell ALL (B-ALL) is more common than T-cell ALL (T-ALL)."
    ],
    "evidence_relations": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
  },
  {
    "id": "Medical-3eede906",
    "source": "Medical",
    "question": "What diagnostic threshold defines ALL based on bone marrow lymphoblasts?",
    "answer": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow."
    ],
    "evidence_relations": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow"
  },
  {
    "id": "Medical-b2e840c7",
    "source": "Medical",
    "question": "Which ALL subtype can cause an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) can cause an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell ALL (T-ALL) can cause an enlarged thymus."
    ],
    "evidence_relations": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-ce4f84f0",
    "source": "Medical",
    "question": "What is mature B-cell ALL also called?",
    "answer": "Mature B-cell ALL is also called Burkitt leukemia.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mature B-cell ALL is also called Burkitt leukemia."
    ],
    "evidence_relations": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-b58d9012",
    "source": "Medical",
    "question": "What is B-cell lymphoblastic lymphoma (B-LL/B-LBL)?",
    "answer": "B-cell lymphoblastic lymphoma occurs when B-cell lymphoblasts grow mostly in lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "B-cell lymphoblastic lymphoma occurs when B-cell lymphoblasts grow.",
      "B-cell lymphoblasts primarily grow in lymph nodes."
    ],
    "evidence_relations": "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes"
  },
  {
    "id": "Medical-1b8db6c8",
    "source": "Medical",
    "question": "What are the main treatment modalities for ALL?",
    "answer": "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Everyone with ALL is treated with steroids.",
      "Everyone with ALL is treated with multiagent chemotherapy."
    ],
    "evidence_relations": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-99cee2d0",
    "source": "Medical",
    "question": "Which ALL subtype is treated with therapies targeting the BCR::ABL protein?",
    "answer": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein."
    ],
    "evidence_relations": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
  },
  {
    "id": "Medical-dfc549c9",
    "source": "Medical",
    "question": "What is the preferred treatment approach for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL?",
    "answer": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are preferred for certain subtypes of ALL.",
      "Certain subtypes include BCR::ABL1-negative or BCR::ABL1-like B-ALL."
    ],
    "evidence_relations": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL"
  },
  {
    "id": "Medical-0b9d8142",
    "source": "Medical",
    "question": "What are the treatment options for T-ALL?",
    "answer": "T-ALL treatment options include chemotherapy and clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-ALL treatment options include chemotherapy.",
      "T-ALL treatment options include clinical trials."
    ],
    "evidence_relations": "T-ALL treatment options include chemotherapy and clinical trials"
  },
  {
    "id": "Medical-3c195424",
    "source": "Medical",
    "question": "What are common symptoms of ALL?",
    "answer": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of ALL may include anemia.",
      "Symptoms of ALL may include infections.",
      "Symptoms of ALL may include bleeding.",
      "Symptoms of ALL may include enlarged lymph nodes.",
      "Symptoms of ALL may include organ involvement."
    ],
    "evidence_relations": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement"
  },
  {
    "id": "Medical-06ecb1df",
    "source": "Medical",
    "question": "What are some risk factors for developing ALL?",
    "answer": "Risk factors for ALL include certain genetic syndromes and family history.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for developing ALL include certain genetic syndromes.",
      "Risk factors for developing ALL include family history."
    ],
    "evidence_relations": "Risk factors for ALL include certain genetic syndromes and family history"
  },
  {
    "id": "Medical-612b302a",
    "source": "Medical",
    "question": "What supportive care should be considered before ALL treatment?",
    "answer": "Fertility preservation should be considered before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation should be considered before ALL treatment."
    ],
    "evidence_relations": "Fertility preservation should be considered before treatment"
  },
  {
    "id": "Medical-5496bd62",
    "source": "Medical",
    "question": "What is included in follow-up for ALL patients?",
    "answer": "Follow-up includes regular blood tests and surveillance for relapse.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for ALL patients includes regular blood tests.",
      "Follow-up for ALL patients includes surveillance for relapse."
    ],
    "evidence_relations": "Follow-up includes regular blood tests and surveillance for relapse"
  },
  {
    "id": "Medical-30093110",
    "source": "Medical",
    "question": "Which organs may show involvement in ALL besides bone marrow?",
    "answer": "ALL may involve blood, lymph nodes, thymus, testicles, and central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL may involve blood.",
      "ALL may involve lymph nodes.",
      "ALL may involve thymus.",
      "ALL may involve testicles.",
      "ALL may involve central nervous system."
    ],
    "evidence_relations": "ALL can be found in bone marrow, blood, testicles, and central nervous system"
  },
  {
    "id": "Medical-a06b41f4",
    "source": "Medical",
    "question": "Which subtype of ALL is associated with an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) is associated with an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell ALL (T-ALL) is associated with an enlarged thymus."
    ],
    "evidence_relations": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-277e2774",
    "source": "Medical",
    "question": "What is the role of steroids in ALL treatment?",
    "answer": "Steroids are part of the standard multiagent chemotherapy for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Steroids are part of the standard multiagent chemotherapy for ALL."
    ],
    "evidence_relations": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-146a909f",
    "source": "Medical",
    "question": "Which subtype of pancreatic cancer is less common?",
    "answer": "Pancreatic neuroendocrine tumor is a less common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer."
    ],
    "evidence_relations": "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer"
  },
  {
    "id": "Medical-69adc0f1",
    "source": "Medical",
    "question": "How is Stage II pancreatic cancer defined?",
    "answer": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage II pancreatic cancer is defined by a tumor larger than 4 cm.",
      "Stage II pancreatic cancer may have spread to 1-3 nearby lymph nodes."
    ],
    "evidence_relations": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes"
  },
  {
    "id": "Medical-62915cf3",
    "source": "Medical",
    "question": "Which hereditary syndromes increase the risk of pancreatic cancer?",
    "answer": "HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HBOC increases the risk of pancreatic cancer.",
      "Peutz-Jeghers syndrome increases the risk of pancreatic cancer.",
      "Lynch syndrome increases the risk of pancreatic cancer.",
      "Li-Fraumeni syndrome increases the risk of pancreatic cancer.",
      "FAMMM syndrome increases the risk of pancreatic cancer.",
      "Hereditary pancreatitis increases the risk of pancreatic cancer."
    ],
    "evidence_relations": "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer"
  },
  {
    "id": "Medical-73631aaa",
    "source": "Medical",
    "question": "What symptom may indicate pancreatic cancer?",
    "answer": "Jaundice (yellowed skin or eyes) may indicate pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Jaundice may indicate pancreatic cancer.",
      "Jaundice is characterized by yellowed skin or eyes."
    ],
    "evidence_relations": "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)"
  },
  {
    "id": "Medical-ba2d6fae",
    "source": "Medical",
    "question": "Are clinical trials available for pancreatic cancer patients?",
    "answer": "Yes, clinical trials are available for pancreatic cancer patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are available for pancreatic cancer patients."
    ],
    "evidence_relations": "Clinical trials are available for pancreatic cancer patients"
  },
  {
    "id": "Medical-e947f2af",
    "source": "Medical",
    "question": "What is the role of supportive care in pancreatic cancer management?",
    "answer": "Supportive care is an important part of pancreatic cancer management.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care is an important part of pancreatic cancer management."
    ],
    "evidence_relations": "Supportive care is an important part of pancreatic cancer management"
  },
  {
    "id": "Medical-34cfff2d",
    "source": "Medical",
    "question": "Name a blood-based diagnostic method for pancreatic cancer.",
    "answer": "Blood test is a blood-based diagnostic method for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood test is a blood-based diagnostic method.",
      "Blood test is a diagnostic method for pancreatic cancer."
    ],
    "evidence_relations": "Blood test is listed as a Diagnostic Method for pancreatic cancer"
  },
  {
    "id": "Medical-33142c97",
    "source": "Medical",
    "question": "Which syndrome is characterized by increased risk of both melanoma and pancreatic cancer?",
    "answer": "Familial malignant melanoma syndrome (FAMMM syndrome) is associated with increased risk of both.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Familial malignant melanoma syndrome is associated with increased risk of melanoma.",
      "Familial malignant melanoma syndrome is associated with increased risk of pancreatic cancer."
    ],
    "evidence_relations": "Familial malignant melanoma syndrome, FAMMM syndrome, is listed under Genetic Syndrome increasing risk of pancreatic cancer"
  },
  {
    "id": "Medical-f7ffe25a",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this dataset?",
    "answer": "Prostate cancer is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Prostate cancer is the primary cancer type discussed in this dataset."
    ],
    "evidence_relations": "Prostate cancer is a disease where cells in the prostate gland grow out of control"
  },
  {
    "id": "Medical-83e047ca",
    "source": "Medical",
    "question": "What stage is regional prostate cancer classified as?",
    "answer": "Regional prostate cancer is classified as advanced-stage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Regional prostate cancer is classified as advanced-stage."
    ],
    "evidence_relations": "Regional prostate cancer has spread to nearby lymph nodes"
  },
  {
    "id": "Medical-c6d69844",
    "source": "Medical",
    "question": "For which patients is germline genetic testing recommended in prostate cancer?",
    "answer": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Germline genetic testing is recommended for patients with high-risk prostate cancer.",
      "Germline genetic testing is recommended for patients with very-high-risk prostate cancer.",
      "Germline genetic testing is recommended for patients with regional prostate cancer.",
      "Germline genetic testing is recommended for patients with metastatic prostate cancer."
    ],
    "evidence_relations": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer"
  },
  {
    "id": "Medical-78a954b5",
    "source": "Medical",
    "question": "What is the role of molecular biomarker testing in prostate cancer?",
    "answer": "Molecular biomarker testing helps assess risk and guide treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Molecular biomarker testing helps assess risk in prostate cancer.",
      "Molecular biomarker testing helps guide treatment decisions in prostate cancer."
    ],
    "evidence_relations": "Molecular biomarker testing helps assess risk and guide treatment decisions"
  },
  {
    "id": "Medical-ae01850d",
    "source": "Medical",
    "question": "Which grading systems are used to estimate prostate cancer aggressiveness?",
    "answer": "Grade Group and Gleason score are used to estimate aggressiveness.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Grade Group is used to estimate prostate cancer aggressiveness.",
      "Gleason score is used to estimate prostate cancer aggressiveness."
    ],
    "evidence_relations": "Grade Group and Gleason score are used to estimate cancer aggressiveness"
  },
  {
    "id": "Medical-261cef1d",
    "source": "Medical",
    "question": "What symptoms are associated with advanced prostate cancer?",
    "answer": "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of advanced prostate cancer include blood in urine.",
      "Symptoms of advanced prostate cancer include blood in semen.",
      "Symptoms of advanced prostate cancer include bone pain.",
      "Symptoms of advanced prostate cancer include weight loss.",
      "Symptoms of advanced prostate cancer include urinary symptoms."
    ],
    "evidence_relations": "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms"
  },
  {
    "id": "Medical-34a94dcc",
    "source": "Medical",
    "question": "Which diagnostic methods are used for localized prostate cancer?",
    "answer": "PSA test, digital rectal exam, biopsy, MRI, and ultrasound are used for localized prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The PSA test is used for localized prostate cancer.",
      "A digital rectal exam is used for localized prostate cancer.",
      "A biopsy is used for localized prostate cancer.",
      "MRI is used for localized prostate cancer.",
      "Ultrasound is used for localized prostate cancer."
    ],
    "evidence_relations": "Localized prostate cancer: Diagnostic Method: PSA test, Digital rectal exam, Biopsy, MRI, Ultrasound"
  },
  {
    "id": "Medical-ff590b8b",
    "source": "Medical",
    "question": "Which treatments are available for metastatic prostate cancer?",
    "answer": "Metastatic prostate cancer treatments include ADT, LHRH agonist/antagonist, chemotherapy, immunotherapy, targeted therapy, radiation therapy, and radiopharmaceuticals.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ADT is a treatment for metastatic prostate cancer.",
      "LHRH agonist/antagonist is a treatment for metastatic prostate cancer.",
      "Chemotherapy is a treatment for metastatic prostate cancer.",
      "Immunotherapy is a treatment for metastatic prostate cancer.",
      "Targeted therapy is a treatment for metastatic prostate cancer.",
      "Radiation therapy is a treatment for metastatic prostate cancer.",
      "Radiopharmaceuticals are a treatment for metastatic prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Treatment: Androgen deprivation therapy (ADT), LHRH agonist, LHRH antagonist, Leuprolide, Goserelin, Triptorelin, Degarelix, Relugolix, Bicalutamide, Flutamide, Nilutamide, Orchiectomy, Chemotherapy, Immunotherapy, Targeted therapy, Radiation therapy, Radiopharmaceuticals"
  },
  {
    "id": "Medical-f9135c63",
    "source": "Medical",
    "question": "Which genetic alterations are associated with metastatic prostate cancer?",
    "answer": "BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, and FANCA are associated with metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BRCA1 is associated with metastatic prostate cancer.",
      "BRCA2 is associated with metastatic prostate cancer.",
      "ATM is associated with metastatic prostate cancer.",
      "CHEK2 is associated with metastatic prostate cancer.",
      "MLH1 is associated with metastatic prostate cancer.",
      "MSH2 is associated with metastatic prostate cancer.",
      "MSH6 is associated with metastatic prostate cancer.",
      "PALB2 is associated with metastatic prostate cancer.",
      "PMS2 is associated with metastatic prostate cancer.",
      "FANCA is associated with metastatic prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA"
  },
  {
    "id": "Medical-677867c1",
    "source": "Medical",
    "question": "Which blood and urine biomarker tests are used in prostate cancer diagnosis?",
    "answer": "4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, and SelectMDx are used for biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "4Kscore is used for biomarker testing in prostate cancer diagnosis.",
      "PHI is used for biomarker testing in prostate cancer diagnosis.",
      "IsoPSA is used for biomarker testing in prostate cancer diagnosis.",
      "ExoDx is used for biomarker testing in prostate cancer diagnosis.",
      "miR Sentinel is used for biomarker testing in prostate cancer diagnosis.",
      "MPS is used for biomarker testing in prostate cancer diagnosis.",
      "PCA3 is used for biomarker testing in prostate cancer diagnosis.",
      "SelectMDx is used for biomarker testing in prostate cancer diagnosis."
    ],
    "evidence_relations": "Blood and urine biomarker tests (4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, SelectMDx)"
  },
  {
    "id": "Medical-babba8f2",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy for patients on active surveillance?",
    "answer": "Repeat biopsy and regular PSA testing are recommended for active surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Repeat biopsy is recommended for patients on active surveillance.",
      "Regular PSA testing is recommended for patients on active surveillance."
    ],
    "evidence_relations": "Follow-up Strategy: Repeat biopsy for active surveillance, Regular PSA testing"
  },
  {
    "id": "Medical-a45d778d",
    "source": "Medical",
    "question": "Which risk group classification guides prognosis and treatment decisions?",
    "answer": "Very low, low, intermediate, high, and very high risk groups guide prognosis and treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Very low risk group guides prognosis and treatment decisions.",
      "Low risk group guides prognosis and treatment decisions.",
      "Intermediate risk group guides prognosis and treatment decisions.",
      "High risk group guides prognosis and treatment decisions.",
      "Very high risk group guides prognosis and treatment decisions."
    ],
    "evidence_relations": "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment"
  },
  {
    "id": "Medical-a0e852ec",
    "source": "Medical",
    "question": "Which treatment is a surgical option for advanced prostate cancer?",
    "answer": "Orchiectomy is a surgical option for advanced prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Orchiectomy is a surgical option for advanced prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Treatment: Orchiectomy"
  },
  {
    "id": "Medical-8a3d6beb",
    "source": "Medical",
    "question": "What is a common symptom of prostate cancer that affects sexual function?",
    "answer": "Erectile dysfunction is a common symptom affecting sexual function.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Erectile dysfunction is a common symptom of prostate cancer.",
      "Erectile dysfunction affects sexual function."
    ],
    "evidence_relations": "Symptom: Erectile dysfunction"
  },
  {
    "id": "Medical-bbe1e6e4",
    "source": "Medical",
    "question": "Which demographic factor increases prostate cancer risk?",
    "answer": "Black race increases the risk of prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Black race increases the risk of prostate cancer."
    ],
    "evidence_relations": "Risk Factor: Black race"
  },
  {
    "id": "Medical-fec61a48",
    "source": "Medical",
    "question": "Which dietary habits are considered risk factors for prostate cancer?",
    "answer": "High-fat diet and low fruit and vegetable intake are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A high-fat diet is a risk factor for prostate cancer.",
      "Low fruit and vegetable intake is a risk factor for prostate cancer."
    ],
    "evidence_relations": "Risk Factor: High-fat diet, Low fruit and vegetable intake"
  },
  {
    "id": "Medical-2eb79e75",
    "source": "Medical",
    "question": "What is the main hormonal therapy for advanced prostate cancer?",
    "answer": "Androgen deprivation therapy (ADT) is the main hormonal therapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Androgen deprivation therapy (ADT) is the main hormonal therapy for advanced prostate cancer."
    ],
    "evidence_relations": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
  },
  {
    "id": "Medical-338ef222",
    "source": "Medical",
    "question": "What is the most common type of adrenal gland tumor?",
    "answer": "Adenoma is the most common type of adrenal gland tumor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma is the most common type of adrenal gland tumor."
    ],
    "evidence_relations": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-29777a9b",
    "source": "Medical",
    "question": "Which adrenal tumor arises from the adrenal cortex and is malignant?",
    "answer": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex."
    ],
    "evidence_relations": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex"
  },
  {
    "id": "Medical-d909a766",
    "source": "Medical",
    "question": "Which adrenal tumor is associated with Cushing syndrome?",
    "answer": "Adenoma producing excess cortisol causes Cushing syndrome.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma producing excess cortisol causes Cushing syndrome."
    ],
    "evidence_relations": "Adenoma producing excess cortisol causes Cushing syndrome"
  },
  {
    "id": "Medical-133462dd",
    "source": "Medical",
    "question": "Which diagnostic methods are used to detect hormone secretion by adrenal tumors?",
    "answer": "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used to detect hormone secretion by adrenal tumors.",
      "Biochemical tests are used to detect hormone secretion by adrenal tumors."
    ],
    "evidence_relations": "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors"
  },
  {
    "id": "Medical-df3d2ccc",
    "source": "Medical",
    "question": "What are common symptoms of adrenocortical carcinoma?",
    "answer": "Symptoms of adrenocortical carcinoma include weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of adrenocortical carcinoma include weight gain.",
      "Common symptoms of adrenocortical carcinoma include muscle weakness.",
      "Common symptoms of adrenocortical carcinoma include pink or purple stretch marks.",
      "Common symptoms of adrenocortical carcinoma include excess facial hair.",
      "Common symptoms of adrenocortical carcinoma include hair loss on the head.",
      "Common symptoms of adrenocortical carcinoma include irregular periods.",
      "Common symptoms of adrenocortical carcinoma include enlarged breast tissue.",
      "Common symptoms of adrenocortical carcinoma include shrinking testicles.",
      "Common symptoms of adrenocortical carcinoma include nausea.",
      "Common symptoms of adrenocortical carcinoma include vomiting.",
      "Common symptoms of adrenocortical carcinoma include abdominal bloating.",
      "Common symptoms of adrenocortical carcinoma include back pain.",
      "Common symptoms of adrenocortical carcinoma include fever.",
      "Common symptoms of adrenocortical carcinoma include loss of appetite.",
      "Common symptoms of adrenocortical carcinoma include loss of weight without trying."
    ],
    "evidence_relations": "Symptom of Adrenocortical Carcinoma (ACC) includes weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying"
  },
  {
    "id": "Medical-f14c7935",
    "source": "Medical",
    "question": "Which symptoms are commonly associated with pheochromocytoma?",
    "answer": "Symptoms of pheochromocytoma include high blood pressure, headache, rapid heartbeat, and sweating.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of pheochromocytoma include high blood pressure.",
      "Symptoms of pheochromocytoma include headache.",
      "Symptoms of pheochromocytoma include rapid heartbeat.",
      "Symptoms of pheochromocytoma include sweating."
    ],
    "evidence_relations": "Symptom of Pheochromocytoma includes high blood pressure, headache, rapid heartbeat, and sweating"
  },
  {
    "id": "Medical-32b97819",
    "source": "Medical",
    "question": "What is the main population at risk for adrenocortical carcinoma?",
    "answer": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adrenocortical carcinoma can occur at any age.",
      "Adrenocortical carcinoma is most likely in children under 5.",
      "Adrenocortical carcinoma is most likely in adults in their 40s and 50s."
    ],
    "evidence_relations": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s"
  },
  {
    "id": "Medical-c78a374e",
    "source": "Medical",
    "question": "Which adrenal tumor may metastasize to bones?",
    "answer": "Neuroblastoma may metastasize to bones.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Neuroblastoma may metastasize to bones."
    ],
    "evidence_relations": "Spread of Neuroblastoma: May metastasize to bones"
  },
  {
    "id": "Medical-7f86e4c5",
    "source": "Medical",
    "question": "What are the two functional categories of adenoma in the adrenal gland?",
    "answer": "Adenoma can be functioning or nonfunctioning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma can be functioning.",
      "Adenoma can be nonfunctioning."
    ],
    "evidence_relations": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-77bf9d25",
    "source": "Medical",
    "question": "What is the biomarker for cortisol-producing adenoma?",
    "answer": "Cortisol is the biomarker for cortisol-producing adenoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cortisol is the biomarker for cortisol-producing adenoma."
    ],
    "evidence_relations": "Biomarker of Cortisol-producing Adenoma: Cortisol"
  },
  {
    "id": "Medical-e171b56c",
    "source": "Medical",
    "question": "Which diagnostic methods are used for pheochromocytoma?",
    "answer": "Diagnostic methods for pheochromocytoma include CT scan, MRI scan, and biochemical test.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for pheochromocytoma include CT scan.",
      "Diagnostic methods for pheochromocytoma include MRI scan.",
      "Diagnostic methods for pheochromocytoma include biochemical test."
    ],
    "evidence_relations": "Diagnostic Method of Pheochromocytoma includes CT scan, MRI scan, Biochemical test"
  },
  {
    "id": "Medical-28728520",
    "source": "Medical",
    "question": "Which diagnostic methods are used for neuroblastoma?",
    "answer": "Diagnostic methods for neuroblastoma include imaging tests and biochemical test.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for neuroblastoma include imaging tests.",
      "Diagnostic methods for neuroblastoma include biochemical test."
    ],
    "evidence_relations": "Diagnostic Method of Neuroblastoma includes Imaging tests, Biochemical test"
  },
  {
    "id": "Medical-2085b009",
    "source": "Medical",
    "question": "What are some risk factors for adrenal tumors in general?",
    "answer": "Certain hereditary syndromes and family history increase the risk of adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Family history increases the risk of adrenal tumors."
    ],
    "evidence_relations": "Risk Factor for Adrenal Tumor includes Hereditary syndromes, Family history"
  },
  {
    "id": "Medical-57129a04",
    "source": "Medical",
    "question": "What subtype of breast cancer is characterized by cancer cells blocking lymph vessels in the skin?",
    "answer": "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels in the skin.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels.",
      "Inflammatory breast cancer (IBC) affects the skin."
    ],
    "evidence_relations": "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin"
  },
  {
    "id": "Medical-8df61619",
    "source": "Medical",
    "question": "Which stages of breast cancer are considered invasive?",
    "answer": "Stages I-III are invasive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stages I-III are considered invasive breast cancer."
    ],
    "evidence_relations": "Stages I-III are invasive breast cancer"
  },
  {
    "id": "Medical-d47d0c68",
    "source": "Medical",
    "question": "Which biomarkers are key for breast cancer?",
    "answer": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hormone receptor status (ER, PR) is a key biomarker for breast cancer.",
      "HER2 status is a key biomarker for breast cancer."
    ],
    "evidence_relations": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer"
  },
  {
    "id": "Medical-3e184ed2",
    "source": "Medical",
    "question": "Which mutation can be targeted with specific therapies in breast cancer?",
    "answer": "PIK3CA mutation can be targeted with specific therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PIK3CA mutation can be targeted with specific therapies in breast cancer."
    ],
    "evidence_relations": "PIK3CA mutation can be targeted with specific therapies"
  },
  {
    "id": "Medical-dd137889",
    "source": "Medical",
    "question": "Which biomarker status may influence immunotherapy options in breast cancer?",
    "answer": "MSI-H/dMMR status may influence immunotherapy options.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MSI-H/dMMR status may influence immunotherapy options in breast cancer."
    ],
    "evidence_relations": "MSI-H/dMMR status may influence immunotherapy options"
  },
  {
    "id": "Medical-03388322",
    "source": "Medical",
    "question": "Which biomarker may guide immunotherapy use in breast cancer?",
    "answer": "PD-L1 expression may guide immunotherapy use.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-L1 expression may guide immunotherapy use in breast cancer."
    ],
    "evidence_relations": "PD-L1 expression may guide immunotherapy use"
  },
  {
    "id": "Medical-1560f6ac",
    "source": "Medical",
    "question": "How is lymph node involvement assessed in breast cancer?",
    "answer": "Sentinel lymph node biopsy is used to assess lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Sentinel lymph node biopsy is used to assess lymph node involvement in breast cancer."
    ],
    "evidence_relations": "Sentinel lymph node biopsy is used to assess lymph node involvement"
  },
  {
    "id": "Medical-6c8055a7",
    "source": "Medical",
    "question": "Which therapy is used for hormone receptor-positive breast cancer?",
    "answer": "Endocrine therapy is used for hormone receptor-positive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Endocrine therapy is used for hormone receptor-positive breast cancer."
    ],
    "evidence_relations": "Endocrine therapy is used for hormone receptor-positive breast cancer"
  },
  {
    "id": "Medical-6fa265bc",
    "source": "Medical",
    "question": "What therapy is used for HER2-positive breast cancer?",
    "answer": "HER2-targeted therapy is used for HER2-positive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HER2-targeted therapy is used for HER2-positive breast cancer."
    ],
    "evidence_relations": "HER2-targeted therapy is used for HER2-positive breast cancer"
  },
  {
    "id": "Medical-6f086f1b",
    "source": "Medical",
    "question": "Which therapy is used for BRCA-mutated, HER2-negative breast cancer?",
    "answer": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer."
    ],
    "evidence_relations": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer"
  },
  {
    "id": "Medical-85ed509e",
    "source": "Medical",
    "question": "Which inhibitors are used for hormone receptor-positive, HER2-negative breast cancer?",
    "answer": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer."
    ],
    "evidence_relations": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer"
  },
  {
    "id": "Medical-869c8d57",
    "source": "Medical",
    "question": "What are common symptoms of breast cancer?",
    "answer": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of breast cancer include breast lump.",
      "Common symptoms of breast cancer include pain.",
      "Common symptoms of breast cancer include nipple discharge.",
      "Common symptoms of breast cancer include skin changes.",
      "Common symptoms of breast cancer include redness.",
      "Common symptoms of breast cancer include swelling.",
      "Common symptoms of breast cancer include peau dorange."
    ],
    "evidence_relations": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange"
  },
  {
    "id": "Medical-69eae99e",
    "source": "Medical",
    "question": "What are risk factors for breast cancer?",
    "answer": "Risk factors include family history, BRCA mutations, and being assigned female at birth.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for breast cancer include family history.",
      "Risk factors for breast cancer include BRCA mutations.",
      "Risk factors for breast cancer include being assigned female at birth."
    ],
    "evidence_relations": "Risk factors include family history, BRCA mutations, and being assigned female at birth"
  },
  {
    "id": "Medical-329de573",
    "source": "Medical",
    "question": "What should be discussed before starting breast cancer treatment regarding reproductive health?",
    "answer": "Fertility preservation should be discussed before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation should be discussed before starting breast cancer treatment."
    ],
    "evidence_relations": "Fertility preservation should be discussed before starting treatment"
  }
]